{"data": [{"edit_history_tweet_ids": ["1600967720123584512"], "text": "RT @profghjackson: #ASH22 a fabulous collection of abstracts and data from the @iStopMM team with practice changing data @sykristinsson #mm\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "profghjackson", "id": "1014890726818238465"}, {"start": 79, "end": 87, "username": "iStopMM", "id": "844232399319941122"}, {"start": 121, "end": 135, "username": "sykristinsson", "id": "3078258341"}], "hashtags": [{"start": 19, "end": 25, "tag": "ASH22"}], "annotations": [{"start": 20, "end": 24, "probability": 0.5711, "type": "Other", "normalized_text": "ASH22"}]}, "created_at": "2022-12-08T21:37:03.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1600763735995736064"}], "id": "1600967720123584512", "lang": "en", "conversation_id": "1600967720123584512", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1600667691198693377"], "text": "RT @sykristinsson: And here are all the abstracts from the @iStopMM study: https://t.co/nhswuksEfL", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}, {"start": 59, "end": 67, "username": "iStopMM", "id": "844232399319941122"}], "urls": [{"start": 75, "end": 98, "url": "https://t.co/nhswuksEfL", "expanded_url": "https://twitter.com/sykristinsson/status/1589629504422805506?s=20&t=g_0BgnWQYjXFx96LRgJKJg", "display_url": "twitter.com/sykristinsson/\u2026"}]}, "created_at": "2022-12-08T01:44:51.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1600544435825438720"}], "id": "1600667691198693377", "lang": "en", "conversation_id": "1600667691198693377", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1600667499825360896"], "text": "RT @ManniMD1: The title of my talk today to rheumatologists, we are already changing practice and minds as a result of the amazing work by\u2026", "entities": {"mentions": [{"start": 3, "end": 12, "username": "ManniMD1", "id": "1269642863924609025"}]}, "created_at": "2022-12-08T01:44:05.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1600545405540126720"}], "id": "1600667499825360896", "lang": "en", "conversation_id": "1600667499825360896", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1600667350822363136"], "text": "RT @sykristinsson: Here is my top list of interesting myeloma abstracts, mostly focusing on MGUS and smoldering, for #ASH22. I have include\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}], "hashtags": [{"start": 117, "end": 123, "tag": "ASH22"}], "annotations": [{"start": 54, "end": 60, "probability": 0.5873, "type": "Other", "normalized_text": "myeloma"}, {"start": 92, "end": 95, "probability": 0.5188, "type": "Other", "normalized_text": "MGUS"}, {"start": 118, "end": 122, "probability": 0.4984, "type": "Other", "normalized_text": "ASH22"}]}, "created_at": "2022-12-08T01:43:30.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1600544417827504144"}], "id": "1600667350822363136", "lang": "en", "conversation_id": "1600667350822363136", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1600125515548876800"], "text": "RT @sykristinsson: The @iStopMM team is very excited to present our findings at #ASH22\n\nPresentations from the study are, like before, prim\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}, {"start": 23, "end": 31, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 80, "end": 86, "tag": "ASH22"}], "annotations": [{"start": 81, "end": 85, "probability": 0.6608, "type": "Other", "normalized_text": "ASH22"}]}, "created_at": "2022-12-06T13:50:26.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1600123462827184128"}], "id": "1600125515548876800", "lang": "en", "conversation_id": "1600125515548876800", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1597242204191600640"], "text": "RT @Abdallah81MD: This large, prospective screening study negates the previously reported biological correlation between autoimmune disease\u2026", "entities": {"mentions": [{"start": 3, "end": 16, "username": "Abdallah81MD", "id": "1026947037080772610"}], "annotations": [{"start": 121, "end": 138, "probability": 0.661, "type": "Other", "normalized_text": "autoimmune disease"}]}, "created_at": "2022-11-28T14:53:11.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1595845251604049920"}], "id": "1597242204191600640", "lang": "en", "conversation_id": "1597242204191600640", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1592607132452814848"], "text": "RT @sykristinsson: Six years since the launch of the iStopMM study today!\n\nOn 11/15 2016, we invited all Icelanders &gt;40 years to participat\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}], "annotations": [{"start": 53, "end": 59, "probability": 0.7566, "type": "Other", "normalized_text": "iStopMM"}]}, "created_at": "2022-11-15T19:55:04.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1592604400178331648"}], "id": "1592607132452814848", "lang": "en", "conversation_id": "1592607132452814848", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1591919605328785408"], "text": "RT @sykristinsson: Thank you so much for choosing our abstract from the @iStopMM study @ManniMD1 !\n@eliaseythorsson has done a fantastic jo\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}, {"start": 72, "end": 80, "username": "iStopMM", "id": "844232399319941122"}, {"start": 87, "end": 96, "username": "ManniMD1", "id": "1269642863924609025"}, {"start": 99, "end": 115, "username": "eliaseythorsson", "id": "133109181"}]}, "created_at": "2022-11-13T22:23:05.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1591899435725987840"}], "id": "1591919605328785408", "lang": "en", "conversation_id": "1591919605328785408", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1591919579034718209"], "text": "RT @ManniMD1: 5. I may now be able to omit bone marrow biopsies as part of initial diagnostic workup for a larger set of patients with MGUS\u2026", "entities": {"mentions": [{"start": 3, "end": 12, "username": "ManniMD1", "id": "1269642863924609025"}], "annotations": [{"start": 135, "end": 138, "probability": 0.4373, "type": "Other", "normalized_text": "MGUS"}]}, "created_at": "2022-11-13T22:22:58.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1590440079591624705"}], "id": "1591919579034718209", "lang": "en", "conversation_id": "1591919579034718209", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1590005223942422529"], "text": "RT @BrunoPaiva_UNAV: @sykristinsson @iStopMM Amazing! And the best is yet to come. Congratulations Sigurdur and team", "entities": {"mentions": [{"start": 3, "end": 19, "username": "BrunoPaiva_UNAV", "id": "1335161063382376448"}, {"start": 21, "end": 35, "username": "sykristinsson", "id": "3078258341"}, {"start": 36, "end": 44, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 99, "end": 106, "probability": 0.462, "type": "Other", "normalized_text": "Sigurdur"}]}, "created_at": "2022-11-08T15:36:00.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1590004512202203136"}], "id": "1590005223942422529", "lang": "en", "conversation_id": "1590005223942422529", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1590004709330685952"], "text": "RT @mvmateos: @sykristinsson @iStopMM Congratulations!!!", "entities": {"mentions": [{"start": 3, "end": 12, "username": "mvmateos", "id": "2239926566"}, {"start": 14, "end": 28, "username": "sykristinsson", "id": "3078258341"}, {"start": 29, "end": 37, "username": "iStopMM", "id": "844232399319941122"}]}, "created_at": "2022-11-08T15:33:58.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1589967051887898624"}], "id": "1590004709330685952", "lang": "en", "conversation_id": "1590004709330685952", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1590004690934431748"], "text": "RT @Taha_CancerDoc: @sykristinsson @iStopMM Impressive work to move the field forward .. congrats to you and the team", "entities": {"mentions": [{"start": 3, "end": 18, "username": "Taha_CancerDoc", "id": "1098172293551927303"}, {"start": 20, "end": 34, "username": "sykristinsson", "id": "3078258341"}, {"start": 35, "end": 43, "username": "iStopMM", "id": "844232399319941122"}]}, "created_at": "2022-11-08T15:33:53.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1589978423816224768"}], "id": "1590004690934431748", "lang": "en", "conversation_id": "1590004690934431748", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1590004650635235328"], "text": "RT @Filippo_Bagnoli: Amazing amount and quality of data from the Icelander @iStopMM study! Kudos to authors", "entities": {"mentions": [{"start": 3, "end": 19, "username": "Filippo_Bagnoli", "id": "4833065482"}, {"start": 75, "end": 83, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 65, "end": 73, "probability": 0.6634, "type": "Other", "normalized_text": "Icelander"}]}, "created_at": "2022-11-08T15:33:44.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1589987324481658880"}], "id": "1590004650635235328", "lang": "en", "conversation_id": "1590004650635235328", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1590004619476103168"], "text": "RT @Mohty_EBMT: @sykristinsson @iStopMM Please keep going and advance this field. Congratulations for such huge achievements.", "entities": {"mentions": [{"start": 3, "end": 14, "username": "Mohty_EBMT", "id": "2626263112"}, {"start": 16, "end": 30, "username": "sykristinsson", "id": "3078258341"}, {"start": 31, "end": 39, "username": "iStopMM", "id": "844232399319941122"}]}, "created_at": "2022-11-08T15:33:36.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1589890786765975552"}], "id": "1590004619476103168", "lang": "en", "conversation_id": "1590004619476103168", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1589974836205727746"], "text": "RT @pathqbank: Really interesting set of abstracts from @iStopMM study", "entities": {"mentions": [{"start": 3, "end": 13, "username": "pathqbank", "id": "1243840145599717376"}, {"start": 56, "end": 64, "username": "iStopMM", "id": "844232399319941122"}]}, "created_at": "2022-11-08T13:35:15.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1589882859816644609"}], "id": "1589974836205727746", "lang": "en", "conversation_id": "1589974836205727746", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1589974818497376257"], "text": "RT @drKamarajk: Excellent summary of what to expect from #ASH2022 from @iStopMM looking forward to the talks #mmsm", "entities": {"mentions": [{"start": 3, "end": 14, "username": "drKamarajk", "id": "66791317"}, {"start": 71, "end": 79, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 57, "end": 65, "tag": "ASH2022"}, {"start": 109, "end": 114, "tag": "mmsm"}], "annotations": [{"start": 58, "end": 64, "probability": 0.6446, "type": "Other", "normalized_text": "ASH2022"}, {"start": 110, "end": 113, "probability": 0.3936, "type": "Other", "normalized_text": "mmsm"}]}, "created_at": "2022-11-08T13:35:11.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1589862212835110913"}], "id": "1589974818497376257", "lang": "en", "conversation_id": "1589974818497376257", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1589974785878261760"], "text": "RT @siddharthkunte: This is brilliant. The @iStopMM is redefining what we take for granted in #mgus! Congratulations to the entire team #mm\u2026", "entities": {"mentions": [{"start": 3, "end": 18, "username": "siddharthkunte", "id": "209212922"}, {"start": 43, "end": 51, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 94, "end": 99, "tag": "mgus"}], "annotations": [{"start": 95, "end": 98, "probability": 0.4961, "type": "Other", "normalized_text": "mgus"}]}, "created_at": "2022-11-08T13:35:03.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1589763561492221952"}], "id": "1589974785878261760", "lang": "en", "conversation_id": "1589974785878261760", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1589724593170042881"], "text": "RT @MarkBustoros: @sykristinsson @iStopMM Congrats Sigurdur and team! Very important topics &amp; abstracts! Look forward to seeing them all.", "entities": {"mentions": [{"start": 3, "end": 16, "username": "MarkBustoros", "id": "247910300"}, {"start": 18, "end": 32, "username": "sykristinsson", "id": "3078258341"}, {"start": 33, "end": 41, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 51, "end": 58, "probability": 0.4491, "type": "Person", "normalized_text": "Sigurdur"}]}, "created_at": "2022-11-07T21:00:53.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1589636265921896448"}], "id": "1589724593170042881", "lang": "en", "conversation_id": "1589724593170042881", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1589724567068516352"], "text": "RT @profBigG: @sykristinsson @iStopMM Fantastic achievement and well deserved", "entities": {"mentions": [{"start": 3, "end": 12, "username": "profBigG", "id": "767011956360347648"}, {"start": 14, "end": 28, "username": "sykristinsson", "id": "3078258341"}, {"start": 29, "end": 37, "username": "iStopMM", "id": "844232399319941122"}]}, "created_at": "2022-11-07T21:00:47.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1589637953361707008"}], "id": "1589724567068516352", "lang": "en", "conversation_id": "1589724567068516352", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1589724534264844288"], "text": "RT @rabonour1: @sykristinsson @iStopMM Congratulations. Amazing work", "entities": {"mentions": [{"start": 3, "end": 13, "username": "rabonour1", "id": "52923484"}, {"start": 15, "end": 29, "username": "sykristinsson", "id": "3078258341"}, {"start": 30, "end": 38, "username": "iStopMM", "id": "844232399319941122"}]}, "created_at": "2022-11-07T21:00:39.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1589643380472287234"}], "id": "1589724534264844288", "lang": "en", "conversation_id": "1589724534264844288", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1589724480532021248"], "text": "RT @MinnemaMonique: @sykristinsson @iStopMM Dear @sykristinsson and team, you really deliver such existing data sets! Congratulations!", "entities": {"mentions": [{"start": 3, "end": 18, "username": "MinnemaMonique", "id": "1108491138581872641"}, {"start": 20, "end": 34, "username": "sykristinsson", "id": "3078258341"}, {"start": 35, "end": 43, "username": "iStopMM", "id": "844232399319941122"}, {"start": 49, "end": 63, "username": "sykristinsson", "id": "3078258341"}]}, "created_at": "2022-11-07T21:00:26.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1589644934470316032"}], "id": "1589724480532021248", "lang": "en", "conversation_id": "1589724480532021248", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1589724208845639680"], "text": "RT @VincentRK: @sykristinsson @iStopMM You are ridiculously productive with a ridiculously productive trial. Congrats to you and your team\u2026", "entities": {"mentions": [{"start": 3, "end": 13, "username": "VincentRK", "id": "24261916"}, {"start": 15, "end": 29, "username": "sykristinsson", "id": "3078258341"}, {"start": 30, "end": 38, "username": "iStopMM", "id": "844232399319941122"}]}, "created_at": "2022-11-07T20:59:21.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1589699878753431552"}], "id": "1589724208845639680", "lang": "en", "conversation_id": "1589724208845639680", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1589724014825861120"], "text": "RT @HiraSMian: Visionary study with of course great results that will lead to changes in everyday clinical management in myeloma, excited t\u2026", "entities": {"mentions": [{"start": 3, "end": 13, "username": "HiraSMian", "id": "419595308"}], "annotations": [{"start": 121, "end": 127, "probability": 0.5759, "type": "Other", "normalized_text": "myeloma"}]}, "created_at": "2022-11-07T20:58:35.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1589638006876827648"}], "id": "1589724014825861120", "lang": "en", "conversation_id": "1589724014825861120", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1589723934240694273"], "text": "RT @rajshekharucms: Stellar abstract by @iStopMM showing \ud835\udc0d\ud835\udc28 association between MGUS and Autoimmune Disease, when MGUS detected by populati\u2026", "entities": {"mentions": [{"start": 3, "end": 18, "username": "rajshekharucms", "id": "140966169"}, {"start": 40, "end": 48, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 80, "end": 83, "probability": 0.5742, "type": "Other", "normalized_text": "MGUS"}, {"start": 89, "end": 106, "probability": 0.8519, "type": "Other", "normalized_text": "Autoimmune Disease"}, {"start": 114, "end": 117, "probability": 0.5824, "type": "Other", "normalized_text": "MGUS"}]}, "created_at": "2022-11-07T20:58:16.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1589712467927928832"}], "id": "1589723934240694273", "lang": "en", "conversation_id": "1589723934240694273", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1589631998968360961"], "text": "RT @sykristinsson: 4 orals, 6 posters, 1 educational and 2 Abstract achievement awards at #ASH22 from the @iStopMM study (w/9 different pre\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}, {"start": 106, "end": 114, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 90, "end": 96, "tag": "ASH22"}], "annotations": [{"start": 91, "end": 95, "probability": 0.6623, "type": "Other", "normalized_text": "ASH22"}]}, "created_at": "2022-11-07T14:52:57.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1589629504422805506"}], "id": "1589631998968360961", "lang": "en", "conversation_id": "1589631998968360961", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1588149288642789376"], "text": "RT @TheBindingSite: In the start of this month's iStopMM scientific discussions, S\u00e6mundur R\u00f6gnvaldsson \u2013 MD at the University of Iceland \u2013\u2026", "entities": {"mentions": [{"start": 3, "end": 18, "username": "TheBindingSite", "id": "321436678"}], "annotations": [{"start": 49, "end": 55, "probability": 0.3814, "type": "Organization", "normalized_text": "iStopMM"}, {"start": 81, "end": 101, "probability": 0.6757, "type": "Person", "normalized_text": "S\u00e6mundur R\u00f6gnvaldsson"}, {"start": 115, "end": 135, "probability": 0.9065, "type": "Organization", "normalized_text": "University of Iceland"}]}, "created_at": "2022-11-03T12:41:11.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1587716139420884993"}], "id": "1588149288642789376", "lang": "en", "conversation_id": "1588149288642789376", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1584472276493537280"], "text": "RT @TheBindingSite: The iStopMM study has been running since 2016 and continues to produce vital data.\n\nJon Porir Oskarsson - PhD candidate\u2026", "entities": {"mentions": [{"start": 3, "end": 18, "username": "TheBindingSite", "id": "321436678"}], "annotations": [{"start": 24, "end": 30, "probability": 0.5741, "type": "Other", "normalized_text": "iStopMM"}, {"start": 104, "end": 122, "probability": 0.8761, "type": "Person", "normalized_text": "Jon Porir Oskarsson"}]}, "created_at": "2022-10-24T09:10:03.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1584439548511064064"}], "id": "1584472276493537280", "lang": "en", "conversation_id": "1584472276493537280", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1583136278807474177"], "text": "RT @SaemundurMD: Last week I defended my PhD thesis: \n\u201cMonoclonal gammopathy of what significance?\u201d \n\nI\u2019m so proud of this work and so grat\u2026", "entities": {"mentions": [{"start": 3, "end": 15, "username": "SaemundurMD", "id": "1054784756704010241"}], "annotations": [{"start": 55, "end": 64, "probability": 0.4781, "type": "Other", "normalized_text": "Monoclonal"}]}, "created_at": "2022-10-20T16:41:16.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1582879446490841088"}], "id": "1583136278807474177", "lang": "en", "conversation_id": "1583136278807474177", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1583136230350680066"], "text": "RT @MarkBustoros: Great start of the full board morning session by the amazing @sykristinsson on the current results of @iStopMM study for\u2026", "entities": {"mentions": [{"start": 3, "end": 16, "username": "MarkBustoros", "id": "247910300"}, {"start": 79, "end": 93, "username": "sykristinsson", "id": "3078258341"}, {"start": 120, "end": 128, "username": "iStopMM", "id": "844232399319941122"}]}, "created_at": "2022-10-20T16:41:05.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1583104027398922240"}], "id": "1583136230350680066", "lang": "en", "conversation_id": "1583136230350680066", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1581202941582938113"], "text": "RT @VincentRK: The iStopMM trial will provide so much information on MGUS, SMM, and MM for years and decades to come. \n\nData from the trial\u2026", "entities": {"mentions": [{"start": 3, "end": 13, "username": "VincentRK", "id": "24261916"}], "annotations": [{"start": 19, "end": 25, "probability": 0.7078, "type": "Other", "normalized_text": "iStopMM"}, {"start": 69, "end": 72, "probability": 0.4782, "type": "Organization", "normalized_text": "MGUS"}, {"start": 75, "end": 77, "probability": 0.5621, "type": "Other", "normalized_text": "SMM"}, {"start": 84, "end": 85, "probability": 0.5733, "type": "Other", "normalized_text": "MM"}]}, "created_at": "2022-10-15T08:38:53.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1581077485340733441"}], "id": "1581202941582938113", "lang": "en", "conversation_id": "1581202941582938113", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1581202904882741249"], "text": "RT @VincentRK: Great Keynote lecture on Screening for MGUS by @sykristinsson at the AMN Meeting. Dr. Kristinsson is leading a nationwide ra\u2026", "entities": {"mentions": [{"start": 3, "end": 13, "username": "VincentRK", "id": "24261916"}, {"start": 62, "end": 76, "username": "sykristinsson", "id": "3078258341"}], "annotations": [{"start": 54, "end": 57, "probability": 0.4892, "type": "Organization", "normalized_text": "MGUS"}, {"start": 84, "end": 86, "probability": 0.434, "type": "Other", "normalized_text": "AMN"}, {"start": 101, "end": 111, "probability": 0.6635, "type": "Other", "normalized_text": "Kristinsson"}]}, "created_at": "2022-10-15T08:38:44.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1581072167315570689"}], "id": "1581202904882741249", "lang": "en", "conversation_id": "1581202904882741249", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1579926701177733120"], "text": "RT @sykristinsson: So proud of @SaemundurMD my PhD student who defended his thesis yesterday.  His performance was outstanding! Congratulat\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}, {"start": 31, "end": 43, "username": "SaemundurMD", "id": "1054784756704010241"}]}, "created_at": "2022-10-11T20:07:33.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1579925997155409920"}], "id": "1579926701177733120", "lang": "en", "conversation_id": "1579926701177733120", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1575089562514165761"], "text": "RT @aishaikh: @sykristinsson @iStopMM @MSK_Neph Congratulations on a very important study, relevant to hematology &amp; nephrology practice!\nTh\u2026", "entities": {"mentions": [{"start": 3, "end": 12, "username": "aishaikh", "id": "42107379"}, {"start": 14, "end": 28, "username": "sykristinsson", "id": "3078258341"}, {"start": 29, "end": 37, "username": "iStopMM", "id": "844232399319941122"}, {"start": 38, "end": 47, "username": "MSK_Neph", "id": "1462362881731743746"}], "annotations": [{"start": 120, "end": 129, "probability": 0.6578, "type": "Other", "normalized_text": "nephrology"}]}, "created_at": "2022-09-28T11:46:30.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1574755505486053382"}], "id": "1575089562514165761", "lang": "en", "conversation_id": "1575089562514165761", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1574680925643821056"], "text": "RT @MichaelJSlade: Interesting work from the phenomenal iStopMM group. This issue is that most EMRs (including Epic) don\u2019t support multiple\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "MichaelJSlade", "id": "626650397"}], "annotations": [{"start": 56, "end": 62, "probability": 0.8841, "type": "Other", "normalized_text": "iStopMM"}]}, "created_at": "2022-09-27T08:42:43.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1574576681238646785"}], "id": "1574680925643821056", "lang": "en", "conversation_id": "1574680925643821056", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1574680911685328896"], "text": "RT @andrewinnes007: These data needs to be reflected in lab normal ranges. Borderline raised SFLC is one of the commonest referral reasons\u2026", "entities": {"mentions": [{"start": 3, "end": 18, "username": "andrewinnes007", "id": "211982416"}], "annotations": [{"start": 93, "end": 96, "probability": 0.5244, "type": "Other", "normalized_text": "SFLC"}]}, "created_at": "2022-09-27T08:42:40.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1574644674773524481"}], "id": "1574680911685328896", "lang": "en", "conversation_id": "1574680911685328896", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1574680817133142016"], "text": "RT @aishaikh: New reference intervals for serum free light chains in CKD. Excited to discuss this study in an upcoming talk. It impacts LC-\u2026", "entities": {"mentions": [{"start": 3, "end": 12, "username": "aishaikh", "id": "42107379"}], "annotations": [{"start": 69, "end": 71, "probability": 0.4386, "type": "Other", "normalized_text": "CKD"}]}, "created_at": "2022-09-27T08:42:17.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1574539658989809670"}], "id": "1574680817133142016", "lang": "en", "conversation_id": "1574680817133142016", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1574680691958513664"], "text": "RT @HadidiSamer: Important paper suggesting a new normal range of serum free light chains in patients with chronic kidney disease  @iStopMM\u2026", "entities": {"mentions": [{"start": 3, "end": 15, "username": "HadidiSamer", "id": "774267564"}, {"start": 131, "end": 139, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 107, "end": 128, "probability": 0.7563, "type": "Other", "normalized_text": "chronic kidney disease"}]}, "created_at": "2022-09-27T08:41:47.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1574579084423663616"}], "id": "1574680691958513664", "lang": "en", "conversation_id": "1574680691958513664", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1574526680563347456"], "text": "RT @dikokaz: This is great for clinical practice so we can use objective cut points rather than guestimate in those with CKD. \n\nOf Note, fo\u2026", "entities": {"mentions": [{"start": 3, "end": 11, "username": "dikokaz", "id": "276053436"}], "annotations": [{"start": 121, "end": 123, "probability": 0.5093, "type": "Other", "normalized_text": "CKD"}]}, "created_at": "2022-09-26T22:29:48.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1574466576761245697"}], "id": "1574526680563347456", "lang": "en", "conversation_id": "1574526680563347456", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1574526589894737920"], "text": "RT @ecoladov: This should be practice-changing indeed. Overinterpreting FLC assays is not innocuous.", "entities": {"mentions": [{"start": 3, "end": 12, "username": "ecoladov", "id": "51187036"}], "annotations": [{"start": 72, "end": 74, "probability": 0.4162, "type": "Organization", "normalized_text": "FLC"}]}, "created_at": "2022-09-26T22:29:26.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1574492256748204032"}], "id": "1574526589894737920", "lang": "en", "conversation_id": "1574526589894737920", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1574526566322823172"], "text": "RT @Psbntn9: @Pathologists", "entities": {"mentions": [{"start": 3, "end": 11, "username": "Psbntn9", "id": "716254481"}, {"start": 13, "end": 26, "username": "Pathologists", "id": "24725678"}]}, "created_at": "2022-09-26T22:29:21.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1574493113854443536"}], "id": "1574526566322823172", "lang": "qam", "conversation_id": "1574526566322823172", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1574526547674947603"], "text": "RT @RamonGarciaSanz: \ud83d\udc4f\ud83d\udc4f\ud83d\udc4f", "entities": {"mentions": [{"start": 3, "end": 19, "username": "RamonGarciaSanz", "id": "846500919021899777"}]}, "created_at": "2022-09-26T22:29:16.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1574503605943443456"}], "id": "1574526547674947603", "lang": "art", "conversation_id": "1574526547674947603", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1574447970522644481"], "text": "RT @JillingtonC: The joy this brings me makes me really wonder if I need to get out more...", "entities": {"mentions": [{"start": 3, "end": 15, "username": "JillingtonC", "id": "757934840"}]}, "created_at": "2022-09-26T17:17:02.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1574432562285608960"}], "id": "1574447970522644481", "lang": "en", "conversation_id": "1574447970522644481", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1574447956845273088"], "text": "RT @KRakszawski: Definitely practice changing! I've already started to incorporate this in our MGUS/CKD referrals. #mmsm", "entities": {"mentions": [{"start": 3, "end": 15, "username": "KRakszawski", "id": "284694610"}], "hashtags": [{"start": 115, "end": 120, "tag": "mmsm"}], "annotations": [{"start": 95, "end": 98, "probability": 0.4389, "type": "Other", "normalized_text": "MGUS"}, {"start": 100, "end": 102, "probability": 0.4925, "type": "Other", "normalized_text": "CKD"}, {"start": 116, "end": 119, "probability": 0.3889, "type": "Other", "normalized_text": "mmsm"}]}, "created_at": "2022-09-26T17:16:59.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1574426253481820161"}], "id": "1574447956845273088", "lang": "en", "conversation_id": "1574447956845273088", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1574447946719977473"], "text": "RT @mtmdphd: #mmsm FLC", "entities": {"mentions": [{"start": 3, "end": 11, "username": "mtmdphd", "id": "190337035"}], "hashtags": [{"start": 13, "end": 18, "tag": "mmsm"}]}, "created_at": "2022-09-26T17:16:56.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1574425998589935618"}], "id": "1574447946719977473", "lang": "und", "conversation_id": "1574447946719977473", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1574423591273336837"], "text": "RT @sykristinsson: New definition for light chain MGUS! \n\nPractice changing: New ref values for free light chains (FLC), kappa+ lambda in p\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}], "annotations": [{"start": 50, "end": 53, "probability": 0.4335, "type": "Other", "normalized_text": "MGUS"}]}, "created_at": "2022-09-26T15:40:10.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1574422541711642625"}], "id": "1574423591273336837", "lang": "en", "conversation_id": "1574423591273336837", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1572613351657672705"], "text": "RT @VincentRK: The serum free light chain assay is important for diagnosis &amp; response assessment in MGUS, myeloma, AL amyloidosis. But the\u2026", "entities": {"mentions": [{"start": 3, "end": 13, "username": "VincentRK", "id": "24261916"}], "annotations": [{"start": 104, "end": 107, "probability": 0.3552, "type": "Other", "normalized_text": "MGUS"}, {"start": 110, "end": 116, "probability": 0.6495, "type": "Other", "normalized_text": "myeloma"}, {"start": 122, "end": 132, "probability": 0.5583, "type": "Other", "normalized_text": "amyloidosis"}]}, "created_at": "2022-09-21T15:46:55.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1572567061150433280"}], "id": "1572613351657672705", "lang": "en", "conversation_id": "1572613351657672705", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1571213319364661250"], "text": "RT @vhugo8762: IStopMm and sFLC! Great work by @sykristinsson team!", "entities": {"mentions": [{"start": 3, "end": 13, "username": "vhugo8762", "id": "114124641"}, {"start": 47, "end": 61, "username": "sykristinsson", "id": "3078258341"}], "annotations": [{"start": 15, "end": 21, "probability": 0.5729, "type": "Other", "normalized_text": "IStopMm"}, {"start": 27, "end": 30, "probability": 0.4677, "type": "Other", "normalized_text": "sFLC"}]}, "created_at": "2022-09-17T19:03:41.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1570762251484954632"}], "id": "1571213319364661250", "lang": "en", "conversation_id": "1571213319364661250", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1571213292051234817"], "text": "RT @Bloodman: Key paper - we got a lot of econsults for slightly abnormal light chains in people with impaired renal function.", "entities": {"mentions": [{"start": 3, "end": 12, "username": "Bloodman", "id": "16827782"}]}, "created_at": "2022-09-17T19:03:35.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1570945974805352449"}], "id": "1571213292051234817", "lang": "en", "conversation_id": "1571213292051234817", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1571213275156586498"], "text": "RT @steinhardtmax: This is gold for everyday decisions. FLC reference intervals (in mainly white population) without selection bias:", "created_at": "2022-09-17T19:03:31.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1571022556739796992"}], "id": "1571213275156586498", "lang": "en", "conversation_id": "1571213275156586498", "entities": {"annotations": [{"start": 56, "end": 58, "probability": 0.4633, "type": "Organization", "normalized_text": "FLC"}]}, "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1571213252956229635"], "text": "RT @JudithTrotman1: Fantastic. Now publish an update in a #nephrology journal to reduce the needless referrals.", "entities": {"mentions": [{"start": 3, "end": 18, "username": "JudithTrotman1", "id": "1687880251"}], "hashtags": [{"start": 58, "end": 69, "tag": "nephrology"}], "annotations": [{"start": 59, "end": 68, "probability": 0.7756, "type": "Other", "normalized_text": "nephrology"}]}, "created_at": "2022-09-17T19:03:25.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1571035404073324546"}], "id": "1571213252956229635", "lang": "en", "conversation_id": "1571213252956229635", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1571213234874597378"], "text": "RT @HemSandoval: Very important and useful paper for both #mmsm &amp; #nephrology. New reference intervals for the FLC ratio in pts with CKI ba\u2026", "entities": {"mentions": [{"start": 3, "end": 15, "username": "HemSandoval", "id": "4067920889"}], "hashtags": [{"start": 58, "end": 63, "tag": "mmsm"}, {"start": 70, "end": 81, "tag": "nephrology"}], "annotations": [{"start": 59, "end": 62, "probability": 0.5548, "type": "Other", "normalized_text": "mmsm"}, {"start": 71, "end": 80, "probability": 0.5298, "type": "Other", "normalized_text": "nephrology"}, {"start": 115, "end": 117, "probability": 0.4563, "type": "Other", "normalized_text": "FLC"}, {"start": 137, "end": 139, "probability": 0.357, "type": "Organization", "normalized_text": "CKI"}]}, "created_at": "2022-09-17T19:03:21.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1571130734311800834"}], "id": "1571213234874597378", "lang": "en", "conversation_id": "1571213234874597378", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1571213215106834432"], "text": "RT @kidney_boy: What's the normal kappa lambda free light chain ratio in CKD? @Amyloid_Planet", "entities": {"mentions": [{"start": 3, "end": 14, "username": "kidney_boy", "id": "18084746"}, {"start": 78, "end": 93, "username": "Amyloid_Planet", "id": "1138405094"}], "annotations": [{"start": 73, "end": 75, "probability": 0.5656, "type": "Other", "normalized_text": "CKD"}]}, "created_at": "2022-09-17T19:03:16.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1571206926314213376"}], "id": "1571213215106834432", "lang": "en", "conversation_id": "1571213215106834432", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1571130484595519500"], "text": "RT @thorirlong: Our paper were we redefine the reference intervals for serum FLCs and FLC ratio in individuals with chronic kidney disease\u2026", "entities": {"mentions": [{"start": 3, "end": 14, "username": "thorirlong", "id": "3009607268"}], "annotations": [{"start": 77, "end": 80, "probability": 0.6191, "type": "Other", "normalized_text": "FLCs"}, {"start": 86, "end": 88, "probability": 0.622, "type": "Other", "normalized_text": "FLC"}]}, "created_at": "2022-09-17T13:34:32.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1570755512580583424"}], "id": "1571130484595519500", "lang": "en", "conversation_id": "1571130484595519500", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1571130307256131589"], "text": "RT @eliaseythorsson: Another fabulous study by the @iStopMM team! The renal reference intervals are an important contribution that would be\u2026", "entities": {"mentions": [{"start": 3, "end": 19, "username": "eliaseythorsson", "id": "133109181"}, {"start": 51, "end": 59, "username": "iStopMM", "id": "844232399319941122"}]}, "created_at": "2022-09-17T13:33:50.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1570805698900135936"}], "id": "1571130307256131589", "lang": "en", "conversation_id": "1571130307256131589", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1571130245981573121"], "text": "RT @GMyelomaAN: Disease progression forms of MGUS and SMM are early stages of #myeloma \n@IMFmyeloma \u2018s @iStopMM project aims to prevent mye\u2026", "entities": {"mentions": [{"start": 3, "end": 14, "username": "GMyelomaAN", "id": "3083937603"}, {"start": 88, "end": 99, "username": "IMFmyeloma", "id": "34340707"}, {"start": 103, "end": 111, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 78, "end": 86, "tag": "myeloma"}], "annotations": [{"start": 45, "end": 48, "probability": 0.53, "type": "Other", "normalized_text": "MGUS"}, {"start": 54, "end": 56, "probability": 0.7154, "type": "Other", "normalized_text": "SMM"}, {"start": 79, "end": 85, "probability": 0.7516, "type": "Other", "normalized_text": "myeloma"}]}, "created_at": "2022-09-17T13:33:35.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1570727119180955648"}], "id": "1571130245981573121", "lang": "en", "conversation_id": "1571130245981573121", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1570597981606547458"], "text": "RT @sykristinsson: What a @iStopMM team! Congratulations @astrunhelga! Well deserved. \nAnd congrats to @Annakaren981 @SaemundurMD @SigrunTh\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}, {"start": 26, "end": 34, "username": "iStopMM", "id": "844232399319941122"}, {"start": 57, "end": 69, "username": "astrunhelga", "id": "2758432772"}, {"start": 103, "end": 116, "username": "Annakaren981", "id": "1268269154022436866"}, {"start": 117, "end": 129, "username": "SaemundurMD", "id": "1054784756704010241"}]}, "created_at": "2022-09-16T02:18:33.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1570515590418403328"}], "id": "1570597981606547458", "lang": "en", "conversation_id": "1570597981606547458", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1570597944029769729"], "text": "RT @SigrunThorstei1: Proud of our students at the #nmsg meeting presenting #iStopMM data and @astrunhelga winning best abstract! @Annakaren\u2026", "entities": {"mentions": [{"start": 3, "end": 19, "username": "SigrunThorstei1", "id": "1198917648630919168"}, {"start": 93, "end": 105, "username": "astrunhelga", "id": "2758432772"}], "hashtags": [{"start": 50, "end": 55, "tag": "nmsg"}, {"start": 75, "end": 83, "tag": "iStopMM"}], "annotations": [{"start": 51, "end": 54, "probability": 0.3991, "type": "Organization", "normalized_text": "nmsg"}, {"start": 76, "end": 82, "probability": 0.603, "type": "Other", "normalized_text": "iStopMM"}]}, "created_at": "2022-09-16T02:18:24.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1570470773609099264"}], "id": "1570597944029769729", "lang": "en", "conversation_id": "1570597944029769729", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1560343636822351873"], "text": "RT @VincentRK: @eliaseythorsson @iStopMM iStopMM is a fantastic study. It will yield important data for years to come.", "entities": {"mentions": [{"start": 3, "end": 13, "username": "VincentRK", "id": "24261916"}, {"start": 15, "end": 31, "username": "eliaseythorsson", "id": "133109181"}, {"start": 32, "end": 40, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 41, "end": 47, "probability": 0.8561, "type": "Other", "normalized_text": "iStopMM"}]}, "created_at": "2022-08-18T19:11:27.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1558530813167370246"}], "id": "1560343636822351873", "lang": "en", "conversation_id": "1560343636822351873", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1552366545355128832"], "text": "RT @sykristinsson: Join me at IMS 2022 where I will share some new findings from the @iStopMM study and discuss the role of early intervent\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}, {"start": 85, "end": 93, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 30, "end": 37, "probability": 0.6893, "type": "Other", "normalized_text": "IMS 2022"}]}, "created_at": "2022-07-27T18:53:20.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1552287402634448897"}], "id": "1552366545355128832", "lang": "en", "conversation_id": "1552366545355128832", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1535179588581588994"], "text": "RT @NorthTxMSG: \"If screening improves OS, we should, if it doesn't, we shouldn't\", \"please give me 2 more years. I'll give you the answer\"\u2026", "entities": {"mentions": [{"start": 3, "end": 14, "username": "NorthTxMSG", "id": "961409220"}], "annotations": [{"start": 39, "end": 40, "probability": 0.5663, "type": "Other", "normalized_text": "OS"}]}, "created_at": "2022-06-10T08:38:30.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1534441924760854528"}], "id": "1535179588581588994", "lang": "en", "conversation_id": "1535179588581588994", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1531391362817527811"], "text": "RT @VincentRK: 11) Does everyone have an MGUS phase before getting myeloma? \n\nYes. And usually MGUS phase is there for many years. The iSTO\u2026", "entities": {"mentions": [{"start": 3, "end": 13, "username": "VincentRK", "id": "24261916"}], "annotations": [{"start": 41, "end": 44, "probability": 0.5184, "type": "Other", "normalized_text": "MGUS"}, {"start": 67, "end": 73, "probability": 0.6482, "type": "Other", "normalized_text": "myeloma"}, {"start": 95, "end": 98, "probability": 0.4111, "type": "Other", "normalized_text": "MGUS"}, {"start": 135, "end": 138, "probability": 0.5509, "type": "Other", "normalized_text": "iSTO"}]}, "created_at": "2022-05-30T21:45:27.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1531290538300911619"}], "id": "1531391362817527811", "lang": "en", "conversation_id": "1531391362817527811", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1525044897513934848"], "text": "RT @MMTrials: Session 4: Plenary lectures Chair: Thierry Facon, France - Advances in WM, Steven Treon, USA -  \u2066@iStopMM\u2069 study \u2013 the impact\u2026", "entities": {"mentions": [{"start": 3, "end": 12, "username": "MMTrials", "id": "1450806488885248005"}, {"start": 111, "end": 119, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 49, "end": 61, "probability": 0.8283, "type": "Person", "normalized_text": "Thierry Facon"}, {"start": 64, "end": 69, "probability": 0.7188, "type": "Place", "normalized_text": "France"}, {"start": 89, "end": 100, "probability": 0.7621, "type": "Person", "normalized_text": "Steven Treon"}, {"start": 103, "end": 105, "probability": 0.8181, "type": "Place", "normalized_text": "USA"}]}, "created_at": "2022-05-13T09:26:52.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1524814264497844230"}], "id": "1525044897513934848", "lang": "en", "conversation_id": "1525044897513934848", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1525044792937299969"], "text": "RT @sykristinsson: The 8th World Congress on CONTROVERSIES IN MULTIPLE MYELOMA (COMy) starts tomorrow in Paris. 4 days of fantastic speaker\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}], "annotations": [{"start": 71, "end": 77, "probability": 0.8318, "type": "Place", "normalized_text": "MYELOMA"}, {"start": 105, "end": 109, "probability": 0.9863, "type": "Place", "normalized_text": "Paris"}]}, "created_at": "2022-05-13T09:26:27.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1524475535056900098"}], "id": "1525044792937299969", "lang": "en", "conversation_id": "1525044792937299969", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1523403687078424577"], "text": "RT @sykristinsson: We wrote a review on risk factors for MGUS: \n\n\"A common limitation to most previous studies on MGUS and its associations\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}], "annotations": [{"start": 57, "end": 60, "probability": 0.5957, "type": "Organization", "normalized_text": "MGUS"}, {"start": 114, "end": 117, "probability": 0.6239, "type": "Organization", "normalized_text": "MGUS"}]}, "created_at": "2022-05-08T20:45:17.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1523399429755383808"}], "id": "1523403687078424577", "lang": "en", "conversation_id": "1523403687078424577", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1523403646595084288"], "text": "RT @sykristinsson: \"... screening studies, such as @iStopMM  are pivotal when it comes to evaluation of the true biological- and epidemiolo\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}, {"start": 51, "end": 59, "username": "iStopMM", "id": "844232399319941122"}]}, "created_at": "2022-05-08T20:45:07.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1523399432565248002"}], "id": "1523403646595084288", "lang": "en", "conversation_id": "1523403646595084288", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1521608060724203528"], "text": "RT @sykristinsson: Next generation myeloma researchers! Congrats!\n\nMedical students @uni_iceland: @Annakaren981 (genetics in MM/SMM) and As\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}, {"start": 84, "end": 96, "username": "uni_iceland", "id": "2769866904"}, {"start": 98, "end": 111, "username": "Annakaren981", "id": "1268269154022436866"}], "annotations": [{"start": 35, "end": 41, "probability": 0.624, "type": "Other", "normalized_text": "myeloma"}, {"start": 128, "end": 130, "probability": 0.4425, "type": "Other", "normalized_text": "SMM"}]}, "created_at": "2022-05-03T21:50:06.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1521606851623849986"}], "id": "1521608060724203528", "lang": "en", "conversation_id": "1521608060724203528", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1520850652817207297"], "text": "RT @ManniMD1: So, in our quest to cure myeloma, will we medicalize large swathes of society, and diagnose them with diseases, that previous\u2026", "entities": {"mentions": [{"start": 3, "end": 12, "username": "ManniMD1", "id": "1269642863924609025"}], "annotations": [{"start": 39, "end": 45, "probability": 0.7387, "type": "Other", "normalized_text": "myeloma"}]}, "created_at": "2022-05-01T19:40:26.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1520793680864555008"}], "id": "1520850652817207297", "lang": "en", "conversation_id": "1520850652817207297", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1517235046050144257"], "text": "RT @angRchen: We just pub'd this article on the myeloma mystery - and how the study of an abnormal protein anomaly with a weird name, MGUS,\u2026", "entities": {"mentions": [{"start": 3, "end": 12, "username": "angRchen", "id": "2305549310"}], "annotations": [{"start": 48, "end": 54, "probability": 0.6858, "type": "Other", "normalized_text": "myeloma"}, {"start": 134, "end": 137, "probability": 0.3256, "type": "Organization", "normalized_text": "MGUS"}]}, "created_at": "2022-04-21T20:13:18.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1517181723431297024"}], "id": "1517235046050144257", "lang": "en", "conversation_id": "1517235046050144257", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1506605836851945474"], "text": "RT @IMFnurseMyeloma: Prevention would be SO nice!  @sykristinsson You can do this!  Talk about #MYelomaACTION #myeloma @IMFmyeloma", "entities": {"mentions": [{"start": 3, "end": 19, "username": "IMFnurseMyeloma", "id": "961398000"}, {"start": 51, "end": 65, "username": "sykristinsson", "id": "3078258341"}, {"start": 119, "end": 130, "username": "IMFmyeloma", "id": "34340707"}], "hashtags": [{"start": 95, "end": 109, "tag": "MYelomaACTION"}, {"start": 110, "end": 118, "tag": "myeloma"}], "annotations": [{"start": 96, "end": 108, "probability": 0.5737, "type": "Other", "normalized_text": "MYelomaACTION"}, {"start": 111, "end": 117, "probability": 0.7562, "type": "Other", "normalized_text": "myeloma"}]}, "created_at": "2022-03-23T12:16:37.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1506082804035170304"}], "id": "1506605836851945474", "lang": "en", "conversation_id": "1506605836851945474", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1504916163444232198"], "text": "RT @sykristinsson: I am so proud to be a @ERC_Research CoG grant recipient. We will build on the success of the @iStopMM and study smolderi\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}, {"start": 41, "end": 54, "username": "ERC_Research", "id": "467551928"}, {"start": 112, "end": 120, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 55, "end": 57, "probability": 0.6981, "type": "Other", "normalized_text": "CoG"}, {"start": 131, "end": 138, "probability": 0.5884, "type": "Other", "normalized_text": "smolderi"}]}, "created_at": "2022-03-18T20:22:28.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1504820397476401156"}], "id": "1504916163444232198", "lang": "en", "conversation_id": "1504916163444232198", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1504527420732411907"], "text": "RT @uni_iceland: Sigur\u00f0ur Yngvi Kristinsson @uni_iceland, was awarded a grant of EUR 2 million, from @ERC_Research to focus on smoldering m\u2026", "entities": {"mentions": [{"start": 3, "end": 15, "username": "uni_iceland", "id": "2769866904"}, {"start": 44, "end": 56, "username": "uni_iceland", "id": "2769866904"}, {"start": 101, "end": 114, "username": "ERC_Research", "id": "467551928"}], "annotations": [{"start": 17, "end": 42, "probability": 0.7199, "type": "Person", "normalized_text": "Sigur\u00f0ur Yngvi Kristinsson"}]}, "created_at": "2022-03-17T18:37:44.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1504421007704170497"}], "id": "1504527420732411907", "lang": "en", "conversation_id": "1504527420732411907", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1493673407619158021"], "text": "RT @MM_Hub: What were the key findings of the @iStopMM trial presented at #ASH21 this year? \ud83d\udcda Read this article for a summary  \ud83d\udc49 https://t.\u2026", "entities": {"mentions": [{"start": 3, "end": 10, "username": "MM_Hub", "id": "857866557778743296"}, {"start": 46, "end": 54, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 74, "end": 80, "tag": "ASH21"}], "annotations": [{"start": 75, "end": 79, "probability": 0.6092, "type": "Other", "normalized_text": "ASH21"}]}, "created_at": "2022-02-15T19:47:46.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1491789705188237314"}], "id": "1493673407619158021", "lang": "en", "conversation_id": "1493673407619158021", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1488161728693211141"], "text": "RT @profghjackson: Brilliant myeloma talks @HT_Medical post ASH meeting from Reuben Benjamin and @BygraveCeri car-t optimumm Bellini Endura\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "profghjackson", "id": "1014890726818238465"}, {"start": 43, "end": 54, "username": "HT_Medical", "id": "731773088"}, {"start": 97, "end": 109, "username": "BygraveCeri", "id": "1060196754367356928"}], "annotations": [{"start": 29, "end": 35, "probability": 0.492, "type": "Other", "normalized_text": "myeloma"}, {"start": 77, "end": 91, "probability": 0.6455, "type": "Person", "normalized_text": "Reuben Benjamin"}, {"start": 125, "end": 138, "probability": 0.5099, "type": "Other", "normalized_text": "Bellini Endura"}]}, "created_at": "2022-01-31T14:46:19.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1486651969028698119"}], "id": "1488161728693211141", "lang": "en", "conversation_id": "1488161728693211141", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1476296660267548678"], "text": "RT @IMFmyeloma: Prevalence of Smoldering Multiple Myeloma: Results from the iStopMM Study @iStopMM https://t.co/Na899FfnTy https://t.co/8zq\u2026", "entities": {"mentions": [{"start": 3, "end": 14, "username": "IMFmyeloma", "id": "34340707"}, {"start": 90, "end": 98, "username": "iStopMM", "id": "844232399319941122"}], "urls": [{"start": 99, "end": 122, "url": "https://t.co/Na899FfnTy", "expanded_url": "https://www.myeloma.org/videos/prevalence-smoldering-multiple-myeloma-results-istopmm-study", "display_url": "myeloma.org/videos/prevale\u2026", "status": 200, "unwound_url": "https://www.myeloma.org/videos/prevalence-smoldering-multiple-myeloma-results-istopmm-study"}], "annotations": [{"start": 50, "end": 56, "probability": 0.4087, "type": "Other", "normalized_text": "Myeloma"}, {"start": 76, "end": 82, "probability": 0.826, "type": "Other", "normalized_text": "iStopMM"}]}, "created_at": "2021-12-29T20:58:46.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1476244403291365379"}], "id": "1476296660267548678", "lang": "en", "conversation_id": "1476296660267548678", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1476296635223261184"], "text": "RT @IMFmyeloma: Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Po\u2026", "entities": {"mentions": [{"start": 3, "end": 14, "username": "IMFmyeloma", "id": "34340707"}]}, "created_at": "2021-12-29T20:58:40.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1476253209056497670"}], "id": "1476296635223261184", "lang": "en", "conversation_id": "1476296635223261184", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1475929652556439557"], "text": "RT @sykristinsson: We take the psychological aspects of screening very seriously in the @iStopMM study.\n\nWe checked mental health before sc\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}, {"start": 88, "end": 96, "username": "iStopMM", "id": "844232399319941122"}]}, "created_at": "2021-12-28T20:40:25.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1475928479539597328"}], "id": "1475929652556439557", "lang": "en", "conversation_id": "1475929652556439557", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1475789970661068804"], "text": "RT @ManniMD1: So if you\u2019ve noticed that the new @iStopMM study from #ASH21 changed the kappa/lambda light chain thresholds for patients wit\u2026", "entities": {"mentions": [{"start": 3, "end": 12, "username": "ManniMD1", "id": "1269642863924609025"}, {"start": 48, "end": 56, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 68, "end": 74, "tag": "ASH21"}], "annotations": [{"start": 69, "end": 73, "probability": 0.6972, "type": "Other", "normalized_text": "ASH21"}]}, "created_at": "2021-12-28T11:25:22.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1474540470944501762"}], "id": "1475789970661068804", "lang": "en", "conversation_id": "1475789970661068804", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1472659890703417349"], "text": "RT @sykristinsson: https://t.co/LOhwEA61MM", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}], "urls": [{"start": 19, "end": 42, "url": "https://t.co/LOhwEA61MM", "expanded_url": "https://twitter.com/sykristinsson/status/1472652466172878856/photo/1", "display_url": "pic.twitter.com/LOhwEA61MM", "media_key": "16_1472652390612488194"}]}, "created_at": "2021-12-19T20:07:33.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1472652466172878856"}], "id": "1472659890703417349", "lang": "zxx", "conversation_id": "1472659890703417349", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1472335704621568002"], "text": "RT @kaufman_MMdoc: Tell everyone https://t.co/835nF6csvJ", "entities": {"mentions": [{"start": 3, "end": 17, "username": "kaufman_MMdoc", "id": "4352079742"}], "urls": [{"start": 33, "end": 56, "url": "https://t.co/835nF6csvJ", "expanded_url": "https://twitter.com/kaufman_MMdoc/status/1472332348175929345/photo/1", "display_url": "pic.twitter.com/835nF6csvJ", "media_key": "3_1472332344916946945"}]}, "created_at": "2021-12-18T22:39:21.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1472332348175929345"}], "id": "1472335704621568002", "lang": "en", "conversation_id": "1472335704621568002", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1471180279381381120"], "text": "RT @Charanpreet_14: Myeloma\n1. New Light chain references in patients with renal dysfunction\nhttps://t.co/KpbZFjIySU\nRobust, large, populat\u2026", "entities": {"mentions": [{"start": 3, "end": 18, "username": "Charanpreet_14", "id": "1041722282"}], "urls": [{"start": 93, "end": 116, "url": "https://t.co/KpbZFjIySU", "expanded_url": "https://doi.org/10.1182/blood-2021-153827", "display_url": "doi.org/10.1182/blood-\u2026", "unwound_url": "https://doi.org/10.1182/blood-2021-153827"}], "annotations": [{"start": 20, "end": 26, "probability": 0.8718, "type": "Other", "normalized_text": "Myeloma"}, {"start": 117, "end": 122, "probability": 0.467, "type": "Other", "normalized_text": "Robust"}]}, "created_at": "2021-12-15T18:08:06.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1471127133485477888"}], "id": "1471180279381381120", "lang": "en", "conversation_id": "1471180279381381120", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1470905721655119873"], "text": "RT @BldCancerDoc: @sykristinsson @iStopMM @andriclausen @SigrunThorstei1 @SaemundurMD @thorirlong @ThorvardurL @asdisrosa78 @jthorir @Kjart\u2026", "entities": {"mentions": [{"start": 3, "end": 16, "username": "BldCancerDoc", "id": "2809497047"}, {"start": 18, "end": 32, "username": "sykristinsson", "id": "3078258341"}, {"start": 33, "end": 41, "username": "iStopMM", "id": "844232399319941122"}, {"start": 42, "end": 55, "username": "andriclausen", "id": "4501760296"}, {"start": 56, "end": 72, "username": "SigrunThorstei1", "id": "1198917648630919168"}, {"start": 73, "end": 85, "username": "SaemundurMD", "id": "1054784756704010241"}, {"start": 86, "end": 97, "username": "thorirlong", "id": "3009607268"}, {"start": 98, "end": 110, "username": "ThorvardurL", "id": "1199342830180651009"}, {"start": 111, "end": 123, "username": "asdisrosa78", "id": "3050942903"}, {"start": 124, "end": 132, "username": "jthorir", "id": "247118539"}]}, "created_at": "2021-12-14T23:57:06.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1470829030362562565"}], "id": "1470905721655119873", "lang": "en", "conversation_id": "1470905721655119873", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1470803429723357186"], "text": "RT @sykristinsson: What a fantastic #ASH21 we in the @iStopMM team have had! Thank you all for the great feedback on our very first abstrac\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}, {"start": 53, "end": 61, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 36, "end": 42, "tag": "ASH21"}], "annotations": [{"start": 37, "end": 41, "probability": 0.604, "type": "Other", "normalized_text": "ASH21"}]}, "created_at": "2021-12-14T17:10:38.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1470801920201736195"}], "id": "1470803429723357186", "lang": "en", "conversation_id": "1470803429723357186", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1470479454765862912"], "text": "RT @AuclairDan: Very good review by Dr. Wendy Cozen of the data presented at #ASH21 during the \u201cASH Advanced COVID Research 2021\u201d around ou\u2026", "entities": {"mentions": [{"start": 3, "end": 14, "username": "AuclairDan", "id": "817184467915853828"}], "hashtags": [{"start": 77, "end": 83, "tag": "ASH21"}], "annotations": [{"start": 40, "end": 50, "probability": 0.5664, "type": "Person", "normalized_text": "Wendy Cozen"}, {"start": 78, "end": 82, "probability": 0.5805, "type": "Other", "normalized_text": "ASH21"}, {"start": 96, "end": 127, "probability": 0.7423, "type": "Other", "normalized_text": "ASH Advanced COVID Research 2021"}]}, "created_at": "2021-12-13T19:43:16.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1470453840734564361"}], "id": "1470479454765862912", "lang": "en", "conversation_id": "1470479454765862912", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1470155766174781450"], "text": "RT @vhugo8762: Great presentation by the iStopMM group! Amazing work! #ASH21 @sykristinsson @iStopMM https://t.co/ZilGlNNvhu", "entities": {"mentions": [{"start": 3, "end": 13, "username": "vhugo8762", "id": "114124641"}, {"start": 77, "end": 91, "username": "sykristinsson", "id": "3078258341"}, {"start": 92, "end": 100, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 70, "end": 76, "tag": "ASH21"}], "urls": [{"start": 101, "end": 124, "url": "https://t.co/ZilGlNNvhu", "expanded_url": "https://twitter.com/vhugo8762/status/1470151722186121216/photo/1", "display_url": "pic.twitter.com/ZilGlNNvhu", "media_key": "3_1470151678380806144"}, {"start": 101, "end": 124, "url": "https://t.co/ZilGlNNvhu", "expanded_url": "https://twitter.com/vhugo8762/status/1470151722186121216/photo/1", "display_url": "pic.twitter.com/ZilGlNNvhu", "media_key": "3_1470151678363987971"}, {"start": 101, "end": 124, "url": "https://t.co/ZilGlNNvhu", "expanded_url": "https://twitter.com/vhugo8762/status/1470151722186121216/photo/1", "display_url": "pic.twitter.com/ZilGlNNvhu", "media_key": "3_1470151678372368385"}, {"start": 101, "end": 124, "url": "https://t.co/ZilGlNNvhu", "expanded_url": "https://twitter.com/vhugo8762/status/1470151722186121216/photo/1", "display_url": "pic.twitter.com/ZilGlNNvhu", "media_key": "3_1470151678372421632"}], "annotations": [{"start": 41, "end": 47, "probability": 0.7958, "type": "Other", "normalized_text": "iStopMM"}]}, "created_at": "2021-12-12T22:17:03.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1470151722186121216"}], "id": "1470155766174781450", "lang": "en", "conversation_id": "1470155766174781450", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1470155656363749377"], "text": "RT @MalinHultcrantz: New suggested renal reference intervals for kappa and lambda FLC -&gt; updated prevalence of light chain MGUS in individu\u2026", "entities": {"mentions": [{"start": 3, "end": 19, "username": "MalinHultcrantz", "id": "212681144"}], "annotations": [{"start": 126, "end": 129, "probability": 0.4161, "type": "Other", "normalized_text": "MGUS"}]}, "created_at": "2021-12-12T22:16:37.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1470152570740121602"}], "id": "1470155656363749377", "lang": "en", "conversation_id": "1470155656363749377", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1470144535212797952"], "text": "Oh, you thought we were only doing epidemiological studies. Think again!\nGo talk to @jthorir at his poster #2645 and he will tell you all about identifying circulating tumor plasma cells in screened MGUS/SMM/MM by flow (NGF) in @iStopMM @sykristinsson \nhttps://t.co/ydiCgLKiTE https://t.co/Z7Cgmb6U0j", "entities": {"mentions": [{"start": 84, "end": 92, "username": "jthorir", "id": "247118539"}, {"start": 228, "end": 236, "username": "iStopMM", "id": "844232399319941122"}, {"start": 237, "end": 251, "username": "sykristinsson", "id": "3078258341"}], "urls": [{"start": 253, "end": 276, "url": "https://t.co/ydiCgLKiTE", "expanded_url": "http://ash.confex.com/ash/2021/webprogram/Paper146363.html", "display_url": "ash.confex.com/ash/2021/webpr\u2026", "status": 200, "unwound_url": "https://ash.confex.com/ash/2021/webprogram/Paper146363.html"}, {"start": 277, "end": 300, "url": "https://t.co/Z7Cgmb6U0j", "expanded_url": "https://twitter.com/iStopMM/status/1470144535212797952/photo/1", "display_url": "pic.twitter.com/Z7Cgmb6U0j", "media_key": "3_1470144127312580611"}], "annotations": [{"start": 199, "end": 202, "probability": 0.5628, "type": "Other", "normalized_text": "MGUS"}, {"start": 204, "end": 206, "probability": 0.6453, "type": "Other", "normalized_text": "SMM"}, {"start": 208, "end": 209, "probability": 0.4729, "type": "Other", "normalized_text": "MM"}]}, "created_at": "2021-12-12T21:32:25.000Z", "author_id": "844232399319941122", "id": "1470144535212797952", "lang": "en", "conversation_id": "1470144535212797952", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1470129620913737736"], "text": "RT @vhugo8762: The highlight of ASh in many ways has been this iStopMM study! Congrats @sykristinsson #ASH21", "entities": {"mentions": [{"start": 3, "end": 13, "username": "vhugo8762", "id": "114124641"}, {"start": 87, "end": 101, "username": "sykristinsson", "id": "3078258341"}], "hashtags": [{"start": 102, "end": 108, "tag": "ASH21"}], "annotations": [{"start": 32, "end": 34, "probability": 0.5457, "type": "Other", "normalized_text": "ASh"}, {"start": 63, "end": 69, "probability": 0.7961, "type": "Other", "normalized_text": "iStopMM"}]}, "created_at": "2021-12-12T20:33:09.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1470127054288867328"}], "id": "1470129620913737736", "lang": "en", "conversation_id": "1470129620913737736", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1470125731049095175"], "text": "https://t.co/4GaOaXxKmY", "in_reply_to_user_id": "844232399319941122", "created_at": "2021-12-12T20:17:42.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "replied_to", "id": "1470125661457166340"}], "id": "1470125731049095175", "lang": "zxx", "conversation_id": "1470125661457166340", "entities": {"urls": [{"start": 0, "end": 23, "url": "https://t.co/4GaOaXxKmY", "expanded_url": "https://ash.confex.com/ash/2021/webprogram/Paper153827.html", "display_url": "ash.confex.com/ash/2021/webpr\u2026", "status": 200, "title": "Paper: Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on Iceland Screens Treats or Prevents Multiple Myeloma (iStopMM) Study", "description": "Program: Oral and Poster Abstracts Type: Oral Session: 652. Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological: Reoptimizing Standards and Redefining Approaches Hematology Disease Topics & Pathways: Adults, Workforce, Plasma Cell Disorders, Diversity, Equity, Inclusion, and Accessibility (DEI/DEIA) , Diseases, Real World Evidence, Lymphoid Malignancies, Study Population Thorir Einarsson Long, MD, PhD 1,2 *, Olafur Skuli Indridason, MD, MHS 3 *, Runolfur Palsson, MD 4,5 *, S\u00e6mundur", "unwound_url": "https://ash.confex.com/ash/2021/webprogram/Paper153827.html"}]}, "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1470125661457166340"], "text": "@thorirlong explains free light chain (FLC) values in individuals with renal dysfunction. Based on &gt;75000 @iStopMM participants, of which &gt;70000 had s-creatinine values, he is proposing new reference ranges for people with renal failure @TheBindingSite @IMFmyeloma @sykristinsson https://t.co/TH8rJa3302", "entities": {"mentions": [{"start": 0, "end": 11, "username": "thorirlong", "id": "3009607268"}, {"start": 109, "end": 117, "username": "iStopMM", "id": "844232399319941122"}, {"start": 243, "end": 258, "username": "TheBindingSite", "id": "321436678"}, {"start": 259, "end": 270, "username": "IMFmyeloma", "id": "34340707"}, {"start": 271, "end": 285, "username": "sykristinsson", "id": "3078258341"}], "urls": [{"start": 286, "end": 309, "url": "https://t.co/TH8rJa3302", "expanded_url": "https://twitter.com/iStopMM/status/1470125661457166340/photo/1", "display_url": "pic.twitter.com/TH8rJa3302", "media_key": "3_1470123657838178306"}], "annotations": [{"start": 39, "end": 41, "probability": 0.3217, "type": "Other", "normalized_text": "FLC"}]}, "in_reply_to_user_id": "3009607268", "created_at": "2021-12-12T20:17:25.000Z", "author_id": "844232399319941122", "id": "1470125661457166340", "lang": "en", "conversation_id": "1470125661457166340", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1470123610216054787"], "text": "RT @SaemundurMD: \u201cI will now tell you what happens when you screen a whole nation for #MGUS\u201d -@sykristinsson @iStopMM #ASH21 #mmsm https://\u2026", "entities": {"mentions": [{"start": 3, "end": 15, "username": "SaemundurMD", "id": "1054784756704010241"}, {"start": 94, "end": 108, "username": "sykristinsson", "id": "3078258341"}, {"start": 109, "end": 117, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 86, "end": 91, "tag": "MGUS"}, {"start": 118, "end": 124, "tag": "ASH21"}, {"start": 125, "end": 130, "tag": "mmsm"}], "annotations": [{"start": 87, "end": 90, "probability": 0.3841, "type": "Organization", "normalized_text": "MGUS"}]}, "created_at": "2021-12-12T20:09:16.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1469741646224973827"}], "id": "1470123610216054787", "lang": "en", "conversation_id": "1470123610216054787", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1470109333664976908"], "text": "RT @sykristinsson: In an individual with kidney failure and GFR=35 mL/min/1.73 m2 what would you consider normal free light chain ratio (FL\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}]}, "created_at": "2021-12-12T19:12:33.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1470108775952572421"}], "id": "1470109333664976908", "lang": "en", "conversation_id": "1470109333664976908", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1469830990633877506"], "text": "RT @BrunoPaiva_UNAV: Key finding from #ASH21: active screening and testing of MGUS increases the diagnosis of malignant gammopathies.\n\nKey\u2026", "entities": {"mentions": [{"start": 3, "end": 19, "username": "BrunoPaiva_UNAV", "id": "1335161063382376448"}], "hashtags": [{"start": 38, "end": 44, "tag": "ASH21"}], "annotations": [{"start": 39, "end": 43, "probability": 0.7228, "type": "Other", "normalized_text": "ASH21"}, {"start": 78, "end": 81, "probability": 0.453, "type": "Other", "normalized_text": "MGUS"}]}, "created_at": "2021-12-12T00:46:30.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1469736192627429390"}], "id": "1469830990633877506", "lang": "en", "conversation_id": "1469830990633877506", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1469788180845109254"], "text": "RT @AuclairDan: Finally, in the last @iStopMM presentation today at #ASH21 , in the RCT portion it was shown that active monitoring identif\u2026", "entities": {"mentions": [{"start": 3, "end": 14, "username": "AuclairDan", "id": "817184467915853828"}, {"start": 37, "end": 45, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 68, "end": 74, "tag": "ASH21"}], "annotations": [{"start": 69, "end": 73, "probability": 0.7108, "type": "Other", "normalized_text": "ASH21"}, {"start": 84, "end": 86, "probability": 0.5711, "type": "Other", "normalized_text": "RCT"}]}, "created_at": "2021-12-11T21:56:24.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1469746149015920650"}], "id": "1469788180845109254", "lang": "en", "conversation_id": "1469788180845109254", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1469767014180925444"], "text": "RT @sykristinsson: @FrancescoMaura4 @iStopMM @DrOlaLandgren @DrGarethMorgan1 I belive I said that you detect more cases by screening BUT we\u2026", "entities": {"mentions": [{"start": 3, "end": 17, "username": "sykristinsson", "id": "3078258341"}, {"start": 19, "end": 35, "username": "FrancescoMaura4", "id": "1158556316576751617"}, {"start": 36, "end": 44, "username": "iStopMM", "id": "844232399319941122"}, {"start": 45, "end": 59, "username": "DrOlaLandgren", "id": "2257190339"}, {"start": 60, "end": 76, "username": "DrGarethMorgan1", "id": "1119004052476633088"}]}, "created_at": "2021-12-11T20:32:17.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1469747824195780613"}], "id": "1469767014180925444", "lang": "en", "conversation_id": "1469767014180925444", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1469749590710706179"], "text": "A\u00f0albj\u00f6rg  Sigurbergsdottir can't wait to show you her poster on the importance of studying screened MGUS compared to clinical (biased) MGUS.\nShe is a very talented medical student presenting for the first time at ASH. Super exciting results!\nPoster #1618 @IMFmyeloma https://t.co/NWjpFqSU3Y", "entities": {"mentions": [{"start": 256, "end": 267, "username": "IMFmyeloma", "id": "34340707"}], "urls": [{"start": 268, "end": 291, "url": "https://t.co/NWjpFqSU3Y", "expanded_url": "https://twitter.com/iStopMM/status/1469749590710706179/photo/1", "display_url": "pic.twitter.com/NWjpFqSU3Y", "media_key": "3_1469749578702458889"}], "annotations": [{"start": 0, "end": 26, "probability": 0.7327, "type": "Person", "normalized_text": "A\u00f0albj\u00f6rg  Sigurbergsdottir"}, {"start": 101, "end": 104, "probability": 0.6089, "type": "Organization", "normalized_text": "MGUS"}, {"start": 136, "end": 139, "probability": 0.6635, "type": "Organization", "normalized_text": "MGUS"}, {"start": 214, "end": 216, "probability": 0.7718, "type": "Organization", "normalized_text": "ASH"}]}, "created_at": "2021-12-11T19:23:03.000Z", "author_id": "844232399319941122", "id": "1469749590710706179", "lang": "en", "conversation_id": "1469749590710706179", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1469696842489159682"], "text": "Are you curious what happens if you screen 75,000 people for MGUS?\n\nThe PI for the @iStopMM study, @sykristinsson will literary tell you in just about 1 hour!\n\n@TheBindingSite @IMFmyeloma https://t.co/f5ZgtfjEkI", "entities": {"mentions": [{"start": 83, "end": 91, "username": "iStopMM", "id": "844232399319941122"}, {"start": 99, "end": 113, "username": "sykristinsson", "id": "3078258341"}, {"start": 160, "end": 175, "username": "TheBindingSite", "id": "321436678"}, {"start": 176, "end": 187, "username": "IMFmyeloma", "id": "34340707"}], "urls": [{"start": 188, "end": 211, "url": "https://t.co/f5ZgtfjEkI", "expanded_url": "https://twitter.com/iStopMM/status/1469696842489159682/photo/1", "display_url": "pic.twitter.com/f5ZgtfjEkI", "media_key": "3_1469696826832007168"}], "annotations": [{"start": 61, "end": 64, "probability": 0.4047, "type": "Other", "normalized_text": "MGUS"}]}, "created_at": "2021-12-11T15:53:27.000Z", "author_id": "844232399319941122", "id": "1469696842489159682", "lang": "en", "conversation_id": "1469696842489159682", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1469690018700615693"], "text": "In less than 2 hours @SaemundurMD will tell you whether MGUS is a risk factor for #covid19 or severe covid. Don't miss it. He is an MD, a PhD student and a brilliant member of the @iStopMM team!\n\n@sykristinsson @IMFmyeloma @TheBindingSite https://t.co/umLqmhSID3", "entities": {"mentions": [{"start": 21, "end": 33, "username": "SaemundurMD", "id": "1054784756704010241"}, {"start": 180, "end": 188, "username": "iStopMM", "id": "844232399319941122"}, {"start": 196, "end": 210, "username": "sykristinsson", "id": "3078258341"}, {"start": 211, "end": 222, "username": "IMFmyeloma", "id": "34340707"}, {"start": 223, "end": 238, "username": "TheBindingSite", "id": "321436678"}], "hashtags": [{"start": 82, "end": 90, "tag": "covid19"}], "urls": [{"start": 239, "end": 262, "url": "https://t.co/umLqmhSID3", "expanded_url": "https://twitter.com/iStopMM/status/1469690018700615693/photo/1", "display_url": "pic.twitter.com/umLqmhSID3", "media_key": "3_1469690008772694017"}], "annotations": [{"start": 56, "end": 59, "probability": 0.5865, "type": "Organization", "normalized_text": "MGUS"}, {"start": 83, "end": 89, "probability": 0.9237, "type": "Other", "normalized_text": "covid19"}, {"start": 101, "end": 105, "probability": 0.8686, "type": "Other", "normalized_text": "covid"}]}, "created_at": "2021-12-11T15:26:20.000Z", "author_id": "844232399319941122", "id": "1469690018700615693", "lang": "en", "conversation_id": "1469690018700615693", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1469688521346719747"], "text": "The rising star in smoldering myeloma (SMM)  @SigrunThorstei1  will present how common smoldering myeloma really is at 12 o'clock today! \nSpoiler alert: It is more common than you think...\n\nThe @iStopMM team is so proud of her!\n@sykristinsson @IMFmyeloma @TheBindingSite https://t.co/HXDTGvdOeE", "entities": {"mentions": [{"start": 45, "end": 61, "username": "SigrunThorstei1", "id": "1198917648630919168"}, {"start": 194, "end": 202, "username": "iStopMM", "id": "844232399319941122"}, {"start": 228, "end": 242, "username": "sykristinsson", "id": "3078258341"}, {"start": 243, "end": 254, "username": "IMFmyeloma", "id": "34340707"}, {"start": 255, "end": 270, "username": "TheBindingSite", "id": "321436678"}], "urls": [{"start": 271, "end": 294, "url": "https://t.co/HXDTGvdOeE", "expanded_url": "https://twitter.com/iStopMM/status/1469688521346719747/photo/1", "display_url": "pic.twitter.com/HXDTGvdOeE", "media_key": "3_1469688511511023624"}], "annotations": [{"start": 30, "end": 36, "probability": 0.6886, "type": "Other", "normalized_text": "myeloma"}, {"start": 39, "end": 41, "probability": 0.4748, "type": "Other", "normalized_text": "SMM"}, {"start": 98, "end": 104, "probability": 0.7008, "type": "Other", "normalized_text": "myeloma"}]}, "created_at": "2021-12-11T15:20:23.000Z", "author_id": "844232399319941122", "id": "1469688521346719747", "lang": "en", "conversation_id": "1469688521346719747", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1469039923969904640"], "text": "RT @IMFnurseMyeloma: @Bethfaiman @sykristinsson @End_myeloma @myelomaMD @IMFjimMYELOMA @khouri_jack @JasonValent1 @Amyloid_Planet Great sel\u2026", "entities": {"mentions": [{"start": 3, "end": 19, "username": "IMFnurseMyeloma", "id": "961398000"}, {"start": 21, "end": 32, "username": "Bethfaiman", "id": "2475877106"}, {"start": 33, "end": 47, "username": "sykristinsson", "id": "3078258341"}, {"start": 48, "end": 60, "username": "End_myeloma", "id": "2538011298"}, {"start": 61, "end": 71, "username": "myelomaMD", "id": "301568235"}, {"start": 72, "end": 86, "username": "IMFjimMYELOMA", "id": "2857731232"}, {"start": 87, "end": 99, "username": "khouri_jack", "id": "1000352595708383232"}, {"start": 100, "end": 113, "username": "JasonValent1", "id": "1329256305492692994"}, {"start": 114, "end": 129, "username": "Amyloid_Planet", "id": "1138405094"}]}, "created_at": "2021-12-09T20:23:05.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1468930957784846336"}], "id": "1469039923969904640", "lang": "en", "conversation_id": "1469039923969904640", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1469039890813890565"], "text": "RT @Bethfaiman: My clinically relevant #pcd #ASH2021. #iStopMM #151,156+542; #821-posttx w/ #bispecifics in RRMM; #79 GRIFFIN, #84 BELLINI,\u2026", "entities": {"mentions": [{"start": 3, "end": 14, "username": "Bethfaiman", "id": "2475877106"}], "hashtags": [{"start": 39, "end": 43, "tag": "pcd"}, {"start": 44, "end": 52, "tag": "ASH2021"}, {"start": 54, "end": 62, "tag": "iStopMM"}, {"start": 92, "end": 104, "tag": "bispecifics"}], "annotations": [{"start": 45, "end": 51, "probability": 0.4652, "type": "Other", "normalized_text": "ASH2021"}, {"start": 55, "end": 61, "probability": 0.6828, "type": "Other", "normalized_text": "iStopMM"}, {"start": 108, "end": 111, "probability": 0.4005, "type": "Other", "normalized_text": "RRMM"}, {"start": 131, "end": 137, "probability": 0.603, "type": "Other", "normalized_text": "BELLINI"}]}, "created_at": "2021-12-09T20:22:58.000Z", "author_id": "844232399319941122", "referenced_tweets": [{"type": "retweeted", "id": "1468900717817741315"}], "id": "1469039890813890565", "lang": "en", "conversation_id": "1469039890813890565", "source": "Twitter Web App"}], "includes": {"users": [{"id": "844232399319941122", "name": "iStopMM", "username": "iStopMM"}, {"id": "3009607268", "name": "\u00de\u00f3rir Long", "username": "thorirlong"}], "tweets": [{"edit_history_tweet_ids": ["1600763735995736064"], "text": "#ASH22 a fabulous collection of abstracts and data from the @iStopMM team with practice changing data @sykristinsson #mmsm https://t.co/lD630Py7md", "entities": {"mentions": [{"start": 60, "end": 68, "username": "iStopMM", "id": "844232399319941122"}, {"start": 102, "end": 116, "username": "sykristinsson", "id": "3078258341"}], "hashtags": [{"start": 0, "end": 6, "tag": "ASH22"}, {"start": 117, "end": 122, "tag": "mmsm"}], "urls": [{"start": 123, "end": 146, "url": "https://t.co/lD630Py7md", "expanded_url": "https://twitter.com/sykristinsson/status/1589629504422805506", "display_url": "twitter.com/sykristinsson/\u2026"}], "annotations": [{"start": 1, "end": 5, "probability": 0.5997, "type": "Other", "normalized_text": "ASH22"}, {"start": 118, "end": 121, "probability": 0.4085, "type": "Other", "normalized_text": "mmsm"}]}, "created_at": "2022-12-08T08:06:30.000Z", "author_id": "1014890726818238465", "referenced_tweets": [{"type": "quoted", "id": "1589629504422805506"}], "id": "1600763735995736064", "lang": "en", "conversation_id": "1600763735995736064", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1600544435825438720"], "text": "And here are all the abstracts from the @iStopMM study: https://t.co/nhswuksEfL", "entities": {"mentions": [{"start": 40, "end": 48, "username": "iStopMM", "id": "844232399319941122"}], "urls": [{"start": 56, "end": 79, "url": "https://t.co/nhswuksEfL", "expanded_url": "https://twitter.com/sykristinsson/status/1589629504422805506?s=20&t=g_0BgnWQYjXFx96LRgJKJg", "display_url": "twitter.com/sykristinsson/\u2026"}]}, "in_reply_to_user_id": "3078258341", "created_at": "2022-12-07T17:35:04.000Z", "author_id": "3078258341", "referenced_tweets": [{"type": "quoted", "id": "1589629504422805506"}, {"type": "replied_to", "id": "1600544434160275457"}], "id": "1600544435825438720", "lang": "en", "conversation_id": "1600544417827504144", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1600545405540126720"], "text": "The title of my talk today to rheumatologists, we are already changing practice and minds as a result of the amazing work by @iStopMM @sykristinsson \n\nhttps://t.co/6Fok0TBUDi\n\nAn example of practice changed even before the actual #ASH22 meeting! https://t.co/QUlXawKR7Z", "entities": {"mentions": [{"start": 125, "end": 133, "username": "iStopMM", "id": "844232399319941122"}, {"start": 134, "end": 148, "username": "sykristinsson", "id": "3078258341"}], "hashtags": [{"start": 230, "end": 236, "tag": "ASH22"}], "urls": [{"start": 151, "end": 174, "url": "https://t.co/6Fok0TBUDi", "expanded_url": "https://ash.confex.com/ash/2022/webprogram/Paper169393.html", "display_url": "ash.confex.com/ash/2022/webpr\u2026", "status": 200, "title": "Paper: Autoimmune Diseases Are Not Associated with Monoclonal Gammopathy of Undetermined Significance: Results of the Prospective Population-Based Istopmm Study", "description": "Program: Oral and Poster Abstracts Session: 652. Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster III Hematology Disease Topics & Pathways: adult, Research, epidemiology, Plasma Cell Disorders, Clinical Research, Diseases, Lymphoid Malignancies, Human, Study Population Ingigerdur S Sverrisdottir, MD 1,2 *, Sigr\u00fan Thorsteinsd\u00f3ttir, MD, PhD 2,3, S\u00e6mundur R\u00f6gnvaldsson, MD 4 *, Thor Aspelund, PhD 2 *, Brynjar Vidarsson, MD 5, P\u00e1ll Torfi \u00d6nundarson, MD 5 *, Bjarni Agnarsson, MD", "unwound_url": "https://ash.confex.com/ash/2022/webprogram/Paper169393.html"}, {"start": 246, "end": 269, "url": "https://t.co/QUlXawKR7Z", "expanded_url": "https://twitter.com/ManniMD1/status/1600545405540126720/photo/1", "display_url": "pic.twitter.com/QUlXawKR7Z", "media_key": "3_1600545179307425792"}], "annotations": [{"start": 231, "end": 235, "probability": 0.6187, "type": "Other", "normalized_text": "ASH22"}]}, "created_at": "2022-12-07T17:38:56.000Z", "author_id": "1269642863924609025", "id": "1600545405540126720", "lang": "en", "conversation_id": "1600545405540126720", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1600544417827504144"], "text": "Here is my top list of interesting myeloma abstracts, mostly focusing on MGUS and smoldering, for #ASH22. I have included a mixture of things, including treatment trials, mass spectrometry, risk models, genetics, amyloidosis and more. @mtmdphd", "entities": {"mentions": [{"start": 235, "end": 243, "username": "mtmdphd", "id": "190337035"}], "hashtags": [{"start": 98, "end": 104, "tag": "ASH22"}], "annotations": [{"start": 35, "end": 41, "probability": 0.5641, "type": "Other", "normalized_text": "myeloma"}, {"start": 73, "end": 76, "probability": 0.711, "type": "Other", "normalized_text": "MGUS"}, {"start": 99, "end": 103, "probability": 0.6266, "type": "Other", "normalized_text": "ASH22"}]}, "created_at": "2022-12-07T17:35:00.000Z", "author_id": "3078258341", "id": "1600544417827504144", "lang": "en", "conversation_id": "1600544417827504144", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1600123462827184128"], "text": "The @iStopMM team is very excited to present our findings at #ASH22\n\nPresentations from the study are, like before, primarily performed by medical student, PhD students, and postdocs. I am so proud of the team!\n\nSee you in New Orleans! https://t.co/UdAS2UvU8m", "entities": {"mentions": [{"start": 4, "end": 12, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 61, "end": 67, "tag": "ASH22"}], "urls": [{"start": 236, "end": 259, "url": "https://t.co/UdAS2UvU8m", "expanded_url": "https://twitter.com/sykristinsson/status/1600123462827184128/photo/1", "display_url": "pic.twitter.com/UdAS2UvU8m", "media_key": "3_1600122050370277376"}], "annotations": [{"start": 62, "end": 66, "probability": 0.7091, "type": "Other", "normalized_text": "ASH22"}, {"start": 223, "end": 233, "probability": 0.986, "type": "Place", "normalized_text": "New Orleans"}]}, "created_at": "2022-12-06T13:42:17.000Z", "author_id": "3078258341", "id": "1600123462827184128", "lang": "en", "conversation_id": "1600123462827184128", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1595845251604049920"], "text": "This large, prospective screening study negates the previously reported biological correlation between autoimmune disease, MGUS and LC-MGUS and shows that autoimmune diseases are not associated with MGUS.@iStopMM #mmsm #myeloma #ASH22 #MedTwitter #MedEd #USMIRC https://t.co/MFEKbKLcpJ", "entities": {"mentions": [{"start": 204, "end": 212, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 213, "end": 218, "tag": "mmsm"}, {"start": 219, "end": 227, "tag": "myeloma"}, {"start": 228, "end": 234, "tag": "ASH22"}, {"start": 235, "end": 246, "tag": "MedTwitter"}, {"start": 247, "end": 253, "tag": "MedEd"}, {"start": 254, "end": 261, "tag": "USMIRC"}], "urls": [{"start": 262, "end": 285, "url": "https://t.co/MFEKbKLcpJ", "expanded_url": "https://twitter.com/Abdallah81MD/status/1595845251604049920/photo/1", "display_url": "pic.twitter.com/MFEKbKLcpJ", "media_key": "3_1595845247795437583"}, {"start": 262, "end": 285, "url": "https://t.co/MFEKbKLcpJ", "expanded_url": "https://twitter.com/Abdallah81MD/status/1595845251604049920/photo/1", "display_url": "pic.twitter.com/MFEKbKLcpJ", "media_key": "3_1595845247807922179"}], "annotations": [{"start": 114, "end": 120, "probability": 0.5047, "type": "Other", "normalized_text": "disease"}, {"start": 123, "end": 126, "probability": 0.5329, "type": "Other", "normalized_text": "MGUS"}, {"start": 132, "end": 138, "probability": 0.6109, "type": "Other", "normalized_text": "LC-MGUS"}, {"start": 199, "end": 202, "probability": 0.4277, "type": "Other", "normalized_text": "MGUS"}, {"start": 214, "end": 217, "probability": 0.4461, "type": "Other", "normalized_text": "mmsm"}, {"start": 220, "end": 226, "probability": 0.5182, "type": "Other", "normalized_text": "myeloma"}, {"start": 229, "end": 233, "probability": 0.4239, "type": "Other", "normalized_text": "ASH22"}, {"start": 236, "end": 245, "probability": 0.5983, "type": "Other", "normalized_text": "MedTwitter"}, {"start": 255, "end": 260, "probability": 0.3803, "type": "Other", "normalized_text": "USMIRC"}]}, "created_at": "2022-11-24T18:22:12.000Z", "author_id": "1026947037080772610", "id": "1595845251604049920", "lang": "en", "conversation_id": "1595845251604049920", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1592604400178331648"], "text": "Six years since the launch of the iStopMM study today!\n\nOn 11/15 2016, we invited all Icelanders &gt;40 years to participate in a clinical trial.\nTo our surprise, &gt;50,000 participants in &lt;30 days!\nIn 2018 a world record of 80,759 had signed informed consent (54% of the population). https://t.co/Xx9jsDDKGx", "created_at": "2022-11-15T19:44:12.000Z", "author_id": "3078258341", "id": "1592604400178331648", "lang": "en", "conversation_id": "1592604400178331648", "entities": {"urls": [{"start": 289, "end": 312, "url": "https://t.co/Xx9jsDDKGx", "expanded_url": "https://twitter.com/sykristinsson/status/1592604400178331648/photo/1", "display_url": "pic.twitter.com/Xx9jsDDKGx", "media_key": "3_1592601628858793984"}], "annotations": [{"start": 34, "end": 40, "probability": 0.7199, "type": "Other", "normalized_text": "iStopMM"}, {"start": 86, "end": 95, "probability": 0.3779, "type": "Other", "normalized_text": "Icelanders"}]}, "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1591899435725987840"], "text": "Thank you so much for choosing our abstract from the @iStopMM study @ManniMD1 !\n@eliaseythorsson has done a fantastic job with our data which I am confident will provide evidence for physicians to omit bone marrow biopsy in individuals with M-proteins. https://t.co/gKQu3Bphcg", "entities": {"mentions": [{"start": 53, "end": 61, "username": "iStopMM", "id": "844232399319941122"}, {"start": 68, "end": 77, "username": "ManniMD1", "id": "1269642863924609025"}, {"start": 80, "end": 96, "username": "eliaseythorsson", "id": "133109181"}], "urls": [{"start": 253, "end": 276, "url": "https://t.co/gKQu3Bphcg", "expanded_url": "https://twitter.com/ManniMD1/status/1590440079591624705", "display_url": "twitter.com/ManniMD1/statu\u2026"}]}, "created_at": "2022-11-13T21:02:56.000Z", "author_id": "3078258341", "referenced_tweets": [{"type": "quoted", "id": "1590440079591624705"}], "id": "1591899435725987840", "lang": "en", "conversation_id": "1591899435725987840", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1590440079591624705"], "text": "5. I may now be able to omit bone marrow biopsies as part of initial diagnostic workup for a larger set of patients with MGUS, compared to what I currently do in practice (I currently omit for low-risk MGUS (IgG,M protein less than 1.5, normal FLC).\n\nhttps://t.co/HXfMqxsOtL", "in_reply_to_user_id": "1269642863924609025", "created_at": "2022-11-09T20:23:58.000Z", "author_id": "1269642863924609025", "referenced_tweets": [{"type": "replied_to", "id": "1590440077658066944"}], "id": "1590440079591624705", "lang": "en", "conversation_id": "1590440063263182851", "entities": {"urls": [{"start": 251, "end": 274, "url": "https://t.co/HXfMqxsOtL", "expanded_url": "https://ash.confex.com/ash/2022/webprogram/Paper170166.html", "display_url": "ash.confex.com/ash/2022/webpr\u2026", "status": 200, "title": "Paper: Predicting the Need for Upfront Bone Marrow Sampling in Individuals with MGUS: Derivation of a Multivariable Prediction Model Using the Prospective Population-Based Istopmm Cohort", "description": "Program: Oral and Poster Abstracts Type: Oral Session: 652. Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological: Precursor States: MGUS and Smoldering Myeloma Hematology Disease Topics & Pathways: adult, Research, Clinical Research, real-world evidence, Human, Study Population Elias Eythorsson, MD, PhD 1 *, S\u00e6mundur R\u00f6gnvaldsson, MD 1,2 *, Sigr\u00fan Thorsteinsd\u00f3ttir, MD, PhD 3,4, Elin Ruth Reed 3 *, Gudr\u00fan \u00c1sta Sigurdard\u00f3ttir 3 *, Brynjar Vidarsson, MD 1, P\u00e1ll Torfi Onundarson, MD 1,", "unwound_url": "https://ash.confex.com/ash/2022/webprogram/Paper170166.html"}], "annotations": [{"start": 121, "end": 124, "probability": 0.505, "type": "Organization", "normalized_text": "MGUS"}, {"start": 202, "end": 205, "probability": 0.5423, "type": "Other", "normalized_text": "MGUS"}]}, "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1590004512202203136"], "text": "@sykristinsson @iStopMM Amazing! And the best is yet to come. Congratulations Sigurdur and team", "entities": {"mentions": [{"start": 0, "end": 14, "username": "sykristinsson", "id": "3078258341"}, {"start": 15, "end": 23, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 78, "end": 85, "probability": 0.4427, "type": "Other", "normalized_text": "Sigurdur"}]}, "in_reply_to_user_id": "3078258341", "created_at": "2022-11-08T15:33:11.000Z", "author_id": "1335161063382376448", "referenced_tweets": [{"type": "replied_to", "id": "1589629504422805506"}], "id": "1590004512202203136", "lang": "en", "conversation_id": "1589629504422805506", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1589967051887898624"], "text": "@sykristinsson @iStopMM Congratulations!!!", "entities": {"mentions": [{"start": 0, "end": 14, "username": "sykristinsson", "id": "3078258341"}, {"start": 15, "end": 23, "username": "iStopMM", "id": "844232399319941122"}]}, "in_reply_to_user_id": "3078258341", "created_at": "2022-11-08T13:04:19.000Z", "author_id": "2239926566", "referenced_tweets": [{"type": "replied_to", "id": "1589629504422805506"}], "id": "1589967051887898624", "lang": "en", "conversation_id": "1589629504422805506", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1589978423816224768"], "text": "@sykristinsson @iStopMM Impressive work to move the field forward .. congrats to you and the team", "entities": {"mentions": [{"start": 0, "end": 14, "username": "sykristinsson", "id": "3078258341"}, {"start": 15, "end": 23, "username": "iStopMM", "id": "844232399319941122"}]}, "in_reply_to_user_id": "3078258341", "created_at": "2022-11-08T13:49:31.000Z", "author_id": "1098172293551927303", "referenced_tweets": [{"type": "replied_to", "id": "1589629504422805506"}], "id": "1589978423816224768", "lang": "en", "conversation_id": "1589629504422805506", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1589987324481658880"], "text": "Amazing amount and quality of data from the Icelander @iStopMM study! Kudos to authors https://t.co/OKzx078SvC", "entities": {"mentions": [{"start": 54, "end": 62, "username": "iStopMM", "id": "844232399319941122"}], "urls": [{"start": 87, "end": 110, "url": "https://t.co/OKzx078SvC", "expanded_url": "https://twitter.com/sykristinsson/status/1589629504422805506", "display_url": "twitter.com/sykristinsson/\u2026"}], "annotations": [{"start": 44, "end": 52, "probability": 0.7025, "type": "Other", "normalized_text": "Icelander"}]}, "created_at": "2022-11-08T14:24:53.000Z", "author_id": "4833065482", "referenced_tweets": [{"type": "quoted", "id": "1589629504422805506"}], "id": "1589987324481658880", "lang": "en", "conversation_id": "1589987324481658880", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1589890786765975552"], "text": "@sykristinsson @iStopMM Please keep going and advance this field. Congratulations for such huge achievements.", "entities": {"mentions": [{"start": 0, "end": 14, "username": "sykristinsson", "id": "3078258341"}, {"start": 15, "end": 23, "username": "iStopMM", "id": "844232399319941122"}]}, "in_reply_to_user_id": "3078258341", "created_at": "2022-11-08T08:01:16.000Z", "author_id": "2626263112", "referenced_tweets": [{"type": "replied_to", "id": "1589629504422805506"}], "id": "1589890786765975552", "lang": "en", "conversation_id": "1589629504422805506", "source": "Twitter for iPad"}, {"edit_history_tweet_ids": ["1589882859816644609"], "text": "Really interesting set of abstracts from @iStopMM study https://t.co/JT0z8cOoZq", "entities": {"mentions": [{"start": 41, "end": 49, "username": "iStopMM", "id": "844232399319941122"}], "urls": [{"start": 56, "end": 79, "url": "https://t.co/JT0z8cOoZq", "expanded_url": "https://twitter.com/sykristinsson/status/1589629504422805506", "display_url": "twitter.com/sykristinsson/\u2026"}]}, "created_at": "2022-11-08T07:29:47.000Z", "author_id": "1243840145599717376", "referenced_tweets": [{"type": "quoted", "id": "1589629504422805506"}], "id": "1589882859816644609", "lang": "en", "conversation_id": "1589882859816644609", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1589862212835110913"], "text": "Excellent summary of what to expect from #ASH2022 from @iStopMM looking forward to the talks #mmsm https://t.co/fldOCN4rOU", "entities": {"mentions": [{"start": 55, "end": 63, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 41, "end": 49, "tag": "ASH2022"}, {"start": 93, "end": 98, "tag": "mmsm"}], "urls": [{"start": 99, "end": 122, "url": "https://t.co/fldOCN4rOU", "expanded_url": "https://twitter.com/sykristinsson/status/1589629504422805506", "display_url": "twitter.com/sykristinsson/\u2026"}], "annotations": [{"start": 42, "end": 48, "probability": 0.6819, "type": "Other", "normalized_text": "ASH2022"}, {"start": 94, "end": 97, "probability": 0.4583, "type": "Other", "normalized_text": "mmsm"}]}, "created_at": "2022-11-08T06:07:44.000Z", "author_id": "66791317", "referenced_tweets": [{"type": "quoted", "id": "1589629504422805506"}], "id": "1589862212835110913", "lang": "en", "conversation_id": "1589862212835110913", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1589763561492221952"], "text": "This is brilliant. The @iStopMM is redefining what we take for granted in #mgus! Congratulations to the entire team #mmsm https://t.co/eb3p2dMePz", "entities": {"mentions": [{"start": 23, "end": 31, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 74, "end": 79, "tag": "mgus"}, {"start": 116, "end": 121, "tag": "mmsm"}], "urls": [{"start": 122, "end": 145, "url": "https://t.co/eb3p2dMePz", "expanded_url": "https://twitter.com/sykristinsson/status/1589629504422805506", "display_url": "twitter.com/sykristinsson/\u2026"}], "annotations": [{"start": 75, "end": 78, "probability": 0.4984, "type": "Other", "normalized_text": "mgus"}, {"start": 117, "end": 120, "probability": 0.4906, "type": "Other", "normalized_text": "mmsm"}]}, "created_at": "2022-11-07T23:35:44.000Z", "author_id": "209212922", "referenced_tweets": [{"type": "quoted", "id": "1589629504422805506"}], "id": "1589763561492221952", "lang": "en", "conversation_id": "1589763561492221952", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1589636265921896448"], "text": "@sykristinsson @iStopMM Congrats Sigurdur and team! Very important topics &amp; abstracts! Look forward to seeing them all.", "entities": {"mentions": [{"start": 0, "end": 14, "username": "sykristinsson", "id": "3078258341"}, {"start": 15, "end": 23, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 33, "end": 40, "probability": 0.5004, "type": "Person", "normalized_text": "Sigurdur"}]}, "in_reply_to_user_id": "3078258341", "created_at": "2022-11-07T15:09:54.000Z", "author_id": "247910300", "referenced_tweets": [{"type": "replied_to", "id": "1589629504422805506"}], "id": "1589636265921896448", "lang": "en", "conversation_id": "1589629504422805506", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1589637953361707008"], "text": "@sykristinsson @iStopMM Fantastic achievement and well deserved", "entities": {"mentions": [{"start": 0, "end": 14, "username": "sykristinsson", "id": "3078258341"}, {"start": 15, "end": 23, "username": "iStopMM", "id": "844232399319941122"}]}, "in_reply_to_user_id": "3078258341", "created_at": "2022-11-07T15:16:36.000Z", "author_id": "767011956360347648", "referenced_tweets": [{"type": "replied_to", "id": "1589629504422805506"}], "id": "1589637953361707008", "lang": "en", "conversation_id": "1589629504422805506", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1589643380472287234"], "text": "@sykristinsson @iStopMM Congratulations. Amazing work", "entities": {"mentions": [{"start": 0, "end": 14, "username": "sykristinsson", "id": "3078258341"}, {"start": 15, "end": 23, "username": "iStopMM", "id": "844232399319941122"}]}, "in_reply_to_user_id": "3078258341", "created_at": "2022-11-07T15:38:10.000Z", "author_id": "52923484", "referenced_tweets": [{"type": "replied_to", "id": "1589629504422805506"}], "id": "1589643380472287234", "lang": "en", "conversation_id": "1589629504422805506", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1589644934470316032"], "text": "@sykristinsson @iStopMM Dear @sykristinsson and team, you really deliver such existing data sets! Congratulations!", "entities": {"mentions": [{"start": 0, "end": 14, "username": "sykristinsson", "id": "3078258341"}, {"start": 15, "end": 23, "username": "iStopMM", "id": "844232399319941122"}, {"start": 29, "end": 43, "username": "sykristinsson", "id": "3078258341"}]}, "in_reply_to_user_id": "3078258341", "created_at": "2022-11-07T15:44:21.000Z", "author_id": "1108491138581872641", "referenced_tweets": [{"type": "replied_to", "id": "1589629504422805506"}], "id": "1589644934470316032", "lang": "en", "conversation_id": "1589629504422805506", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1589699878753431552"], "text": "@sykristinsson @iStopMM You are ridiculously productive with a ridiculously productive trial. Congrats to you and your team Sigurdur. \nSee you at ASH.", "entities": {"mentions": [{"start": 0, "end": 14, "username": "sykristinsson", "id": "3078258341"}, {"start": 15, "end": 23, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 124, "end": 131, "probability": 0.4637, "type": "Person", "normalized_text": "Sigurdur"}, {"start": 146, "end": 148, "probability": 0.7253, "type": "Organization", "normalized_text": "ASH"}]}, "in_reply_to_user_id": "3078258341", "created_at": "2022-11-07T19:22:40.000Z", "author_id": "24261916", "referenced_tweets": [{"type": "replied_to", "id": "1589629504422805506"}], "id": "1589699878753431552", "lang": "en", "conversation_id": "1589629504422805506", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1589638006876827648"], "text": "Visionary study with of course great results that will lead to changes in everyday clinical management in myeloma, excited to hear these results at #ASH22 https://t.co/S4CgyPYBMF", "created_at": "2022-11-07T15:16:49.000Z", "entities": {"hashtags": [{"start": 148, "end": 154, "tag": "ASH22"}], "urls": [{"start": 155, "end": 178, "url": "https://t.co/S4CgyPYBMF", "expanded_url": "https://twitter.com/sykristinsson/status/1589629504422805506", "display_url": "twitter.com/sykristinsson/\u2026"}], "annotations": [{"start": 106, "end": 112, "probability": 0.5117, "type": "Other", "normalized_text": "myeloma"}, {"start": 149, "end": 153, "probability": 0.5901, "type": "Other", "normalized_text": "ASH22"}]}, "author_id": "419595308", "referenced_tweets": [{"type": "quoted", "id": "1589629504422805506"}], "id": "1589638006876827648", "lang": "en", "conversation_id": "1589638006876827648", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1589712467927928832"], "text": "Stellar abstract by @iStopMM showing \ud835\udc0d\ud835\udc28 association between MGUS and Autoimmune Disease, when MGUS detected by population-level screening. A high number of MGUS referrals in pts with autoimmune diseases in our clinics likely represent selection bias 2/2 increased testing! https://t.co/aLCbRFm2WQ", "entities": {"mentions": [{"start": 20, "end": 28, "username": "iStopMM", "id": "844232399319941122"}], "urls": [{"start": 273, "end": 296, "url": "https://t.co/aLCbRFm2WQ", "expanded_url": "https://twitter.com/sykristinsson/status/1589629545870929920", "display_url": "twitter.com/sykristinsson/\u2026"}], "annotations": [{"start": 60, "end": 63, "probability": 0.535, "type": "Other", "normalized_text": "MGUS"}, {"start": 69, "end": 86, "probability": 0.8882, "type": "Other", "normalized_text": "Autoimmune Disease"}, {"start": 94, "end": 97, "probability": 0.4482, "type": "Other", "normalized_text": "MGUS"}, {"start": 156, "end": 159, "probability": 0.4994, "type": "Other", "normalized_text": "MGUS"}]}, "created_at": "2022-11-07T20:12:42.000Z", "author_id": "140966169", "referenced_tweets": [{"type": "quoted", "id": "1589629545870929920"}], "id": "1589712467927928832", "lang": "en", "conversation_id": "1589712467927928832", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1589629504422805506"], "text": "4 orals, 6 posters, 1 educational and 2 Abstract achievement awards at #ASH22 from the @iStopMM study (w/9 different presenters)!\nWe are ridiculously excited to share our results after screening &gt;75,000 Icelanders for MGUS.\nAnd we are just beginning!\n#mmsm \ud83e\uddf5Abstracts:", "entities": {"mentions": [{"start": 87, "end": 95, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 71, "end": 77, "tag": "ASH22"}, {"start": 254, "end": 259, "tag": "mmsm"}], "annotations": [{"start": 72, "end": 76, "probability": 0.6339, "type": "Other", "normalized_text": "ASH22"}, {"start": 221, "end": 224, "probability": 0.4122, "type": "Organization", "normalized_text": "MGUS"}]}, "created_at": "2022-11-07T14:43:02.000Z", "author_id": "3078258341", "id": "1589629504422805506", "lang": "en", "conversation_id": "1589629504422805506", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1587716139420884993"], "text": "In the start of this month's iStopMM scientific discussions, S\u00e6mundur R\u00f6gnvaldsson \u2013 MD at the University of Iceland \u2013 shares his experiences and responsibilities within the iStopMM project, as well as the key findings so far.\n\nWatch now: https://t.co/5KZTD7ItZQ https://t.co/Hr2C8asA4n", "created_at": "2022-11-02T08:00:00.000Z", "author_id": "321436678", "id": "1587716139420884993", "lang": "en", "conversation_id": "1587716139420884993", "entities": {"urls": [{"start": 239, "end": 262, "url": "https://t.co/5KZTD7ItZQ", "expanded_url": "https://hubs.li/Q01r5nsx0", "display_url": "hubs.li/Q01r5nsx0", "images": [{"url": "https://pbs.twimg.com/news_img/1587716141669048320/Y3Mj_Prw?format=jpg&name=orig", "width": 1280, "height": 720}, {"url": "https://pbs.twimg.com/news_img/1587716141669048320/Y3Mj_Prw?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "iStopMM Scientific Discussion - S\u00e6mundur Ro\u0308gnvaldsson", "unwound_url": "https://www.youtube.com/watch?utm_campaign=Social+Media&utm_content=221343276&utm_medium=social&utm_source=twitter&hss_channel=tw-321436678&v=N78pYZBun_s&feature=youtu.be"}, {"start": 263, "end": 286, "url": "https://t.co/Hr2C8asA4n", "expanded_url": "https://twitter.com/TheBindingSite/status/1587716139420884993/photo/1", "display_url": "pic.twitter.com/Hr2C8asA4n", "media_key": "3_1587716137126662146"}], "annotations": [{"start": 29, "end": 35, "probability": 0.6652, "type": "Other", "normalized_text": "iStopMM"}, {"start": 61, "end": 81, "probability": 0.7689, "type": "Person", "normalized_text": "S\u00e6mundur R\u00f6gnvaldsson"}, {"start": 95, "end": 115, "probability": 0.9593, "type": "Organization", "normalized_text": "University of Iceland"}, {"start": 174, "end": 180, "probability": 0.4452, "type": "Other", "normalized_text": "iStopMM"}]}, "source": "HubSpot"}, {"edit_history_tweet_ids": ["1584439548511064064"], "text": "The iStopMM study has been running since 2016 and continues to produce vital data.\n\nJon Porir Oskarsson - PhD candidate at the University of Iceland highlights the work he is conducting in the study and the data collected so far.\n\nWatch it now: https://t.co/Df4oGbHbel https://t.co/7ymWzcb3LJ", "created_at": "2022-10-24T07:00:00.000Z", "author_id": "321436678", "id": "1584439548511064064", "lang": "en", "conversation_id": "1584439548511064064", "entities": {"urls": [{"start": 245, "end": 268, "url": "https://t.co/Df4oGbHbel", "expanded_url": "https://hubs.li/Q01qdY_X0", "display_url": "hubs.li/Q01qdY_X0", "images": [{"url": "https://pbs.twimg.com/news_img/1584439552277553152/KTGfwPiI?format=jpg&name=orig", "width": 1280, "height": 720}, {"url": "https://pbs.twimg.com/news_img/1584439552277553152/KTGfwPiI?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "iStopMM Scientific Discussion - Jon Porir Oskarsson", "unwound_url": "https://www.youtube.com/watch?utm_campaign=Social+Media&utm_content=221328397&utm_medium=social&utm_source=twitter&hss_channel=tw-321436678&v=1QH8GmZxv_s&feature=youtu.be"}, {"start": 269, "end": 292, "url": "https://t.co/7ymWzcb3LJ", "expanded_url": "https://twitter.com/TheBindingSite/status/1584439548511064064/photo/1", "display_url": "pic.twitter.com/7ymWzcb3LJ", "media_key": "3_1584439546338484224"}], "annotations": [{"start": 4, "end": 10, "probability": 0.4884, "type": "Organization", "normalized_text": "iStopMM"}, {"start": 84, "end": 102, "probability": 0.6754, "type": "Person", "normalized_text": "Jon Porir Oskarsson"}, {"start": 127, "end": 147, "probability": 0.9725, "type": "Organization", "normalized_text": "University of Iceland"}]}, "source": "HubSpot"}, {"edit_history_tweet_ids": ["1582879446490841088"], "text": "Last week I defended my PhD thesis: \n\u201cMonoclonal gammopathy of what significance?\u201d \n\nI\u2019m so proud of this work and so grateful to @sykristinsson, the @iStopMM team, and so many more!\n\nBonus pic of me in 2016 camping while recruiting labs for istop. It\u2019s been a wild ride\u2026 https://t.co/wcEESO5TgJ", "entities": {"mentions": [{"start": 130, "end": 144, "username": "sykristinsson", "id": "3078258341"}, {"start": 150, "end": 158, "username": "iStopMM", "id": "844232399319941122"}], "urls": [{"start": 272, "end": 295, "url": "https://t.co/wcEESO5TgJ", "expanded_url": "https://twitter.com/SaemundurMD/status/1582879446490841088/photo/1", "display_url": "pic.twitter.com/wcEESO5TgJ", "media_key": "3_1582879423585452032"}, {"start": 272, "end": 295, "url": "https://t.co/wcEESO5TgJ", "expanded_url": "https://twitter.com/SaemundurMD/status/1582879446490841088/photo/1", "display_url": "pic.twitter.com/wcEESO5TgJ", "media_key": "3_1582879423568781313"}, {"start": 272, "end": 295, "url": "https://t.co/wcEESO5TgJ", "expanded_url": "https://twitter.com/SaemundurMD/status/1582879446490841088/photo/1", "display_url": "pic.twitter.com/wcEESO5TgJ", "media_key": "3_1582879423577182208"}], "annotations": [{"start": 38, "end": 47, "probability": 0.5467, "type": "Other", "normalized_text": "Monoclonal"}]}, "created_at": "2022-10-19T23:40:43.000Z", "author_id": "1054784756704010241", "id": "1582879446490841088", "lang": "en", "conversation_id": "1582879446490841088", "source": "Twitter for Mac"}, {"edit_history_tweet_ids": ["1583104027398922240"], "text": "Great start of the full board morning session by the amazing @sykristinsson on the current results of @iStopMM study for screening  #MGUS &amp; #SMM and how we approach this topic. Eagerly wait for final results. #mmsm #llmcongress2022 https://t.co/iAVbkKhtfm", "entities": {"mentions": [{"start": 61, "end": 75, "username": "sykristinsson", "id": "3078258341"}, {"start": 102, "end": 110, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 132, "end": 137, "tag": "MGUS"}, {"start": 144, "end": 148, "tag": "SMM"}, {"start": 213, "end": 218, "tag": "mmsm"}, {"start": 219, "end": 235, "tag": "llmcongress2022"}], "urls": [{"start": 236, "end": 259, "url": "https://t.co/iAVbkKhtfm", "expanded_url": "https://twitter.com/MarkBustoros/status/1583104027398922240/photo/1", "display_url": "pic.twitter.com/iAVbkKhtfm", "media_key": "3_1583104022067789824"}, {"start": 236, "end": 259, "url": "https://t.co/iAVbkKhtfm", "expanded_url": "https://twitter.com/MarkBustoros/status/1583104027398922240/photo/1", "display_url": "pic.twitter.com/iAVbkKhtfm", "media_key": "3_1583104022063480833"}, {"start": 236, "end": 259, "url": "https://t.co/iAVbkKhtfm", "expanded_url": "https://twitter.com/MarkBustoros/status/1583104027398922240/photo/1", "display_url": "pic.twitter.com/iAVbkKhtfm", "media_key": "3_1583104022071869440"}, {"start": 236, "end": 259, "url": "https://t.co/iAVbkKhtfm", "expanded_url": "https://twitter.com/MarkBustoros/status/1583104027398922240/photo/1", "display_url": "pic.twitter.com/iAVbkKhtfm", "media_key": "3_1583104022063497217"}], "annotations": [{"start": 133, "end": 136, "probability": 0.6115, "type": "Organization", "normalized_text": "MGUS"}, {"start": 145, "end": 147, "probability": 0.5233, "type": "Organization", "normalized_text": "SMM"}]}, "created_at": "2022-10-20T14:33:07.000Z", "author_id": "247910300", "id": "1583104027398922240", "lang": "en", "conversation_id": "1583104027398922240", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1581077485340733441"], "text": "The iStopMM trial will provide so much information on MGUS, SMM, and MM for years and decades to come. \n\nData from the trial has recently defined normal reference range for free light chains in people with renal failure. https://t.co/ncOLj3btOL", "in_reply_to_user_id": "24261916", "created_at": "2022-10-15T00:20:22.000Z", "author_id": "24261916", "referenced_tweets": [{"type": "quoted", "id": "1572567061150433280"}, {"type": "replied_to", "id": "1581076287543967747"}], "id": "1581077485340733441", "lang": "en", "conversation_id": "1581072167315570689", "entities": {"urls": [{"start": 221, "end": 244, "url": "https://t.co/ncOLj3btOL", "expanded_url": "https://twitter.com/VincentRK/status/1572567061150433280", "display_url": "twitter.com/VincentRK/stat\u2026"}], "annotations": [{"start": 4, "end": 10, "probability": 0.7121, "type": "Other", "normalized_text": "iStopMM"}, {"start": 54, "end": 57, "probability": 0.4301, "type": "Other", "normalized_text": "MGUS"}, {"start": 60, "end": 62, "probability": 0.6398, "type": "Other", "normalized_text": "SMM"}, {"start": 69, "end": 70, "probability": 0.6002, "type": "Other", "normalized_text": "MM"}]}, "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1581072167315570689"], "text": "Great Keynote lecture on Screening for MGUS by @sykristinsson at the AMN Meeting. Dr. Kristinsson is leading a nationwide randomized trial, iSTOPMM in Iceland. @IMFmyeloma @iStopMM #medtwitter \n\nPeople can talk about screening. Takes great vision and leadership to pull off an RCT https://t.co/NAXrKb5iwt", "entities": {"mentions": [{"start": 47, "end": 61, "username": "sykristinsson", "id": "3078258341"}, {"start": 160, "end": 171, "username": "IMFmyeloma", "id": "34340707"}, {"start": 172, "end": 180, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 181, "end": 192, "tag": "medtwitter"}], "urls": [{"start": 281, "end": 304, "url": "https://t.co/NAXrKb5iwt", "expanded_url": "https://twitter.com/VincentRK/status/1581072167315570689/photo/1", "display_url": "pic.twitter.com/NAXrKb5iwt", "media_key": "3_1581072148390563840"}], "annotations": [{"start": 39, "end": 42, "probability": 0.4877, "type": "Organization", "normalized_text": "MGUS"}, {"start": 69, "end": 71, "probability": 0.4313, "type": "Other", "normalized_text": "AMN"}, {"start": 86, "end": 96, "probability": 0.637, "type": "Other", "normalized_text": "Kristinsson"}, {"start": 140, "end": 146, "probability": 0.4415, "type": "Other", "normalized_text": "iSTOPMM"}, {"start": 151, "end": 157, "probability": 0.9525, "type": "Place", "normalized_text": "Iceland"}]}, "created_at": "2022-10-14T23:59:14.000Z", "author_id": "24261916", "id": "1581072167315570689", "lang": "en", "conversation_id": "1581072167315570689", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1579925997155409920"], "text": "So proud of @SaemundurMD my PhD student who defended his thesis yesterday.  His performance was outstanding! Congratulations!\n\nAnd thank you @ADispenzieri for being the perfect opponent! https://t.co/JQ4hu334Ix", "entities": {"mentions": [{"start": 12, "end": 24, "username": "SaemundurMD", "id": "1054784756704010241"}, {"start": 141, "end": 154, "username": "ADispenzieri", "id": "2172483547"}], "urls": [{"start": 187, "end": 210, "url": "https://t.co/JQ4hu334Ix", "expanded_url": "https://twitter.com/sykristinsson/status/1579925997155409920/photo/1", "display_url": "pic.twitter.com/JQ4hu334Ix", "media_key": "3_1579925972173873180"}, {"start": 187, "end": 210, "url": "https://t.co/JQ4hu334Ix", "expanded_url": "https://twitter.com/sykristinsson/status/1579925997155409920/photo/1", "display_url": "pic.twitter.com/JQ4hu334Ix", "media_key": "3_1579925978498883584"}, {"start": 187, "end": 210, "url": "https://t.co/JQ4hu334Ix", "expanded_url": "https://twitter.com/sykristinsson/status/1579925997155409920/photo/1", "display_url": "pic.twitter.com/JQ4hu334Ix", "media_key": "3_1579925985851498500"}]}, "created_at": "2022-10-11T20:04:45.000Z", "author_id": "3078258341", "id": "1579925997155409920", "lang": "en", "conversation_id": "1579925997155409920", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1574755505486053382"], "text": "@sykristinsson @iStopMM @MSK_Neph Congratulations on a very important study, relevant to hematology &amp; nephrology practice!\nThe strength of the study is: large # of participants w/more preserved GFR 51 ml/min vs the previous study (29 ml/min) from which FLC &amp; ratio in CKD was derived (cont.)", "entities": {"mentions": [{"start": 0, "end": 14, "username": "sykristinsson", "id": "3078258341"}, {"start": 15, "end": 23, "username": "iStopMM", "id": "844232399319941122"}, {"start": 24, "end": 33, "username": "MSK_Neph", "id": "1462362881731743746"}], "annotations": [{"start": 276, "end": 278, "probability": 0.3896, "type": "Other", "normalized_text": "CKD"}]}, "in_reply_to_user_id": "3078258341", "created_at": "2022-09-27T13:39:04.000Z", "author_id": "42107379", "referenced_tweets": [{"type": "replied_to", "id": "1574681807911518209"}], "id": "1574755505486053382", "lang": "en", "conversation_id": "1574539658989809670", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1574576681238646785"], "text": "Interesting work from the phenomenal iStopMM group. This issue is that most EMRs (including Epic) don\u2019t support multiple reference intervals for one lab value. There are alternative approaches, one coming soon from our group! https://t.co/kxxmHAUlud", "created_at": "2022-09-27T01:48:29.000Z", "author_id": "626650397", "referenced_tweets": [{"type": "quoted", "id": "1574422541711642625"}], "id": "1574576681238646785", "lang": "en", "conversation_id": "1574576681238646785", "entities": {"urls": [{"start": 226, "end": 249, "url": "https://t.co/kxxmHAUlud", "expanded_url": "https://twitter.com/sykristinsson/status/1574422541711642625", "display_url": "twitter.com/sykristinsson/\u2026"}], "annotations": [{"start": 37, "end": 43, "probability": 0.8663, "type": "Other", "normalized_text": "iStopMM"}]}, "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1574644674773524481"], "text": "These data needs to be reflected in lab normal ranges. Borderline raised SFLC is one of the commonest referral reasons from #GeneralPractice/#GP to #TeamHaem. https://t.co/n0vl9eoOh6", "created_at": "2022-09-27T06:18:40.000Z", "entities": {"hashtags": [{"start": 124, "end": 140, "tag": "GeneralPractice"}, {"start": 141, "end": 144, "tag": "GP"}, {"start": 148, "end": 157, "tag": "TeamHaem"}], "urls": [{"start": 159, "end": 182, "url": "https://t.co/n0vl9eoOh6", "expanded_url": "https://twitter.com/sykristinsson/status/1574422541711642625", "display_url": "twitter.com/sykristinsson/\u2026"}], "annotations": [{"start": 73, "end": 76, "probability": 0.4327, "type": "Organization", "normalized_text": "SFLC"}, {"start": 149, "end": 156, "probability": 0.4078, "type": "Other", "normalized_text": "TeamHaem"}]}, "author_id": "211982416", "referenced_tweets": [{"type": "quoted", "id": "1574422541711642625"}], "id": "1574644674773524481", "lang": "en", "conversation_id": "1574644674773524481", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1574539658989809670"], "text": "New reference intervals for serum free light chains in CKD. Excited to discuss this study in an upcoming talk. It impacts LC-MGUS definition which can be a precursor to LC-MM,AL amyloidosis. New vs old ref. range\ud83d\udc47\ud83c\udffd\nhttps://t.co/NkC56WqUZp\n#OncoNephrology https://t.co/0gvf2YLY2B", "created_at": "2022-09-26T23:21:22.000Z", "entities": {"hashtags": [{"start": 239, "end": 254, "tag": "OncoNephrology"}], "urls": [{"start": 215, "end": 238, "url": "https://t.co/NkC56WqUZp", "expanded_url": "https://pubmed.ncbi.nlm.nih.gov/36100605/", "display_url": "pubmed.ncbi.nlm.nih.gov/36100605/", "status": 200, "title": "Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study - PubMed", "description": "Serum free light chain (FLC) concentration is greatly affected by kidney function. Using a large prospective population-based cohort, we aimed to establish a reference interval for FLCs in persons with chronic kidney disease (CKD). A total of 75422 participants of the iStopMM study were screened wit \u2026", "unwound_url": "https://pubmed.ncbi.nlm.nih.gov/36100605/"}, {"start": 255, "end": 278, "url": "https://t.co/0gvf2YLY2B", "expanded_url": "https://twitter.com/aishaikh/status/1574539658989809670/photo/1", "display_url": "pic.twitter.com/0gvf2YLY2B", "media_key": "3_1574539654128435200"}, {"start": 255, "end": 278, "url": "https://t.co/0gvf2YLY2B", "expanded_url": "https://twitter.com/aishaikh/status/1574539658989809670/photo/1", "display_url": "pic.twitter.com/0gvf2YLY2B", "media_key": "3_1574539654107484167"}], "annotations": [{"start": 55, "end": 57, "probability": 0.5629, "type": "Other", "normalized_text": "CKD"}, {"start": 122, "end": 128, "probability": 0.6033, "type": "Other", "normalized_text": "LC-MGUS"}, {"start": 169, "end": 170, "probability": 0.5415, "type": "Other", "normalized_text": "LC"}, {"start": 178, "end": 188, "probability": 0.5778, "type": "Other", "normalized_text": "amyloidosis"}]}, "author_id": "42107379", "id": "1574539658989809670", "lang": "en", "conversation_id": "1574539658989809670", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1574579084423663616"], "text": "Important paper suggesting a new normal range of serum free light chains in patients with chronic kidney disease  @iStopMM #mmsm \n\nhttps://t.co/aowv9yA3Iz https://t.co/eFwrFg8qyj", "entities": {"mentions": [{"start": 114, "end": 122, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 123, "end": 128, "tag": "mmsm"}], "urls": [{"start": 131, "end": 154, "url": "https://t.co/aowv9yA3Iz", "expanded_url": "https://www.nature.com/articles/s41408-022-00732-3", "display_url": "nature.com/articles/s4140\u2026", "images": [{"url": "https://pbs.twimg.com/news_img/1574143094328623105/0RfCjRTj?format=png&name=orig", "width": 955, "height": 1078}, {"url": "https://pbs.twimg.com/news_img/1574143094328623105/0RfCjRTj?format=png&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study", "description": "Blood Cancer Journal - Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study", "unwound_url": "https://www.nature.com/articles/s41408-022-00732-3"}, {"start": 155, "end": 178, "url": "https://t.co/eFwrFg8qyj", "expanded_url": "https://twitter.com/HadidiSamer/status/1574579084423663616/photo/1", "display_url": "pic.twitter.com/eFwrFg8qyj", "media_key": "3_1574579080128774162"}], "annotations": [{"start": 90, "end": 111, "probability": 0.6688, "type": "Other", "normalized_text": "chronic kidney disease"}, {"start": 124, "end": 127, "probability": 0.5142, "type": "Other", "normalized_text": "mmsm"}]}, "created_at": "2022-09-27T01:58:02.000Z", "author_id": "774267564", "id": "1574579084423663616", "lang": "en", "conversation_id": "1574579084423663616", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1574466576761245697"], "text": "This is great for clinical practice so we can use objective cut points rather than guestimate in those with CKD. \n\nOf Note, for those who don't do MM everyday, NOTE the units are mg/L in the chart and NOT mg/dL which is often used in the US! https://t.co/68aLK7oXzQ", "created_at": "2022-09-26T18:30:58.000Z", "author_id": "276053436", "referenced_tweets": [{"type": "quoted", "id": "1574422541711642625"}], "id": "1574466576761245697", "lang": "en", "conversation_id": "1574466576761245697", "entities": {"urls": [{"start": 242, "end": 265, "url": "https://t.co/68aLK7oXzQ", "expanded_url": "https://twitter.com/sykristinsson/status/1574422541711642625", "display_url": "twitter.com/sykristinsson/\u2026"}], "annotations": [{"start": 108, "end": 110, "probability": 0.599, "type": "Other", "normalized_text": "CKD"}, {"start": 147, "end": 148, "probability": 0.4785, "type": "Other", "normalized_text": "MM"}, {"start": 238, "end": 239, "probability": 0.9515, "type": "Place", "normalized_text": "US"}]}, "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1574492256748204032"], "text": "This should be practice-changing indeed. Overinterpreting FLC assays is not innocuous. https://t.co/r1BaaIW4km", "created_at": "2022-09-26T20:13:01.000Z", "author_id": "51187036", "referenced_tweets": [{"type": "quoted", "id": "1574422541711642625"}], "id": "1574492256748204032", "lang": "en", "conversation_id": "1574492256748204032", "entities": {"urls": [{"start": 87, "end": 110, "url": "https://t.co/r1BaaIW4km", "expanded_url": "https://twitter.com/sykristinsson/status/1574422541711642625", "display_url": "twitter.com/sykristinsson/\u2026"}], "annotations": [{"start": 58, "end": 60, "probability": 0.4817, "type": "Other", "normalized_text": "FLC"}]}, "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1574493113854443536"], "text": "@Pathologists https://t.co/GLhDyyCqKK", "entities": {"mentions": [{"start": 0, "end": 13, "username": "Pathologists", "id": "24725678"}], "urls": [{"start": 14, "end": 37, "url": "https://t.co/GLhDyyCqKK", "expanded_url": "https://twitter.com/sykristinsson/status/1574422541711642625", "display_url": "twitter.com/sykristinsson/\u2026"}]}, "in_reply_to_user_id": "24725678", "created_at": "2022-09-26T20:16:25.000Z", "author_id": "716254481", "referenced_tweets": [{"type": "quoted", "id": "1574422541711642625"}], "id": "1574493113854443536", "lang": "qam", "conversation_id": "1574493113854443536", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1574503605943443456"], "text": "\ud83d\udc4f\ud83d\udc4f\ud83d\udc4f https://t.co/kUEBqkLuCA", "created_at": "2022-09-26T20:58:07.000Z", "author_id": "846500919021899777", "referenced_tweets": [{"type": "quoted", "id": "1574422541711642625"}], "id": "1574503605943443456", "lang": "art", "conversation_id": "1574503605943443456", "entities": {"urls": [{"start": 4, "end": 27, "url": "https://t.co/kUEBqkLuCA", "expanded_url": "https://twitter.com/sykristinsson/status/1574422541711642625", "display_url": "twitter.com/sykristinsson/\u2026"}]}, "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1574432562285608960"], "text": "The joy this brings me makes me really wonder if I need to get out more... https://t.co/kSNwbAbqMf", "created_at": "2022-09-26T16:15:49.000Z", "author_id": "757934840", "referenced_tweets": [{"type": "quoted", "id": "1574422541711642625"}], "id": "1574432562285608960", "lang": "en", "conversation_id": "1574432562285608960", "entities": {"urls": [{"start": 75, "end": 98, "url": "https://t.co/kSNwbAbqMf", "expanded_url": "https://twitter.com/sykristinsson/status/1574422541711642625", "display_url": "twitter.com/sykristinsson/\u2026"}]}, "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1574426253481820161"], "text": "Definitely practice changing! I've already started to incorporate this in our MGUS/CKD referrals. #mmsm https://t.co/JfuMi7rPUd", "created_at": "2022-09-26T15:50:44.000Z", "entities": {"hashtags": [{"start": 98, "end": 103, "tag": "mmsm"}], "urls": [{"start": 104, "end": 127, "url": "https://t.co/JfuMi7rPUd", "expanded_url": "https://twitter.com/sykristinsson/status/1574422541711642625", "display_url": "twitter.com/sykristinsson/\u2026"}], "annotations": [{"start": 78, "end": 81, "probability": 0.481, "type": "Other", "normalized_text": "MGUS"}, {"start": 83, "end": 85, "probability": 0.5175, "type": "Other", "normalized_text": "CKD"}, {"start": 99, "end": 102, "probability": 0.436, "type": "Other", "normalized_text": "mmsm"}]}, "author_id": "284694610", "referenced_tweets": [{"type": "quoted", "id": "1574422541711642625"}], "id": "1574426253481820161", "lang": "en", "conversation_id": "1574426253481820161", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1574425998589935618"], "text": "#mmsm FLC https://t.co/V8dK4XXFCe", "created_at": "2022-09-26T15:49:44.000Z", "entities": {"hashtags": [{"start": 0, "end": 5, "tag": "mmsm"}], "urls": [{"start": 10, "end": 33, "url": "https://t.co/V8dK4XXFCe", "expanded_url": "https://twitter.com/sykristinsson/status/1574422541711642625", "display_url": "twitter.com/sykristinsson/\u2026"}]}, "author_id": "190337035", "referenced_tweets": [{"type": "quoted", "id": "1574422541711642625"}], "id": "1574425998589935618", "lang": "und", "conversation_id": "1574425998589935618", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1574422541711642625"], "text": "New definition for light chain MGUS! \n\nPractice changing: New ref values for free light chains (FLC), kappa+ lambda in people with kidney dysfunction (GFR&lt;60) just published: https://t.co/xWzjdbrMYw @thorirlong \n\nAvoid unnecessary consultations, bone marrows, and\u2b07\ufe0fpatient anxiety https://t.co/jGL2LO9cuw", "entities": {"mentions": [{"start": 202, "end": 213, "username": "thorirlong", "id": "3009607268"}], "urls": [{"start": 178, "end": 201, "url": "https://t.co/xWzjdbrMYw", "expanded_url": "https://rdcu.be/cVw40", "display_url": "rdcu.be/cVw40", "status": 200, "unwound_url": "https://www.nature.com/articles/s41408-022-00732-3.epdf?sharing_token=be_jyr5_H0n0KX4Ae9Tl4tRgN0jAjWel9jnR3ZoTv0OhZ7TA_7WiBKrFOCJxMthJbyzHLTvYped-D9O_r3sEwUciwYize6yB4vNfAdOUgpUowNt8hvVF0HRLK5VyCU63JAo6rUjGdycaq4FC3pxeL8hc33kkWkxAJpLGZAd_nw4%3D&error=cookies_not_supported&code=879af185-f6a8-4c38-a1a9-331b83cc5f68"}, {"start": 284, "end": 307, "url": "https://t.co/jGL2LO9cuw", "expanded_url": "https://twitter.com/sykristinsson/status/1574422541711642625/photo/1", "display_url": "pic.twitter.com/jGL2LO9cuw", "media_key": "3_1574415310794407936"}], "annotations": [{"start": 31, "end": 34, "probability": 0.5665, "type": "Other", "normalized_text": "MGUS"}]}, "created_at": "2022-09-26T15:35:59.000Z", "author_id": "3078258341", "id": "1574422541711642625", "lang": "en", "conversation_id": "1574422541711642625", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1572567061150433280"], "text": "The serum free light chain assay is important for diagnosis &amp; response assessment in MGUS, myeloma, AL amyloidosis. But the normal range is affected by renal function. \n\n@thorirlong @sykristinsson establish reference ranges in renal failure @BloodCancerJnl https://t.co/t7fz8Ggnzb https://t.co/fIx0XdkIw8", "entities": {"mentions": [{"start": 174, "end": 185, "username": "thorirlong", "id": "3009607268"}, {"start": 186, "end": 200, "username": "sykristinsson", "id": "3078258341"}, {"start": 245, "end": 260, "username": "BloodCancerJnl", "id": "1417061180997345288"}], "urls": [{"start": 261, "end": 284, "url": "https://t.co/t7fz8Ggnzb", "expanded_url": "https://www.nature.com/articles/s41408-022-00732-3", "display_url": "nature.com/articles/s4140\u2026", "images": [{"url": "https://pbs.twimg.com/news_img/1574143094328623105/0RfCjRTj?format=png&name=orig", "width": 955, "height": 1078}, {"url": "https://pbs.twimg.com/news_img/1574143094328623105/0RfCjRTj?format=png&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study", "description": "Blood Cancer Journal - Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study", "unwound_url": "https://www.nature.com/articles/s41408-022-00732-3"}, {"start": 285, "end": 308, "url": "https://t.co/fIx0XdkIw8", "expanded_url": "https://twitter.com/VincentRK/status/1572567061150433280/photo/1", "display_url": "pic.twitter.com/fIx0XdkIw8", "media_key": "3_1572567057790652418"}], "annotations": [{"start": 89, "end": 92, "probability": 0.4051, "type": "Place", "normalized_text": "MGUS"}, {"start": 95, "end": 101, "probability": 0.5671, "type": "Other", "normalized_text": "myeloma"}, {"start": 107, "end": 117, "probability": 0.631, "type": "Other", "normalized_text": "amyloidosis"}]}, "created_at": "2022-09-21T12:42:58.000Z", "author_id": "24261916", "id": "1572567061150433280", "lang": "en", "conversation_id": "1572567061150433280", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1570762251484954632"], "text": "IStopMm and sFLC! Great work by @sykristinsson team! https://t.co/tAsIYviv7C", "entities": {"mentions": [{"start": 32, "end": 46, "username": "sykristinsson", "id": "3078258341"}], "urls": [{"start": 53, "end": 76, "url": "https://t.co/tAsIYviv7C", "expanded_url": "https://twitter.com/thorirlong/status/1570755512580583424", "display_url": "twitter.com/thorirlong/sta\u2026"}], "annotations": [{"start": 0, "end": 6, "probability": 0.5498, "type": "Other", "normalized_text": "IStopMm"}, {"start": 12, "end": 15, "probability": 0.432, "type": "Other", "normalized_text": "sFLC"}]}, "created_at": "2022-09-16T13:11:18.000Z", "author_id": "114124641", "referenced_tweets": [{"type": "quoted", "id": "1570755512580583424"}], "id": "1570762251484954632", "lang": "en", "conversation_id": "1570762251484954632", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1570945974805352449"], "text": "Key paper - we got a lot of econsults for slightly abnormal light chains in people with impaired renal function. https://t.co/X6HaFqW3el", "created_at": "2022-09-17T01:21:21.000Z", "author_id": "16827782", "referenced_tweets": [{"type": "quoted", "id": "1570755512580583424"}], "id": "1570945974805352449", "lang": "en", "conversation_id": "1570945974805352449", "entities": {"urls": [{"start": 113, "end": 136, "url": "https://t.co/X6HaFqW3el", "expanded_url": "https://twitter.com/thorirlong/status/1570755512580583424", "display_url": "twitter.com/thorirlong/sta\u2026"}]}, "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1571022556739796992"], "text": "This is gold for everyday decisions. FLC reference intervals (in mainly white population) without selection bias: https://t.co/PbuKKLVLvu", "created_at": "2022-09-17T06:25:40.000Z", "author_id": "1172919281513897984", "referenced_tweets": [{"type": "quoted", "id": "1570755512580583424"}], "id": "1571022556739796992", "lang": "en", "conversation_id": "1571022556739796992", "entities": {"urls": [{"start": 114, "end": 137, "url": "https://t.co/PbuKKLVLvu", "expanded_url": "https://twitter.com/thorirlong/status/1570755512580583424", "display_url": "twitter.com/thorirlong/sta\u2026"}], "annotations": [{"start": 37, "end": 39, "probability": 0.4267, "type": "Other", "normalized_text": "FLC"}]}, "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1571035404073324546"], "text": "Fantastic. Now publish an update in a #nephrology journal to reduce the needless referrals. https://t.co/9t3qco0Kw4", "created_at": "2022-09-17T07:16:43.000Z", "entities": {"hashtags": [{"start": 38, "end": 49, "tag": "nephrology"}], "urls": [{"start": 92, "end": 115, "url": "https://t.co/9t3qco0Kw4", "expanded_url": "https://twitter.com/thorirlong/status/1570755512580583424", "display_url": "twitter.com/thorirlong/sta\u2026"}], "annotations": [{"start": 39, "end": 48, "probability": 0.7623, "type": "Other", "normalized_text": "nephrology"}]}, "author_id": "1687880251", "referenced_tweets": [{"type": "quoted", "id": "1570755512580583424"}], "id": "1571035404073324546", "lang": "en", "conversation_id": "1571035404073324546", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1571130734311800834"], "text": "Very important and useful paper for both #mmsm &amp; #nephrology. New reference intervals for the FLC ratio in pts with CKI bases on the prospective #iStopMM project. Major weakness: minimal minority pts included in the cohort. @ManniMD1 @Drjhoffmanmiami @Humberto_MarCor https://t.co/a82WWid2ah", "entities": {"mentions": [{"start": 228, "end": 237, "username": "ManniMD1", "id": "1269642863924609025"}, {"start": 238, "end": 254, "username": "Drjhoffmanmiami", "id": "1225723298"}, {"start": 255, "end": 271, "username": "Humberto_MarCor", "id": "242985837"}], "hashtags": [{"start": 41, "end": 46, "tag": "mmsm"}, {"start": 53, "end": 64, "tag": "nephrology"}, {"start": 149, "end": 157, "tag": "iStopMM"}], "urls": [{"start": 272, "end": 295, "url": "https://t.co/a82WWid2ah", "expanded_url": "https://twitter.com/thorirlong/status/1570755512580583424", "display_url": "twitter.com/thorirlong/sta\u2026"}], "annotations": [{"start": 42, "end": 45, "probability": 0.6224, "type": "Other", "normalized_text": "mmsm"}, {"start": 54, "end": 63, "probability": 0.6124, "type": "Other", "normalized_text": "nephrology"}, {"start": 98, "end": 100, "probability": 0.4962, "type": "Other", "normalized_text": "FLC"}, {"start": 120, "end": 122, "probability": 0.4945, "type": "Other", "normalized_text": "CKI"}, {"start": 150, "end": 156, "probability": 0.7726, "type": "Other", "normalized_text": "iStopMM"}]}, "created_at": "2022-09-17T13:35:31.000Z", "author_id": "4067920889", "referenced_tweets": [{"type": "quoted", "id": "1570755512580583424"}], "id": "1571130734311800834", "lang": "en", "conversation_id": "1571130734311800834", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1571206926314213376"], "text": "What's the normal kappa lambda free light chain ratio in CKD? @Amyloid_Planet https://t.co/GdJ62jN6M7", "entities": {"mentions": [{"start": 62, "end": 77, "username": "Amyloid_Planet", "id": "1138405094"}], "urls": [{"start": 78, "end": 101, "url": "https://t.co/GdJ62jN6M7", "expanded_url": "https://twitter.com/thorirlong/status/1570755512580583424", "display_url": "twitter.com/thorirlong/sta\u2026"}], "annotations": [{"start": 18, "end": 22, "probability": 0.464, "type": "Other", "normalized_text": "kappa"}, {"start": 57, "end": 59, "probability": 0.5161, "type": "Other", "normalized_text": "CKD"}]}, "created_at": "2022-09-17T18:38:17.000Z", "author_id": "18084746", "referenced_tweets": [{"type": "quoted", "id": "1570755512580583424"}], "id": "1571206926314213376", "lang": "en", "conversation_id": "1571206926314213376", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1570755512580583424"], "text": "Our paper were we redefine the reference intervals for serum FLCs and FLC ratio in individuals with chronic kidney disease using the #iStopMM data has been published!  Full paper here:\nhttps://t.co/igtZ2xZUUV\n#mmsm #Nephrology \nSummary of the new reference intervals: https://t.co/IjGAMPzk5a", "created_at": "2022-09-16T12:44:32.000Z", "entities": {"hashtags": [{"start": 133, "end": 141, "tag": "iStopMM"}, {"start": 209, "end": 214, "tag": "mmsm"}, {"start": 215, "end": 226, "tag": "Nephrology"}], "urls": [{"start": 185, "end": 208, "url": "https://t.co/igtZ2xZUUV", "expanded_url": "https://www.nature.com/articles/s41408-022-00732-3", "display_url": "nature.com/articles/s4140\u2026", "images": [{"url": "https://pbs.twimg.com/news_img/1574143094328623105/0RfCjRTj?format=png&name=orig", "width": 955, "height": 1078}, {"url": "https://pbs.twimg.com/news_img/1574143094328623105/0RfCjRTj?format=png&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study", "description": "Blood Cancer Journal - Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study", "unwound_url": "https://www.nature.com/articles/s41408-022-00732-3"}, {"start": 268, "end": 291, "url": "https://t.co/IjGAMPzk5a", "expanded_url": "https://twitter.com/thorirlong/status/1570755512580583424/photo/1", "display_url": "pic.twitter.com/IjGAMPzk5a", "media_key": "3_1570752862019362819"}], "annotations": [{"start": 61, "end": 64, "probability": 0.5472, "type": "Other", "normalized_text": "FLCs"}, {"start": 70, "end": 72, "probability": 0.5697, "type": "Other", "normalized_text": "FLC"}, {"start": 115, "end": 121, "probability": 0.5115, "type": "Other", "normalized_text": "disease"}, {"start": 134, "end": 140, "probability": 0.8143, "type": "Other", "normalized_text": "iStopMM"}, {"start": 216, "end": 225, "probability": 0.4976, "type": "Other", "normalized_text": "Nephrology"}]}, "author_id": "3009607268", "id": "1570755512580583424", "lang": "en", "conversation_id": "1570755512580583424", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1570805698900135936"], "text": "Another fabulous study by the @iStopMM team! The renal reference intervals are an important contribution that would be impossible without the data generated by our study https://t.co/OrzVb8pZWu", "entities": {"mentions": [{"start": 30, "end": 38, "username": "iStopMM", "id": "844232399319941122"}], "urls": [{"start": 170, "end": 193, "url": "https://t.co/OrzVb8pZWu", "expanded_url": "https://twitter.com/thorirlong/status/1570755512580583424", "display_url": "twitter.com/thorirlong/sta\u2026"}]}, "created_at": "2022-09-16T16:03:57.000Z", "author_id": "133109181", "referenced_tweets": [{"type": "quoted", "id": "1570755512580583424"}], "id": "1570805698900135936", "lang": "en", "conversation_id": "1570805698900135936", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1570727119180955648"], "text": "Disease progression forms of MGUS and SMM are early stages of #myeloma \n@IMFmyeloma \u2018s @iStopMM project aims to prevent myeloma with understanding MGUS &amp; SMM \n#knowmyeloma #istopMM #MultipleMyeloma #BloodCancerAwarenessMonth https://t.co/IUJNpFZf9f", "entities": {"mentions": [{"start": 72, "end": 83, "username": "IMFmyeloma", "id": "34340707"}, {"start": 87, "end": 95, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 62, "end": 70, "tag": "myeloma"}, {"start": 163, "end": 175, "tag": "knowmyeloma"}, {"start": 176, "end": 184, "tag": "istopMM"}, {"start": 185, "end": 201, "tag": "MultipleMyeloma"}, {"start": 202, "end": 228, "tag": "BloodCancerAwarenessMonth"}], "urls": [{"start": 229, "end": 252, "url": "https://t.co/IUJNpFZf9f", "expanded_url": "https://twitter.com/GMyelomaAN/status/1570727119180955648/photo/1", "display_url": "pic.twitter.com/IUJNpFZf9f", "media_key": "3_1570727110423052289"}, {"start": 229, "end": 252, "url": "https://t.co/IUJNpFZf9f", "expanded_url": "https://twitter.com/GMyelomaAN/status/1570727119180955648/photo/1", "display_url": "pic.twitter.com/IUJNpFZf9f", "media_key": "3_1570727110402101249"}], "annotations": [{"start": 29, "end": 32, "probability": 0.4952, "type": "Other", "normalized_text": "MGUS"}, {"start": 38, "end": 40, "probability": 0.6303, "type": "Other", "normalized_text": "SMM"}, {"start": 63, "end": 69, "probability": 0.6733, "type": "Other", "normalized_text": "myeloma"}, {"start": 120, "end": 126, "probability": 0.5014, "type": "Other", "normalized_text": "myeloma"}, {"start": 147, "end": 150, "probability": 0.4492, "type": "Other", "normalized_text": "MGUS"}, {"start": 158, "end": 160, "probability": 0.4871, "type": "Other", "normalized_text": "SMM"}, {"start": 186, "end": 200, "probability": 0.5054, "type": "Other", "normalized_text": "MultipleMyeloma"}]}, "created_at": "2022-09-16T10:51:42.000Z", "author_id": "3083937603", "id": "1570727119180955648", "lang": "en", "conversation_id": "1570727119180955648", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1570515590418403328"], "text": "What a @iStopMM team! Congratulations @astrunhelga! Well deserved. \nAnd congrats to @Annakaren981 @SaemundurMD @SigrunThorstei1 for great projects. Myeloma research is moving fast forward with these rising stars!\n@IMFmyeloma https://t.co/NrocETCrRV", "entities": {"mentions": [{"start": 7, "end": 15, "username": "iStopMM", "id": "844232399319941122"}, {"start": 38, "end": 50, "username": "astrunhelga", "id": "2758432772"}, {"start": 84, "end": 97, "username": "Annakaren981", "id": "1268269154022436866"}, {"start": 98, "end": 110, "username": "SaemundurMD", "id": "1054784756704010241"}, {"start": 111, "end": 127, "username": "SigrunThorstei1", "id": "1198917648630919168"}, {"start": 213, "end": 224, "username": "IMFmyeloma", "id": "34340707"}], "urls": [{"start": 225, "end": 248, "url": "https://t.co/NrocETCrRV", "expanded_url": "https://twitter.com/SigrunThorstei1/status/1570470773609099264", "display_url": "twitter.com/SigrunThorstei\u2026"}], "annotations": [{"start": 148, "end": 154, "probability": 0.5916, "type": "Other", "normalized_text": "Myeloma"}]}, "created_at": "2022-09-15T20:51:10.000Z", "author_id": "3078258341", "referenced_tweets": [{"type": "quoted", "id": "1570470773609099264"}], "id": "1570515590418403328", "lang": "en", "conversation_id": "1570515590418403328", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1570470773609099264"], "text": "Proud of our students at the #nmsg meeting presenting #iStopMM data and @astrunhelga winning best abstract! @Annakaren981 @SaemundurMD @sykristinsson https://t.co/tRSOCuF0QV", "entities": {"mentions": [{"start": 72, "end": 84, "username": "astrunhelga", "id": "2758432772"}, {"start": 108, "end": 121, "username": "Annakaren981", "id": "1268269154022436866"}, {"start": 122, "end": 134, "username": "SaemundurMD", "id": "1054784756704010241"}, {"start": 135, "end": 149, "username": "sykristinsson", "id": "3078258341"}], "hashtags": [{"start": 29, "end": 34, "tag": "nmsg"}, {"start": 54, "end": 62, "tag": "iStopMM"}], "urls": [{"start": 150, "end": 173, "url": "https://t.co/tRSOCuF0QV", "expanded_url": "https://twitter.com/SigrunThorstei1/status/1570470773609099264/photo/1", "display_url": "pic.twitter.com/tRSOCuF0QV", "media_key": "3_1570470770270261248"}], "annotations": [{"start": 30, "end": 33, "probability": 0.3982, "type": "Other", "normalized_text": "nmsg"}, {"start": 55, "end": 61, "probability": 0.6975, "type": "Other", "normalized_text": "iStopMM"}]}, "created_at": "2022-09-15T17:53:05.000Z", "author_id": "1198917648630919168", "id": "1570470773609099264", "lang": "en", "conversation_id": "1570470773609099264", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1558530813167370246"], "text": "@eliaseythorsson @iStopMM iStopMM is a fantastic study. It will yield important data for years to come.", "entities": {"mentions": [{"start": 0, "end": 16, "username": "eliaseythorsson", "id": "133109181"}, {"start": 17, "end": 25, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 26, "end": 32, "probability": 0.8652, "type": "Other", "normalized_text": "iStopMM"}]}, "in_reply_to_user_id": "133109181", "created_at": "2022-08-13T19:07:56.000Z", "author_id": "24261916", "referenced_tweets": [{"type": "replied_to", "id": "1558526217187377152"}], "id": "1558530813167370246", "lang": "en", "conversation_id": "1558526217187377152", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1552287402634448897"], "text": "Join me at IMS 2022 where I will share some new findings from the @iStopMM study and discuss the role of early intervention in myeloma\n\n@Myeloma_Society @IMFmyeloma #mmsm \n\nhttps://t.co/CnAOhgmCJ5", "entities": {"mentions": [{"start": 66, "end": 74, "username": "iStopMM", "id": "844232399319941122"}, {"start": 136, "end": 152, "username": "Myeloma_Society", "id": "841751045034369025"}, {"start": 153, "end": 164, "username": "IMFmyeloma", "id": "34340707"}], "hashtags": [{"start": 165, "end": 170, "tag": "mmsm"}], "urls": [{"start": 173, "end": 196, "url": "https://t.co/CnAOhgmCJ5", "expanded_url": "https://l.feathr.co/IMS-2022/Sigurdur-Y-Kristinsson", "display_url": "l.feathr.co/IMS-2022/Sigur\u2026", "images": [{"url": "https://pbs.twimg.com/news_img/1552287425820561408/Jtq1jYRH?format=jpg&name=orig", "width": 1200, "height": 630}, {"url": "https://pbs.twimg.com/news_img/1552287425820561408/Jtq1jYRH?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Join me for IMS 2022!", "description": "Join me at the 19th International Myeloma Society Annual Meeting this August in Los Angeles, California!", "unwound_url": "https://l.feathr.co/IMS-2022/Sigurdur-Y-Kristinsson"}], "annotations": [{"start": 11, "end": 18, "probability": 0.6704, "type": "Other", "normalized_text": "IMS 2022"}, {"start": 127, "end": 133, "probability": 0.6351, "type": "Other", "normalized_text": "myeloma"}]}, "created_at": "2022-07-27T13:38:51.000Z", "author_id": "3078258341", "id": "1552287402634448897", "lang": "en", "conversation_id": "1552287402634448897", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1534441924760854528"], "text": "\"If screening improves OS, we should, if it doesn't, we shouldn't\", \"please give me 2 more years. I'll give you the answer\" @sykristinsson of @iStopMM \n@SagarLonialMD cautioning generalization from predominantly Caucasian pt base to non-Caucasian pts. #mmsm #IMWG2022 #smm https://t.co/4p1SrQaEVG", "entities": {"mentions": [{"start": 124, "end": 138, "username": "sykristinsson", "id": "3078258341"}, {"start": 142, "end": 150, "username": "iStopMM", "id": "844232399319941122"}, {"start": 152, "end": 166, "username": "SagarLonialMD", "id": "2289851689"}], "hashtags": [{"start": 252, "end": 257, "tag": "mmsm"}, {"start": 258, "end": 267, "tag": "IMWG2022"}, {"start": 268, "end": 272, "tag": "smm"}], "urls": [{"start": 273, "end": 296, "url": "https://t.co/4p1SrQaEVG", "expanded_url": "https://twitter.com/NorthTxMSG/status/1534441924760854528/photo/1", "display_url": "pic.twitter.com/4p1SrQaEVG", "media_key": "3_1534441919652184064"}, {"start": 273, "end": 296, "url": "https://t.co/4p1SrQaEVG", "expanded_url": "https://twitter.com/NorthTxMSG/status/1534441924760854528/photo/1", "display_url": "pic.twitter.com/4p1SrQaEVG", "media_key": "3_1534441922391048192"}], "annotations": [{"start": 23, "end": 24, "probability": 0.4795, "type": "Other", "normalized_text": "OS"}, {"start": 253, "end": 256, "probability": 0.4898, "type": "Other", "normalized_text": "mmsm"}, {"start": 259, "end": 266, "probability": 0.5874, "type": "Other", "normalized_text": "IMWG2022"}]}, "created_at": "2022-06-08T07:47:18.000Z", "author_id": "961409220", "id": "1534441924760854528", "lang": "en", "conversation_id": "1534441924760854528", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1531290538300911619"], "text": "11) Does everyone have an MGUS phase before getting myeloma? \n\nYes. And usually MGUS phase is there for many years. The iSTOPMM randomized trial led by @sykristinsson is testing the role of screening.", "entities": {"mentions": [{"start": 152, "end": 166, "username": "sykristinsson", "id": "3078258341"}], "annotations": [{"start": 26, "end": 29, "probability": 0.6129, "type": "Other", "normalized_text": "MGUS"}, {"start": 52, "end": 58, "probability": 0.6977, "type": "Other", "normalized_text": "myeloma"}, {"start": 80, "end": 83, "probability": 0.4022, "type": "Other", "normalized_text": "MGUS"}, {"start": 120, "end": 126, "probability": 0.7208, "type": "Other", "normalized_text": "iSTOPMM"}]}, "in_reply_to_user_id": "24261916", "created_at": "2022-05-30T15:04:48.000Z", "author_id": "24261916", "referenced_tweets": [{"type": "replied_to", "id": "1531290537432686592"}], "id": "1531290538300911619", "lang": "en", "conversation_id": "1531290525738885121", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1524814264497844230"], "text": "Session 4: Plenary lectures Chair: Thierry Facon, France - Advances in WM, Steven Treon, USA -  \u2066@iStopMM\u2069 study \u2013 the impact of nationwide screening, Sigurdur Kristinsson, Iceland #COMY22 #mmsm \u2066@COMyCongress\u2069 #MGUS #MultipleMyeloma https://t.co/lsqDcql5iV", "entities": {"mentions": [{"start": 97, "end": 105, "username": "iStopMM", "id": "844232399319941122"}, {"start": 196, "end": 209, "username": "COMyCongress", "id": "722448698307919872"}], "hashtags": [{"start": 181, "end": 188, "tag": "COMY22"}, {"start": 189, "end": 194, "tag": "mmsm"}, {"start": 211, "end": 216, "tag": "MGUS"}, {"start": 217, "end": 233, "tag": "MultipleMyeloma"}], "urls": [{"start": 234, "end": 257, "url": "https://t.co/lsqDcql5iV", "expanded_url": "https://twitter.com/MMTrials/status/1524814264497844230/photo/1", "display_url": "pic.twitter.com/lsqDcql5iV", "media_key": "3_1524814247850561536"}, {"start": 234, "end": 257, "url": "https://t.co/lsqDcql5iV", "expanded_url": "https://twitter.com/MMTrials/status/1524814264497844230/photo/1", "display_url": "pic.twitter.com/lsqDcql5iV", "media_key": "3_1524814252229513231"}, {"start": 234, "end": 257, "url": "https://t.co/lsqDcql5iV", "expanded_url": "https://twitter.com/MMTrials/status/1524814264497844230/photo/1", "display_url": "pic.twitter.com/lsqDcql5iV", "media_key": "3_1524814255920500736"}, {"start": 234, "end": 257, "url": "https://t.co/lsqDcql5iV", "expanded_url": "https://twitter.com/MMTrials/status/1524814264497844230/photo/1", "display_url": "pic.twitter.com/lsqDcql5iV", "media_key": "3_1524814259003203585"}], "annotations": [{"start": 35, "end": 47, "probability": 0.7275, "type": "Person", "normalized_text": "Thierry Facon"}, {"start": 50, "end": 55, "probability": 0.8144, "type": "Place", "normalized_text": "France"}, {"start": 75, "end": 86, "probability": 0.6018, "type": "Person", "normalized_text": "Steven Treon"}, {"start": 89, "end": 91, "probability": 0.8923, "type": "Place", "normalized_text": "USA"}, {"start": 147, "end": 166, "probability": 0.4695, "type": "Place", "normalized_text": "ng, Sigurdur Kristin"}, {"start": 169, "end": 175, "probability": 0.942, "type": "Place", "normalized_text": "on, Ice"}]}, "created_at": "2022-05-12T18:10:24.000Z", "author_id": "1450806488885248005", "id": "1524814264497844230", "lang": "en", "conversation_id": "1524814264497844230", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1524475535056900098"], "text": "The 8th World Congress on CONTROVERSIES IN MULTIPLE MYELOMA (COMy) starts tomorrow in Paris. 4 days of fantastic speakers, pretty much covering all aspects of MM/MGUS! @Mohty_EBMT \n\nMy talk: \"@iStopMM study - the impact of nationwide  screening\" on on at 7.05 pm CEST. https://t.co/Tfbg4KJk2j", "entities": {"mentions": [{"start": 168, "end": 179, "username": "Mohty_EBMT", "id": "2626263112"}, {"start": 192, "end": 200, "username": "iStopMM", "id": "844232399319941122"}], "urls": [{"start": 269, "end": 292, "url": "https://t.co/Tfbg4KJk2j", "expanded_url": "https://twitter.com/COMyCongress/status/1524439920349265925", "display_url": "twitter.com/COMyCongress/s\u2026"}], "annotations": [{"start": 52, "end": 58, "probability": 0.7503, "type": "Place", "normalized_text": "MYELOMA"}, {"start": 86, "end": 90, "probability": 0.9849, "type": "Place", "normalized_text": "Paris"}, {"start": 162, "end": 165, "probability": 0.555, "type": "Place", "normalized_text": "MGUS"}]}, "created_at": "2022-05-11T19:44:25.000Z", "author_id": "3078258341", "referenced_tweets": [{"type": "quoted", "id": "1524439920349265925"}], "id": "1524475535056900098", "lang": "en", "conversation_id": "1524475535056900098", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1523399429755383808"], "text": "We wrote a review on risk factors for MGUS: \n\n\"A common limitation to most previous studies on MGUS and its associations with other diseases, is the fact that they are based on clinical cohorts, resulting in selection bias.\" https://t.co/L7AM7WumZ7", "created_at": "2022-05-08T20:28:22.000Z", "author_id": "3078258341", "referenced_tweets": [{"type": "quoted", "id": "1519731175060692993"}], "id": "1523399429755383808", "lang": "en", "conversation_id": "1523399429755383808", "entities": {"urls": [{"start": 225, "end": 248, "url": "https://t.co/L7AM7WumZ7", "expanded_url": "https://twitter.com/FrontImmunol/status/1519731175060692993", "display_url": "twitter.com/FrontImmunol/s\u2026"}], "annotations": [{"start": 38, "end": 41, "probability": 0.6592, "type": "Organization", "normalized_text": "MGUS"}, {"start": 95, "end": 98, "probability": 0.6159, "type": "Organization", "normalized_text": "MGUS"}]}, "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1523399432565248002"], "text": "\"... screening studies, such as @iStopMM  are pivotal when it comes to evaluation of the true biological- and epidemiological implications of MGUS, before causation is confirmed.\"", "entities": {"mentions": [{"start": 32, "end": 40, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 142, "end": 145, "probability": 0.5222, "type": "Organization", "normalized_text": "MGUS"}]}, "in_reply_to_user_id": "3078258341", "created_at": "2022-05-08T20:28:22.000Z", "author_id": "3078258341", "referenced_tweets": [{"type": "replied_to", "id": "1523399429755383808"}], "id": "1523399432565248002", "lang": "en", "conversation_id": "1523399429755383808", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1521606851623849986"], "text": "Next generation myeloma researchers! Congrats!\n\nMedical students @uni_iceland: @Annakaren981 (genetics in MM/SMM) and Astrun H Jonsdottir (\u2b06\ufe0fCa++ in MGUS) present their Bachelor of Science projects. Future stars of myeloma research! #mmsm @SaemundurMD @SigrunThorstei1 @iStopMM https://t.co/DKCcjWcnj6", "entities": {"mentions": [{"start": 65, "end": 77, "username": "uni_iceland", "id": "2769866904"}, {"start": 79, "end": 92, "username": "Annakaren981", "id": "1268269154022436866"}, {"start": 239, "end": 251, "username": "SaemundurMD", "id": "1054784756704010241"}, {"start": 252, "end": 268, "username": "SigrunThorstei1", "id": "1198917648630919168"}, {"start": 269, "end": 277, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 233, "end": 238, "tag": "mmsm"}], "urls": [{"start": 278, "end": 301, "url": "https://t.co/DKCcjWcnj6", "expanded_url": "https://twitter.com/sykristinsson/status/1521606851623849986/photo/1", "display_url": "pic.twitter.com/DKCcjWcnj6", "media_key": "3_1521604197468327939"}, {"start": 278, "end": 301, "url": "https://t.co/DKCcjWcnj6", "expanded_url": "https://twitter.com/sykristinsson/status/1521606851623849986/photo/1", "display_url": "pic.twitter.com/DKCcjWcnj6", "media_key": "3_1521606699286769665"}], "annotations": [{"start": 16, "end": 22, "probability": 0.5549, "type": "Other", "normalized_text": "myeloma"}, {"start": 109, "end": 111, "probability": 0.429, "type": "Other", "normalized_text": "SMM"}, {"start": 118, "end": 136, "probability": 0.764, "type": "Other", "normalized_text": "Astrun H Jonsdottir"}, {"start": 149, "end": 152, "probability": 0.3769, "type": "Organization", "normalized_text": "MGUS"}]}, "created_at": "2022-05-03T21:45:18.000Z", "author_id": "3078258341", "id": "1521606851623849986", "lang": "en", "conversation_id": "1521606851623849986", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1520793680864555008"], "text": "So, in our quest to cure myeloma, will we medicalize large swathes of society, and diagnose them with diseases, that previously did not exist? \n\nI do not know the answer to that question, but I ponder deeply.\n\nI anxiously await results from @iStopMM to give us a better answer.", "entities": {"mentions": [{"start": 241, "end": 249, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 25, "end": 31, "probability": 0.7446, "type": "Other", "normalized_text": "myeloma"}]}, "in_reply_to_user_id": "1269642863924609025", "created_at": "2022-05-01T15:54:03.000Z", "author_id": "1269642863924609025", "referenced_tweets": [{"type": "replied_to", "id": "1520793677345574915"}], "id": "1520793680864555008", "lang": "en", "conversation_id": "1520793612023480324", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1517181723431297024"], "text": "We just pub'd this article on the myeloma mystery - and how the study of an abnormal protein anomaly with a weird name, MGUS, could solve it. This story looks at work from: @IreneGhobrial + @iStopMM. Hold onto your hats this is gonna be a long thread\n\nhttps://t.co/WzeXBon9bx", "entities": {"mentions": [{"start": 173, "end": 187, "username": "IreneGhobrial", "id": "452461489"}, {"start": 190, "end": 198, "username": "iStopMM", "id": "844232399319941122"}], "urls": [{"start": 252, "end": 275, "url": "https://t.co/WzeXBon9bx", "expanded_url": "https://www.statnews.com/2022/04/21/searching-for-early-detection-of-multiple-myeloma/", "display_url": "statnews.com/2022/04/21/sea\u2026", "status": 200, "unwound_url": "https://www.statnews.com/2022/04/21/searching-for-early-detection-of-multiple-myeloma/"}], "annotations": [{"start": 34, "end": 40, "probability": 0.7309, "type": "Other", "normalized_text": "myeloma"}, {"start": 120, "end": 123, "probability": 0.3867, "type": "Other", "normalized_text": "MGUS"}]}, "created_at": "2022-04-21T16:41:25.000Z", "author_id": "2305549310", "id": "1517181723431297024", "lang": "en", "conversation_id": "1517181723431297024", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1506082804035170304"], "text": "Prevention would be SO nice!  @sykristinsson You can do this!  Talk about #MYelomaACTION #myeloma @IMFmyeloma https://t.co/ag3shhEcky", "entities": {"mentions": [{"start": 30, "end": 44, "username": "sykristinsson", "id": "3078258341"}, {"start": 98, "end": 109, "username": "IMFmyeloma", "id": "34340707"}], "hashtags": [{"start": 74, "end": 88, "tag": "MYelomaACTION"}, {"start": 89, "end": 97, "tag": "myeloma"}], "urls": [{"start": 110, "end": 133, "url": "https://t.co/ag3shhEcky", "expanded_url": "https://twitter.com/uni_iceland/status/1504421007704170497", "display_url": "twitter.com/uni_iceland/st\u2026"}], "annotations": [{"start": 75, "end": 87, "probability": 0.6456, "type": "Other", "normalized_text": "MYelomaACTION"}, {"start": 90, "end": 96, "probability": 0.755, "type": "Other", "normalized_text": "myeloma"}]}, "created_at": "2022-03-22T01:38:16.000Z", "author_id": "961398000", "referenced_tweets": [{"type": "quoted", "id": "1504421007704170497"}], "id": "1506082804035170304", "lang": "en", "conversation_id": "1506082804035170304", "source": "Twitter for iPad"}, {"edit_history_tweet_ids": ["1504820397476401156"], "text": "I am so proud to be a @ERC_Research CoG grant recipient. We will build on the success of the @iStopMM and study smoldering myeloma in ridiculous detail! \nEpidemiology, progression, QoL, early intervention, role of mass spectrometry, flow cytometry, germline/somatic genetics #mmsm https://t.co/kvsXiqPh6a", "entities": {"mentions": [{"start": 22, "end": 35, "username": "ERC_Research", "id": "467551928"}, {"start": 93, "end": 101, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 275, "end": 280, "tag": "mmsm"}], "urls": [{"start": 281, "end": 304, "url": "https://t.co/kvsXiqPh6a", "expanded_url": "https://twitter.com/ERC_Research/status/1504412294033264643", "display_url": "twitter.com/ERC_Research/s\u2026"}], "annotations": [{"start": 36, "end": 38, "probability": 0.6783, "type": "Other", "normalized_text": "CoG"}, {"start": 123, "end": 129, "probability": 0.6821, "type": "Other", "normalized_text": "myeloma"}, {"start": 181, "end": 183, "probability": 0.4629, "type": "Other", "normalized_text": "QoL"}, {"start": 276, "end": 279, "probability": 0.555, "type": "Other", "normalized_text": "mmsm"}]}, "created_at": "2022-03-18T14:01:55.000Z", "author_id": "3078258341", "referenced_tweets": [{"type": "quoted", "id": "1504412294033264643"}], "id": "1504820397476401156", "lang": "en", "conversation_id": "1504820397476401156", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1504421007704170497"], "text": "Sigur\u00f0ur Yngvi Kristinsson @uni_iceland, was awarded a grant of EUR 2 million, from @ERC_Research to focus on smoldering myeloma in iStopMM \u2013 a national initiative to combat multiple myeloma. The study is conducted by an interdisciplinary research team.\n\ud83d\udc47\nhttps://t.co/EcqQgZRlxP https://t.co/t6682Q1BDu", "entities": {"mentions": [{"start": 27, "end": 39, "username": "uni_iceland", "id": "2769866904"}, {"start": 84, "end": 97, "username": "ERC_Research", "id": "467551928"}], "urls": [{"start": 256, "end": 279, "url": "https://t.co/EcqQgZRlxP", "expanded_url": "http://bit.ly/3qflmwd", "display_url": "bit.ly/3qflmwd", "status": 200, "unwound_url": "https://english.hi.is/news/major_grant_for_further_research_on_multiple_myeloma"}, {"start": 280, "end": 303, "url": "https://t.co/t6682Q1BDu", "expanded_url": "https://twitter.com/uni_iceland/status/1504421007704170497/photo/1", "display_url": "pic.twitter.com/t6682Q1BDu", "media_key": "3_1504418819124649986"}, {"start": 280, "end": 303, "url": "https://t.co/t6682Q1BDu", "expanded_url": "https://twitter.com/uni_iceland/status/1504421007704170497/photo/1", "display_url": "pic.twitter.com/t6682Q1BDu", "media_key": "3_1504419183949451265"}], "annotations": [{"start": 0, "end": 25, "probability": 0.5227, "type": "Person", "normalized_text": "Sigur\u00f0ur Yngvi Kristinsson"}, {"start": 132, "end": 138, "probability": 0.4542, "type": "Other", "normalized_text": "iStopMM"}]}, "created_at": "2022-03-17T11:34:53.000Z", "author_id": "2769866904", "id": "1504421007704170497", "lang": "en", "conversation_id": "1504421007704170497", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1491789705188237314"], "text": "What were the key findings of the @iStopMM trial presented at #ASH21 this year? \ud83d\udcda Read this article for a summary  \ud83d\udc49 https://t.co/0u7iUP9OgC \ud83d\udc48\n#mmsm #myeloma @SigrunThorstei1 @sykristinsson https://t.co/7eMWfqnDcS", "entities": {"mentions": [{"start": 34, "end": 42, "username": "iStopMM", "id": "844232399319941122"}, {"start": 158, "end": 174, "username": "SigrunThorstei1", "id": "1198917648630919168"}, {"start": 175, "end": 189, "username": "sykristinsson", "id": "3078258341"}], "hashtags": [{"start": 62, "end": 68, "tag": "ASH21"}, {"start": 143, "end": 148, "tag": "mmsm"}, {"start": 149, "end": 157, "tag": "myeloma"}], "urls": [{"start": 117, "end": 140, "url": "https://t.co/0u7iUP9OgC", "expanded_url": "https://loom.ly/xrfUUGg", "display_url": "loom.ly/xrfUUGg", "status": 200, "unwound_url": "https://multiplemyelomahub.com/medical-information/the-iceland-screens-treats-or-prevents-multiple-myeloma-istopmm-study"}, {"start": 190, "end": 213, "url": "https://t.co/7eMWfqnDcS", "expanded_url": "https://twitter.com/MM_Hub/status/1491789705188237314/photo/1", "display_url": "pic.twitter.com/7eMWfqnDcS", "media_key": "3_1491789703384756237"}], "annotations": [{"start": 63, "end": 67, "probability": 0.6753, "type": "Other", "normalized_text": "ASH21"}, {"start": 150, "end": 156, "probability": 0.6584, "type": "Other", "normalized_text": "myeloma"}]}, "created_at": "2022-02-10T15:02:36.000Z", "author_id": "857866557778743296", "id": "1491789705188237314", "lang": "en", "conversation_id": "1491789705188237314", "source": "Loomly"}, {"edit_history_tweet_ids": ["1486651969028698119"], "text": "Brilliant myeloma talks @HT_Medical post ASH meeting from Reuben Benjamin and @BygraveCeri car-t optimumm Bellini Endurance and @iStopMM and Isa VRD", "entities": {"mentions": [{"start": 24, "end": 35, "username": "HT_Medical", "id": "731773088"}, {"start": 78, "end": 90, "username": "BygraveCeri", "id": "1060196754367356928"}, {"start": 128, "end": 136, "username": "iStopMM", "id": "844232399319941122"}], "annotations": [{"start": 10, "end": 16, "probability": 0.51, "type": "Other", "normalized_text": "myeloma"}, {"start": 58, "end": 72, "probability": 0.5106, "type": "Person", "normalized_text": "Reuben Benjamin"}, {"start": 106, "end": 112, "probability": 0.5401, "type": "Other", "normalized_text": "Bellini"}, {"start": 141, "end": 147, "probability": 0.5287, "type": "Other", "normalized_text": "Isa VRD"}]}, "created_at": "2022-01-27T10:47:04.000Z", "author_id": "1014890726818238465", "id": "1486651969028698119", "lang": "en", "conversation_id": "1486651969028698119", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1476244403291365379"], "text": "Prevalence of Smoldering Multiple Myeloma: Results from the iStopMM Study @iStopMM https://t.co/Na899FfnTy https://t.co/8zqhbeqlVP", "entities": {"mentions": [{"start": 74, "end": 82, "username": "iStopMM", "id": "844232399319941122"}], "urls": [{"start": 83, "end": 106, "url": "https://t.co/Na899FfnTy", "expanded_url": "https://www.myeloma.org/videos/prevalence-smoldering-multiple-myeloma-results-istopmm-study", "display_url": "myeloma.org/videos/prevale\u2026", "status": 200, "unwound_url": "https://www.myeloma.org/videos/prevalence-smoldering-multiple-myeloma-results-istopmm-study"}, {"start": 107, "end": 130, "url": "https://t.co/8zqhbeqlVP", "expanded_url": "https://twitter.com/IMFmyeloma/status/1476244403291365379/photo/1", "display_url": "pic.twitter.com/8zqhbeqlVP", "media_key": "3_1476244399256481797"}], "annotations": [{"start": 34, "end": 40, "probability": 0.4282, "type": "Other", "normalized_text": "Myeloma"}, {"start": 60, "end": 66, "probability": 0.8584, "type": "Other", "normalized_text": "iStopMM"}]}, "created_at": "2021-12-29T17:31:07.000Z", "author_id": "34340707", "id": "1476244403291365379", "lang": "en", "conversation_id": "1476244403291365379", "source": "Agorapulse app"}, {"edit_history_tweet_ids": ["1476253209056497670"], "text": "Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on iStopMM Study @iStopMM \nhttps://t.co/A64Bq8gzpD https://t.co/M721PtWnQz", "entities": {"mentions": [{"start": 156, "end": 164, "username": "iStopMM", "id": "844232399319941122"}], "urls": [{"start": 166, "end": 189, "url": "https://t.co/A64Bq8gzpD", "expanded_url": "https://www.myeloma.org/videos/defining-new-reference-intervals-serum-free-light-chains-individuals-reduced-kidney-function", "display_url": "myeloma.org/videos/definin\u2026", "status": 200, "unwound_url": "https://www.myeloma.org/videos/defining-new-reference-intervals-serum-free-light-chains-individuals-reduced-kidney-function"}, {"start": 190, "end": 213, "url": "https://t.co/M721PtWnQz", "expanded_url": "https://twitter.com/IMFmyeloma/status/1476253209056497670/photo/1", "display_url": "pic.twitter.com/M721PtWnQz", "media_key": "3_1476253205155696640"}], "annotations": [{"start": 142, "end": 148, "probability": 0.7354, "type": "Other", "normalized_text": "iStopMM"}]}, "created_at": "2021-12-29T18:06:07.000Z", "author_id": "34340707", "id": "1476253209056497670", "lang": "en", "conversation_id": "1476253209056497670", "source": "Agorapulse app"}, {"edit_history_tweet_ids": ["1475928479539597328"], "text": "We take the psychological aspects of screening very seriously in the @iStopMM study.\n\nWe checked mental health before screening, immediately after screening, and very regularly thereafter.\n\nIn fact we evaluate psychological health more frequently  than the M-spike :) https://t.co/fEI9U0UJnG https://t.co/snpuRcIOXs", "entities": {"mentions": [{"start": 69, "end": 77, "username": "iStopMM", "id": "844232399319941122"}], "urls": [{"start": 268, "end": 291, "url": "https://t.co/fEI9U0UJnG", "expanded_url": "https://twitter.com/sykristinsson/status/1475928479539597328/photo/1", "display_url": "pic.twitter.com/fEI9U0UJnG", "media_key": "3_1475927070777692161"}, {"start": 292, "end": 315, "url": "https://t.co/snpuRcIOXs", "expanded_url": "https://twitter.com/ManniMD1/status/1475861113547804672", "display_url": "twitter.com/ManniMD1/statu\u2026"}]}, "created_at": "2021-12-28T20:35:45.000Z", "author_id": "3078258341", "referenced_tweets": [{"type": "quoted", "id": "1475861113547804672"}], "id": "1475928479539597328", "lang": "en", "conversation_id": "1475928479539597328", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1474540470944501762"], "text": "So if you\u2019ve noticed that the new @iStopMM study from #ASH21 changed the kappa/lambda light chain thresholds for patients with renal insufficiency, here\u2019s the biological reasoning behind \u201cwhy\u201d!\n#mmsm https://t.co/rA3tFKIjNP https://t.co/AekpZoOxnA", "entities": {"mentions": [{"start": 34, "end": 42, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 54, "end": 60, "tag": "ASH21"}, {"start": 194, "end": 199, "tag": "mmsm"}], "urls": [{"start": 200, "end": 223, "url": "https://t.co/rA3tFKIjNP", "expanded_url": "https://twitter.com/ManniMD1/status/1474540470944501762/photo/1", "display_url": "pic.twitter.com/rA3tFKIjNP", "media_key": "3_1474540466490200067"}, {"start": 200, "end": 223, "url": "https://t.co/rA3tFKIjNP", "expanded_url": "https://twitter.com/ManniMD1/status/1474540470944501762/photo/1", "display_url": "pic.twitter.com/rA3tFKIjNP", "media_key": "3_1474540466486063116"}, {"start": 224, "end": 247, "url": "https://t.co/AekpZoOxnA", "expanded_url": "https://twitter.com/ManniMD1/status/1445507511717482506", "display_url": "twitter.com/ManniMD1/statu\u2026"}], "annotations": [{"start": 55, "end": 59, "probability": 0.8155, "type": "Other", "normalized_text": "ASH21"}, {"start": 195, "end": 198, "probability": 0.4983, "type": "Other", "normalized_text": "mmsm"}]}, "created_at": "2021-12-25T00:40:18.000Z", "author_id": "1269642863924609025", "referenced_tweets": [{"type": "quoted", "id": "1445507511717482506"}], "id": "1474540470944501762", "lang": "en", "conversation_id": "1474540470944501762", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1472652466172878856"], "text": "https://t.co/LOhwEA61MM https://t.co/QbgeTSn1Ur", "created_at": "2021-12-19T19:38:03.000Z", "author_id": "3078258341", "referenced_tweets": [{"type": "quoted", "id": "1472298659572334596"}], "id": "1472652466172878856", "lang": "zxx", "conversation_id": "1472652466172878856", "entities": {"urls": [{"start": 0, "end": 23, "url": "https://t.co/LOhwEA61MM", "expanded_url": "https://twitter.com/sykristinsson/status/1472652466172878856/photo/1", "display_url": "pic.twitter.com/LOhwEA61MM", "media_key": "16_1472652390612488194"}, {"start": 24, "end": 47, "url": "https://t.co/QbgeTSn1Ur", "expanded_url": "https://twitter.com/sykristinsson/status/1472298659572334596", "display_url": "twitter.com/sykristinsson/\u2026"}]}, "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1472332348175929345"], "text": "Tell everyone https://t.co/835nF6csvJ https://t.co/zyH7KrWThT", "created_at": "2021-12-18T22:26:01.000Z", "author_id": "4352079742", "referenced_tweets": [{"type": "quoted", "id": "1470125661457166340"}], "id": "1472332348175929345", "lang": "en", "conversation_id": "1472332348175929345", "entities": {"urls": [{"start": 14, "end": 37, "url": "https://t.co/835nF6csvJ", "expanded_url": "https://twitter.com/kaufman_MMdoc/status/1472332348175929345/photo/1", "display_url": "pic.twitter.com/835nF6csvJ", "media_key": "3_1472332344916946945"}, {"start": 38, "end": 61, "url": "https://t.co/zyH7KrWThT", "expanded_url": "https://twitter.com/iStopMM/status/1470125661457166340", "display_url": "twitter.com/iStopMM/status\u2026"}]}, "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1471127133485477888"], "text": "Myeloma\n1. New Light chain references in patients with renal dysfunction\nhttps://t.co/KpbZFjIySU\nRobust, large, population based data; Amazing work by the @iStopMM team", "entities": {"mentions": [{"start": 155, "end": 163, "username": "iStopMM", "id": "844232399319941122"}], "urls": [{"start": 73, "end": 96, "url": "https://t.co/KpbZFjIySU", "expanded_url": "https://doi.org/10.1182/blood-2021-153827", "display_url": "doi.org/10.1182/blood-\u2026", "unwound_url": "https://doi.org/10.1182/blood-2021-153827"}], "annotations": [{"start": 0, "end": 8, "probability": 0.7105, "type": "Other", "normalized_text": "Myeloma\n1"}, {"start": 97, "end": 102, "probability": 0.6674, "type": "Other", "normalized_text": "Robust"}]}, "in_reply_to_user_id": "1041722282", "created_at": "2021-12-15T14:36:55.000Z", "author_id": "1041722282", "referenced_tweets": [{"type": "replied_to", "id": "1471127131501604870"}], "id": "1471127133485477888", "lang": "en", "conversation_id": "1471127113432551433", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1470829030362562565"], "text": "@sykristinsson @iStopMM @andriclausen @SigrunThorstei1 @SaemundurMD @thorirlong @ThorvardurL @asdisrosa78 @jthorir @KjartanGauti Congratulations on your work!! Looking forward to more studies and data that will come from @iStopMM study and will help define #myeloma", "entities": {"mentions": [{"start": 0, "end": 14, "username": "sykristinsson", "id": "3078258341"}, {"start": 15, "end": 23, "username": "iStopMM", "id": "844232399319941122"}, {"start": 24, "end": 37, "username": "andriclausen", "id": "4501760296"}, {"start": 38, "end": 54, "username": "SigrunThorstei1", "id": "1198917648630919168"}, {"start": 55, "end": 67, "username": "SaemundurMD", "id": "1054784756704010241"}, {"start": 68, "end": 79, "username": "thorirlong", "id": "3009607268"}, {"start": 80, "end": 92, "username": "ThorvardurL", "id": "1199342830180651009"}, {"start": 93, "end": 105, "username": "asdisrosa78", "id": "3050942903"}, {"start": 106, "end": 114, "username": "jthorir", "id": "247118539"}, {"start": 115, "end": 128, "username": "KjartanGauti", "id": "1204778211265130498"}, {"start": 221, "end": 229, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 257, "end": 265, "tag": "myeloma"}], "annotations": [{"start": 258, "end": 264, "probability": 0.8321, "type": "Other", "normalized_text": "myeloma"}]}, "in_reply_to_user_id": "3078258341", "created_at": "2021-12-14T18:52:22.000Z", "author_id": "2809497047", "referenced_tweets": [{"type": "replied_to", "id": "1470801920201736195"}], "id": "1470829030362562565", "lang": "en", "conversation_id": "1470801920201736195", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1470801920201736195"], "text": "What a fantastic #ASH21 we in the @iStopMM team have had! Thank you all for the great feedback on our very first abstracts and all the encouragement!\n\nIt felt amazing!\n\nSee you in New Orleans 2022! https://t.co/9Z2enUplWq", "entities": {"mentions": [{"start": 34, "end": 42, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 17, "end": 23, "tag": "ASH21"}], "urls": [{"start": 198, "end": 221, "url": "https://t.co/9Z2enUplWq", "expanded_url": "https://twitter.com/sykristinsson/status/1470801920201736195/photo/1", "display_url": "pic.twitter.com/9Z2enUplWq", "media_key": "3_1470800870195531778"}], "annotations": [{"start": 18, "end": 22, "probability": 0.6273, "type": "Other", "normalized_text": "ASH21"}, {"start": 180, "end": 190, "probability": 0.9801, "type": "Place", "normalized_text": "New Orleans"}]}, "created_at": "2021-12-14T17:04:38.000Z", "author_id": "3078258341", "id": "1470801920201736195", "lang": "en", "conversation_id": "1470801920201736195", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1470453840734564361"], "text": "Very good review by Dr. Wendy Cozen of the data presented at #ASH21 during the \u201cASH Advanced COVID Research 2021\u201d around outcome of #COVID19 infection in hematology patients. Low/no increased risk in MGUS patients from \u2066@iStopMM\u2069 highlighted again. #mmsm https://t.co/tFdjKyLkQS", "entities": {"mentions": [{"start": 220, "end": 228, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 61, "end": 67, "tag": "ASH21"}, {"start": 132, "end": 140, "tag": "COVID19"}, {"start": 249, "end": 254, "tag": "mmsm"}], "urls": [{"start": 255, "end": 278, "url": "https://t.co/tFdjKyLkQS", "expanded_url": "https://twitter.com/AuclairDan/status/1470453840734564361/photo/1", "display_url": "pic.twitter.com/tFdjKyLkQS", "media_key": "3_1470453814025203716"}, {"start": 255, "end": 278, "url": "https://t.co/tFdjKyLkQS", "expanded_url": "https://twitter.com/AuclairDan/status/1470453840734564361/photo/1", "display_url": "pic.twitter.com/tFdjKyLkQS", "media_key": "3_1470453820027285511"}, {"start": 255, "end": 278, "url": "https://t.co/tFdjKyLkQS", "expanded_url": "https://twitter.com/AuclairDan/status/1470453840734564361/photo/1", "display_url": "pic.twitter.com/tFdjKyLkQS", "media_key": "3_1470453826423603203"}, {"start": 255, "end": 278, "url": "https://t.co/tFdjKyLkQS", "expanded_url": "https://twitter.com/AuclairDan/status/1470453840734564361/photo/1", "display_url": "pic.twitter.com/tFdjKyLkQS", "media_key": "3_1470453833285390337"}], "annotations": [{"start": 24, "end": 34, "probability": 0.539, "type": "Other", "normalized_text": "Wendy Cozen"}, {"start": 62, "end": 66, "probability": 0.7825, "type": "Other", "normalized_text": "ASH21"}, {"start": 80, "end": 111, "probability": 0.8547, "type": "Other", "normalized_text": "ASH Advanced COVID Research 2021"}, {"start": 133, "end": 139, "probability": 0.9724, "type": "Other", "normalized_text": "COVID19"}, {"start": 200, "end": 203, "probability": 0.4608, "type": "Other", "normalized_text": "MGUS"}, {"start": 246, "end": 249, "probability": 0.5264, "type": "Other", "normalized_text": "n. #"}]}, "created_at": "2021-12-13T18:01:29.000Z", "author_id": "817184467915853828", "id": "1470453840734564361", "lang": "en", "conversation_id": "1470453840734564361", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1470151722186121216"], "text": "Great presentation by the iStopMM group! Amazing work! #ASH21 @sykristinsson @iStopMM https://t.co/ZilGlNNvhu", "entities": {"mentions": [{"start": 62, "end": 76, "username": "sykristinsson", "id": "3078258341"}, {"start": 77, "end": 85, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 55, "end": 61, "tag": "ASH21"}], "urls": [{"start": 86, "end": 109, "url": "https://t.co/ZilGlNNvhu", "expanded_url": "https://twitter.com/vhugo8762/status/1470151722186121216/photo/1", "display_url": "pic.twitter.com/ZilGlNNvhu", "media_key": "3_1470151678380806144"}, {"start": 86, "end": 109, "url": "https://t.co/ZilGlNNvhu", "expanded_url": "https://twitter.com/vhugo8762/status/1470151722186121216/photo/1", "display_url": "pic.twitter.com/ZilGlNNvhu", "media_key": "3_1470151678363987971"}, {"start": 86, "end": 109, "url": "https://t.co/ZilGlNNvhu", "expanded_url": "https://twitter.com/vhugo8762/status/1470151722186121216/photo/1", "display_url": "pic.twitter.com/ZilGlNNvhu", "media_key": "3_1470151678372368385"}, {"start": 86, "end": 109, "url": "https://t.co/ZilGlNNvhu", "expanded_url": "https://twitter.com/vhugo8762/status/1470151722186121216/photo/1", "display_url": "pic.twitter.com/ZilGlNNvhu", "media_key": "3_1470151678372421632"}], "annotations": [{"start": 26, "end": 32, "probability": 0.7668, "type": "Other", "normalized_text": "iStopMM"}, {"start": 56, "end": 60, "probability": 0.5242, "type": "Other", "normalized_text": "ASH21"}]}, "created_at": "2021-12-12T22:00:59.000Z", "author_id": "114124641", "id": "1470151722186121216", "lang": "en", "conversation_id": "1470151722186121216", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1470152570740121602"], "text": "New suggested renal reference intervals for kappa and lambda FLC -&gt; updated prevalence of light chain MGUS in individuals with CKD @thorirlong @iStopMM #mmsm #ASH21 #ASH21_MSKMM https://t.co/5fFqeom9pB", "entities": {"mentions": [{"start": 134, "end": 145, "username": "thorirlong", "id": "3009607268"}, {"start": 146, "end": 154, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 155, "end": 160, "tag": "mmsm"}, {"start": 161, "end": 167, "tag": "ASH21"}, {"start": 168, "end": 180, "tag": "ASH21_MSKMM"}], "urls": [{"start": 181, "end": 204, "url": "https://t.co/5fFqeom9pB", "expanded_url": "https://twitter.com/MalinHultcrantz/status/1470152570740121602/photo/1", "display_url": "pic.twitter.com/5fFqeom9pB", "media_key": "3_1470152566898151425"}, {"start": 181, "end": 204, "url": "https://t.co/5fFqeom9pB", "expanded_url": "https://twitter.com/MalinHultcrantz/status/1470152570740121602/photo/1", "display_url": "pic.twitter.com/5fFqeom9pB", "media_key": "3_1470152566902337544"}, {"start": 181, "end": 204, "url": "https://t.co/5fFqeom9pB", "expanded_url": "https://twitter.com/MalinHultcrantz/status/1470152570740121602/photo/1", "display_url": "pic.twitter.com/5fFqeom9pB", "media_key": "3_1470152566902345730"}, {"start": 181, "end": 204, "url": "https://t.co/5fFqeom9pB", "expanded_url": "https://twitter.com/MalinHultcrantz/status/1470152570740121602/photo/1", "display_url": "pic.twitter.com/5fFqeom9pB", "media_key": "3_1470152566906535938"}], "annotations": [{"start": 105, "end": 108, "probability": 0.3577, "type": "Other", "normalized_text": "MGUS"}, {"start": 130, "end": 132, "probability": 0.3849, "type": "Organization", "normalized_text": "CKD"}]}, "created_at": "2021-12-12T22:04:21.000Z", "author_id": "212681144", "id": "1470152570740121602", "lang": "en", "conversation_id": "1470152570740121602", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1470127054288867328"], "text": "The highlight of ASh in many ways has been this iStopMM study! Congrats @sykristinsson #ASH21 https://t.co/nm2lPOzk1f", "entities": {"mentions": [{"start": 72, "end": 86, "username": "sykristinsson", "id": "3078258341"}], "hashtags": [{"start": 87, "end": 93, "tag": "ASH21"}], "urls": [{"start": 94, "end": 117, "url": "https://t.co/nm2lPOzk1f", "expanded_url": "https://twitter.com/iStopMM/status/1470125661457166340", "display_url": "twitter.com/iStopMM/status\u2026"}], "annotations": [{"start": 17, "end": 19, "probability": 0.6171, "type": "Other", "normalized_text": "ASh"}, {"start": 48, "end": 54, "probability": 0.8032, "type": "Other", "normalized_text": "iStopMM"}, {"start": 88, "end": 92, "probability": 0.4889, "type": "Other", "normalized_text": "ASH21"}]}, "created_at": "2021-12-12T20:22:58.000Z", "author_id": "114124641", "referenced_tweets": [{"type": "quoted", "id": "1470125661457166340"}], "id": "1470127054288867328", "lang": "en", "conversation_id": "1470127054288867328", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1470125661457166340"], "text": "@thorirlong explains free light chain (FLC) values in individuals with renal dysfunction. Based on &gt;75000 @iStopMM participants, of which &gt;70000 had s-creatinine values, he is proposing new reference ranges for people with renal failure @TheBindingSite @IMFmyeloma @sykristinsson https://t.co/TH8rJa3302", "entities": {"mentions": [{"start": 0, "end": 11, "username": "thorirlong", "id": "3009607268"}, {"start": 109, "end": 117, "username": "iStopMM", "id": "844232399319941122"}, {"start": 243, "end": 258, "username": "TheBindingSite", "id": "321436678"}, {"start": 259, "end": 270, "username": "IMFmyeloma", "id": "34340707"}, {"start": 271, "end": 285, "username": "sykristinsson", "id": "3078258341"}], "urls": [{"start": 286, "end": 309, "url": "https://t.co/TH8rJa3302", "expanded_url": "https://twitter.com/iStopMM/status/1470125661457166340/photo/1", "display_url": "pic.twitter.com/TH8rJa3302", "media_key": "3_1470123657838178306"}], "annotations": [{"start": 39, "end": 41, "probability": 0.3217, "type": "Other", "normalized_text": "FLC"}]}, "in_reply_to_user_id": "3009607268", "created_at": "2021-12-12T20:17:25.000Z", "author_id": "844232399319941122", "id": "1470125661457166340", "lang": "en", "conversation_id": "1470125661457166340", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1469741646224973827"], "text": "\u201cI will now tell you what happens when you screen a whole nation for #MGUS\u201d -@sykristinsson @iStopMM #ASH21 #mmsm https://t.co/hRTRrmIjtd", "entities": {"mentions": [{"start": 77, "end": 91, "username": "sykristinsson", "id": "3078258341"}, {"start": 92, "end": 100, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 69, "end": 74, "tag": "MGUS"}, {"start": 101, "end": 107, "tag": "ASH21"}, {"start": 108, "end": 113, "tag": "mmsm"}], "urls": [{"start": 114, "end": 137, "url": "https://t.co/hRTRrmIjtd", "expanded_url": "https://twitter.com/SaemundurMD/status/1469741646224973827/photo/1", "display_url": "pic.twitter.com/hRTRrmIjtd", "media_key": "3_1469741630760574988"}], "annotations": [{"start": 70, "end": 73, "probability": 0.3277, "type": "Organization", "normalized_text": "MGUS"}]}, "created_at": "2021-12-11T18:51:29.000Z", "author_id": "1054784756704010241", "id": "1469741646224973827", "lang": "en", "conversation_id": "1469741646224973827", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1470108775952572421"], "text": "In an individual with kidney failure and GFR=35 mL/min/1.73 m2 what would you consider normal free light chain ratio (FLC)? \n\n@IMFmyeloma @TheBindingSite @iStopMM @thorirlong @VincentRK @mtmdphd  \n\nhttps://t.co/os5Dq40P3H", "entities": {"mentions": [{"start": 126, "end": 137, "username": "IMFmyeloma", "id": "34340707"}, {"start": 138, "end": 153, "username": "TheBindingSite", "id": "321436678"}, {"start": 154, "end": 162, "username": "iStopMM", "id": "844232399319941122"}, {"start": 163, "end": 174, "username": "thorirlong", "id": "3009607268"}, {"start": 175, "end": 185, "username": "VincentRK", "id": "24261916"}, {"start": 186, "end": 194, "username": "mtmdphd", "id": "190337035"}], "urls": [{"start": 198, "end": 221, "url": "https://t.co/os5Dq40P3H", "expanded_url": "https://ash.confex.com/ash/2021/webprogram/Paper153827.html", "display_url": "ash.confex.com/ash/2021/webpr\u2026", "status": 200, "title": "Paper: Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on Iceland Screens Treats or Prevents Multiple Myeloma (iStopMM) Study", "description": "Program: Oral and Poster Abstracts Type: Oral Session: 652. Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological: Reoptimizing Standards and Redefining Approaches Hematology Disease Topics & Pathways: Adults, Workforce, Plasma Cell Disorders, Diversity, Equity, Inclusion, and Accessibility (DEI/DEIA) , Diseases, Real World Evidence, Lymphoid Malignancies, Study Population Thorir Einarsson Long, MD, PhD 1,2 *, Olafur Skuli Indridason, MD, MHS 3 *, Runolfur Palsson, MD 4,5 *, S\u00e6mundur", "unwound_url": "https://ash.confex.com/ash/2021/webprogram/Paper153827.html"}]}, "created_at": "2021-12-12T19:10:20.000Z", "author_id": "3078258341", "id": "1470108775952572421", "lang": "en", "conversation_id": "1470108775952572421", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1469736192627429390"], "text": "Key finding from #ASH21: active screening and testing of MGUS increases the diagnosis of malignant gammopathies.\n\nKey finding from #ASH31: does this increase overall survival?\n\n@sykristinsson and the @iStopMM will give us the answer. Huge congratulations!\n#mmsm https://t.co/m5xt61q1a1", "entities": {"mentions": [{"start": 177, "end": 191, "username": "sykristinsson", "id": "3078258341"}, {"start": 200, "end": 208, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 17, "end": 23, "tag": "ASH21"}, {"start": 131, "end": 137, "tag": "ASH31"}, {"start": 256, "end": 261, "tag": "mmsm"}], "urls": [{"start": 262, "end": 285, "url": "https://t.co/m5xt61q1a1", "expanded_url": "https://twitter.com/BrunoPaiva_UNAV/status/1469736192627429390/photo/1", "display_url": "pic.twitter.com/m5xt61q1a1", "media_key": "3_1469736034749591552"}], "annotations": [{"start": 18, "end": 22, "probability": 0.6298, "type": "Other", "normalized_text": "ASH21"}, {"start": 57, "end": 60, "probability": 0.4565, "type": "Other", "normalized_text": "MGUS"}, {"start": 132, "end": 136, "probability": 0.6183, "type": "Other", "normalized_text": "ASH31"}, {"start": 257, "end": 260, "probability": 0.4633, "type": "Other", "normalized_text": "mmsm"}]}, "created_at": "2021-12-11T18:29:49.000Z", "author_id": "1335161063382376448", "id": "1469736192627429390", "lang": "en", "conversation_id": "1469736192627429390", "source": "Twitter Web App"}, {"edit_history_tweet_ids": ["1469746149015920650"], "text": "Finally, in the last @iStopMM presentation today at #ASH21 , in the RCT portion it was shown that active monitoring identified significantly higher portion of individual with smoldering and active disease, laying a path toward early screening #mmsm https://t.co/YlJ4LluhWU https://t.co/G2MdlAeJfL", "entities": {"mentions": [{"start": 21, "end": 29, "username": "iStopMM", "id": "844232399319941122"}], "hashtags": [{"start": 52, "end": 58, "tag": "ASH21"}, {"start": 243, "end": 248, "tag": "mmsm"}], "urls": [{"start": 249, "end": 272, "url": "https://t.co/YlJ4LluhWU", "expanded_url": "https://twitter.com/AuclairDan/status/1469746149015920650/photo/1", "display_url": "pic.twitter.com/YlJ4LluhWU", "media_key": "3_1469746144213405699"}, {"start": 249, "end": 272, "url": "https://t.co/YlJ4LluhWU", "expanded_url": "https://twitter.com/AuclairDan/status/1469746149015920650/photo/1", "display_url": "pic.twitter.com/YlJ4LluhWU", "media_key": "3_1469746144230232064"}, {"start": 249, "end": 272, "url": "https://t.co/YlJ4LluhWU", "expanded_url": "https://twitter.com/AuclairDan/status/1469746149015920650/photo/1", "display_url": "pic.twitter.com/YlJ4LluhWU", "media_key": "3_1469746144255299596"}, {"start": 249, "end": 272, "url": "https://t.co/YlJ4LluhWU", "expanded_url": "https://twitter.com/AuclairDan/status/1469746149015920650/photo/1", "display_url": "pic.twitter.com/YlJ4LluhWU", "media_key": "3_1469746144242806790"}, {"start": 273, "end": 296, "url": "https://t.co/G2MdlAeJfL", "expanded_url": "https://twitter.com/AuclairDan/status/1469742222010691584", "display_url": "twitter.com/AuclairDan/sta\u2026"}], "annotations": [{"start": 53, "end": 57, "probability": 0.6893, "type": "Other", "normalized_text": "ASH21"}, {"start": 68, "end": 70, "probability": 0.4905, "type": "Other", "normalized_text": "RCT"}, {"start": 244, "end": 247, "probability": 0.4997, "type": "Other", "normalized_text": "mmsm"}]}, "created_at": "2021-12-11T19:09:23.000Z", "author_id": "817184467915853828", "referenced_tweets": [{"type": "quoted", "id": "1469742222010691584"}], "id": "1469746149015920650", "lang": "en", "conversation_id": "1469746149015920650", "source": "Twitter for iPhone"}, {"edit_history_tweet_ids": ["1469747824195780613"], "text": "@FrancescoMaura4 @iStopMM @DrOlaLandgren @DrGarethMorgan1 I belive I said that you detect more cases by screening BUT we advice against systematic MGUS screening until final data from @iStopMM are out :) https://t.co/DnLWrT42wU", "entities": {"mentions": [{"start": 0, "end": 16, "username": "FrancescoMaura4", "id": "1158556316576751617"}, {"start": 17, "end": 25, "username": "iStopMM", "id": "844232399319941122"}, {"start": 26, "end": 40, "username": "DrOlaLandgren", "id": "2257190339"}, {"start": 41, "end": 57, "username": "DrGarethMorgan1", "id": "1119004052476633088"}, {"start": 184, "end": 192, "username": "iStopMM", "id": "844232399319941122"}], "urls": [{"start": 204, "end": 227, "url": "https://t.co/DnLWrT42wU", "expanded_url": "https://twitter.com/sykristinsson/status/1469747824195780613/photo/1", "display_url": "pic.twitter.com/DnLWrT42wU", "media_key": "3_1469747821008105475"}], "annotations": [{"start": 147, "end": 150, "probability": 0.5539, "type": "Other", "normalized_text": "MGUS"}]}, "in_reply_to_user_id": "1158556316576751617", "created_at": "2021-12-11T19:16:02.000Z", "author_id": "3078258341", "referenced_tweets": [{"type": "replied_to", "id": "1469735636290707457"}], "id": "1469747824195780613", "lang": "en", "conversation_id": "1469735636290707457", "source": "Twitter for Android"}, {"edit_history_tweet_ids": ["1468930957784846336"], "text": "@Bethfaiman @sykristinsson @End_myeloma @myelomaMD @IMFjimMYELOMA @khouri_jack @JasonValent1 @Amyloid_Planet Great selections!  The Epi  Sessions feature many @iStopMM abstracts to watch. #ASH21 #mmsm #myeloma \n@ADispenzieri @_DrCP moderators\nhttps://t.co/u9So6LDzNm #ASH21\n@DrOlaLandgren @JuanDU_DUJuan moderators\nhttps://t.co/1xYI1df6VA #ASH21", "entities": {"mentions": [{"start": 0, "end": 11, "username": "Bethfaiman", "id": "2475877106"}, {"start": 12, "end": 26, "username": "sykristinsson", "id": "3078258341"}, {"start": 27, "end": 39, "username": "End_myeloma", "id": "2538011298"}, {"start": 40, "end": 50, "username": "myelomaMD", "id": "301568235"}, {"start": 51, "end": 65, "username": "IMFjimMYELOMA", "id": "2857731232"}, {"start": 66, "end": 78, "username": "khouri_jack", "id": "1000352595708383232"}, {"start": 79, "end": 92, "username": "JasonValent1", "id": "1329256305492692994"}, {"start": 93, "end": 108, "username": "Amyloid_Planet", "id": "1138405094"}, {"start": 159, "end": 167, "username": "iStopMM", "id": "844232399319941122"}, {"start": 211, "end": 224, "username": "ADispenzieri", "id": "2172483547"}, {"start": 225, "end": 231, "username": "_DrCP", "id": "1004730606"}, {"start": 274, "end": 288, "username": "DrOlaLandgren", "id": "2257190339"}, {"start": 289, "end": 303, "username": "JuanDU_DUJuan", "id": "1191849880773246976"}], "hashtags": [{"start": 188, "end": 194, "tag": "ASH21"}, {"start": 195, "end": 200, "tag": "mmsm"}, {"start": 201, "end": 209, "tag": "myeloma"}, {"start": 267, "end": 273, "tag": "ASH21"}, {"start": 339, "end": 345, "tag": "ASH21"}], "urls": [{"start": 243, "end": 266, "url": "https://t.co/u9So6LDzNm", "expanded_url": "https://ativsoftware.com/appinfo.php?page=Session&project=ASH21&server=eventpilot.us&id=20946", "display_url": "ativsoftware.com/appinfo.php?pa\u2026", "unwound_url": "https://ativsoftware.com/appinfo.php?page=Session&project=ASH21&server=eventpilot.us&id=20946"}, {"start": 315, "end": 338, "url": "https://t.co/1xYI1df6VA", "expanded_url": "https://ativsoftware.com/appinfo.php?page=Session&project=ASH21&server=eventpilot.us&id=20947", "display_url": "ativsoftware.com/appinfo.php?pa\u2026", "unwound_url": "https://ativsoftware.com/appinfo.php?page=Session&project=ASH21&server=eventpilot.us&id=20947"}], "annotations": [{"start": 132, "end": 144, "probability": 0.6277, "type": "Other", "normalized_text": "Epi  Sessions"}, {"start": 202, "end": 208, "probability": 0.6339, "type": "Other", "normalized_text": "myeloma"}]}, "in_reply_to_user_id": "2475877106", "created_at": "2021-12-09T13:10:06.000Z", "author_id": "961398000", "referenced_tweets": [{"type": "replied_to", "id": "1468900717817741315"}], "id": "1468930957784846336", "lang": "en", "conversation_id": "1468900717817741315", "source": "Twitter for iPad"}, {"edit_history_tweet_ids": ["1468900717817741315"], "text": "My clinically relevant #pcd #ASH2021. #iStopMM #151,156+542; #821-posttx w/ #bispecifics in RRMM; #79 GRIFFIN, #84 BELLINI, #481 MASTER #2724 CAEL #amyloidosis @sykristinsson @End_myeloma @myelomaMD @IMFjimMYELOMA @IMFnurseMyeloma @khouri_jack @JasonValent1 @Amyloid_Planet #mmsm", "entities": {"mentions": [{"start": 160, "end": 174, "username": "sykristinsson", "id": "3078258341"}, {"start": 175, "end": 187, "username": "End_myeloma", "id": "2538011298"}, {"start": 188, "end": 198, "username": "myelomaMD", "id": "301568235"}, {"start": 199, "end": 213, "username": "IMFjimMYELOMA", "id": "2857731232"}, {"start": 214, "end": 230, "username": "IMFnurseMyeloma", "id": "961398000"}, {"start": 231, "end": 243, "username": "khouri_jack", "id": "1000352595708383232"}, {"start": 244, "end": 257, "username": "JasonValent1", "id": "1329256305492692994"}, {"start": 258, "end": 273, "username": "Amyloid_Planet", "id": "1138405094"}], "hashtags": [{"start": 23, "end": 27, "tag": "pcd"}, {"start": 28, "end": 36, "tag": "ASH2021"}, {"start": 38, "end": 46, "tag": "iStopMM"}, {"start": 76, "end": 88, "tag": "bispecifics"}, {"start": 147, "end": 159, "tag": "amyloidosis"}, {"start": 274, "end": 279, "tag": "mmsm"}], "annotations": [{"start": 29, "end": 35, "probability": 0.4987, "type": "Other", "normalized_text": "ASH2021"}, {"start": 39, "end": 45, "probability": 0.7748, "type": "Other", "normalized_text": "iStopMM"}, {"start": 66, "end": 71, "probability": 0.5312, "type": "Other", "normalized_text": "posttx"}, {"start": 92, "end": 95, "probability": 0.4837, "type": "Other", "normalized_text": "RRMM"}, {"start": 102, "end": 108, "probability": 0.5, "type": "Other", "normalized_text": "GRIFFIN"}, {"start": 115, "end": 121, "probability": 0.7385, "type": "Other", "normalized_text": "BELLINI"}, {"start": 142, "end": 145, "probability": 0.5018, "type": "Other", "normalized_text": "CAEL"}, {"start": 148, "end": 158, "probability": 0.6762, "type": "Other", "normalized_text": "amyloidosis"}]}, "created_at": "2021-12-09T11:09:56.000Z", "author_id": "2475877106", "id": "1468900717817741315", "lang": "en", "conversation_id": "1468900717817741315", "source": "Twitter for iPhone"}]}, "meta": {"next_token": "7140dibdnow9c7btw3z3b491etb7a3tr0p2r2m5ppx8hh", "result_count": 100, "newest_id": "1600967720123584512", "oldest_id": "1469039890813890565"}, "neighbors": ["3078258341", "844232399319941122", "34340707", "24261916", "1054784756704010241", "321436678"]}